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ABSTRACT 
  
 The Tremethick laboratory in 2012 discovered a new mouse histone variant, which 
was designated H2A.Lap1 (Lack of an acidic patch), which, in the adult, is uniquely 
expressed in the testis and the brain. It was proposed that in the testis, H2A.Lap1 is 
involved in a new mechanism of gene regulation whereby H2A.Lap1 co-ordinately 
activates the expression of many genes by being targeted to and directly opening the 
chromatin region encompassing their transcription start site (TSS). More recently, this 
laboratory also identified H2A.Lap1 as a component of the intron-exon boundary of 
active genes expressed in the testis and the brain. These observations suggested a role in 
transcription and splicing but all the experiments to date have been correlative in nature. 
Therefore, the major aim of this thesis was to generate an in vivo mouse knockout model 
in order to directly test the importance of H2A.Lap1.  
 However, the generation of a H2A.Lap1 knockout (KO) mouse was potentially a 
technically challenging feat because the H2A.Lap1 protein is expressed from three 
different genes (all located on the X chromosome). In this thesis, we report a simplified 
TALEN approach that achieved this goal whereby we used one pair of TALENs to 
simultaneously disrupt the three gene copies of H2A.Lap1. To our knowledge, this has 
not been done before. Importantly, bioinformatics analyses and wet-lab validation on 
exome sequencing data of our KO mice did not reveal any TALEN-induced off-target 
mutations, proving the reliability of this genome editing approach in generating a 
H2A.Lap1-specific KO model. 
 Since H2A.Lap1 is predominantly expressed in the testis, we first explored 
whether are H2A.Lap1 KO mice are fertile. Our results showed that the loss of 
H2A.Lap1 caused a mild subfertility phenotype that manifested itself in smaller litter 
sizes when the hemizygous KO males (H2A.Lap1 -/Y) were mated with wild type females 
(H2A.Lap1 +/+). Given that these hemizygous KO mice are still able to reproduce despite 
the absence of H2A.Lap1 suggested that H2A.Lap1 is important but not essential for 
fertility. Alternatively though, H2A.Lap1 may be critical but compensatory epigenetic 
mechanisms may come into play in its absence.   
 To test this hypothesis, I examined the immunofluorescence distribution of several 
active promoter-associated histone post translational modifications (PTMs) in germ 
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cells, as well as investigating another H2A.Lap1 like histone variant, H2A.L.2 
(expressed at latter spermatogenesis stages compared to H2A.Lap1) in H2A.Lap1 -/Y 
mice and their wt siblings. The immunostaining analyses showed that, in comparison to 
the wt mice, H3K4me3 become more enriched in the euchromatin of round spermatids 
of KO mice, implying a possible involvement of this PTM in a compensation 
mechanism. In addition, and most interestingly, H2A.L.2 changed its timing of 
expression being expressed earlier in the round spermatid stage thus also possibly 
compensating for the loss of H2A.Lap1.  
Another striking observation in this thesis is that, in the absence of H2A.Lap1, 
the nuclei of round spermatids become significantly compacted consistent with its in 
vitro ability to decompact chromatin. Further, the nuclei of round spermatids in KO 
males showed RNA Polymerase II (RNA Pol II) no longer occupies microscopically 
distinct transcription hubs. Significantly, RNA-Seq data revealed an increase in intron 
retention in the absence of H2A.Lap1. Therefore, despite possible compensatory 
mechanisms, clear changes to the functional organisation of the nucleus and splicing are 
observed. 
During meiosis, sex chromosome becomes highly condensed and silenced to 
ensure that there is no recombination between the X and Y chromosomes. This 
inactivation continues post-meiotically, which is referred to post meiotic sex 
chromosome (PMSC). However, as early round spermatids (ERS) develop into late 
round spermatids (LRS), approximately 20 % of X-chromosome genes required for 
spermiogenesis become activated. In the absence of H2A.Lap1, the expression of several 
X-linked genes (as well as examined autosomal genes) is significantly reduced.  
Another interesting observation arising from the immunostaining of active and 
repressive marks are the dynamic epigenetic changes between ERS and LRS, which has 
not been observed before. The repressive mark H3K9me3 becomes more enriched in 
LRS on PMSC which coincides with a depletion in the active marks H4K8Ac and Kcr. 
At euchromatin, we also observed other active marks (H3K36me3 and H3K4me3) 
become depleted in LRS in wt mice. This reduction of active marks as round spermatids 
differentiate suggests that these cells are preparing for a global transcription shut down, 
which occurs in subsequent developmental stages. 
Finally, we examined a possibly phagocytic role for H2A.Lap1 in Sertoli cells. 
Microscopic analysis of seminiferous tubules of the testes showed that the KO mice have 
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an increased number of clogged tubules indicating an inefficient clearance of residual 
bodies (RBs) by Sertoli cells, which could also explain why H2A.Lap1 KO mice are 
subfertile.  
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CHAPTER 1 
INTRODUCTION 
 
 
1.1 Epigenetics and chromatin  
In 1942, C.H. Waddington introduced the term ‘epigenetics’, which he defined 
as changes in phenotype without changes in genotype. Today, epigenetics is defined as 
a number of mechanisms that ensure the inheritance of patterns gene expression 
without changes occurring in the corresponding DNA sequence. Epigenetic-based 
mechanisms influence the structure and compaction of chromatin, a complex of DNA, 
histones and many other associated proteins. Chromatin serves as a reversible structure 
for complex gene regulation and governs diverse processes including gene 
transcription, DNA replication, and DNA repair. 
The fundamental unit of chromatin is the nucleosome, consisting on average, 
of 147 bp of DNA wound approximately 1.6 turns around a histone octamer, which 
contains one H3–H4 tetramer and two H2A–H2B dimers (Figure 1-1 A) (Luger et al. 
1997). The linker histone consists of a winged helix motif flanked by N- and C- 
terminal tails. It binds to linker DNA that connects adjacent nucleosomes and is 
responsible for the higher order folding into a 30-nm chromatin fibre. Significantly, the 
structure of a histone H1-bound nucleosome was recently solved (Bednar et al. 2017) 
(Figure 1-1). Each of the core histones is composed of a structured globular domain 
and unstructured N- and C-terminal tails. A striking feature of histones is that their 
unstructured tails can be post-translationally modified. Different types of modifications 
such as acetylation, phosphorylation methylation, ubiquitylation, and sumoylation 
among others influence the charge and the repertoire of chromatin binding proteins, 
thus changing the structure and function of a nucleosome (Grant 2001). 
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Figure 1-1: Schematic diagram of chromatin. A) The breakdown unit of 
chromatin, which is a nucleosome. B) Crystal structure of nucleosome.  
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The states of chromatin compaction can be simplistically categorized as active 
euchromatin (EC) (‘open’ state) and inactive heterochromatin (HC) (‘closed’ state) 
with each of these states marked by a distinct epigenetic modification (Kouzarides 
2007; Woodcock & Ghosh 2010). Euchromatin, or ‘active’ state, consists primarily of 
coding and regulatory sequences (e.g., enhancers and promoters), which only account 
for a small fraction (less than 4%) of the genome, in mammals (Allis et al. 2007). 
Heterochromatin tends to be located at the nuclear periphery, where specific 
interactions with the envelope may occur. It often forms blocks surrounding the 
nucleolus and is usually associated with repression of transcription. Heterochromatin 
may be further classified as constitutive or facultative. Constitutive heterochromatin 
typically remains condensed throughout the cell cycle and tends to be enriched in 
repetitive, gene-poor and late replicating DNA sequences. Examples of constitutive 
heterochromatin are telomeric, centromeric and pericentromeric regions. In contrast, 
facultative heterochromatin can undergo reversible transition from a more open 
transcriptionally active state to a compact, transcriptionally inactive state, as occurs 
during differentiation (Bell et al. 2011; Woodcock & Ghosh 2010). 
  Berger et al. (2009) stated that there are three categories of signals that 
culminate in the establishment of a given heritable epigenetic state of chromatin. 
Firstly, the "Epigenator", which originates from changes in the environment of the cell 
(e.g., temperature) and triggers an intracellular pathway (either protein-protein or 
modification-based). The signal is short-lived, but sufficient for the epigenetic 
phenotype to occur. Secondly, the Epigenetic Initiator signal which responds to the 
Epigenator and is necessary to define the precise location of the epigenetic chromatin 
environment (e.g., a DNA-binding protein, non-coding RNA (ncRNA) or any 
molecule(s) that can define the coordinates of chromatin to be assembled). It should be 
able to self-reintroduce and self-renew through positive feedback mechanisms. Thirdly, 
the Epigenetic Maintainer signal which sustains the chromatin environment throughout 
the generations by a variety of different epigenetic processes as outlined below (Berger 
et al. 2009). 
The complexity of higher organisms is associated with the evolution of 
epigenetics to maintain stable gene expression throughout cell division. To date, a 
number of epigenetic machineries that maintain this stable and heritable state of 
genome expression have been identified. They include DNA modifications (e.g., 
methylation), post-translational modifications of histones, non-coding RNA, ATP-
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dependent remodelers, nucleosome positioning and histone variants (Berger et al. 
2009), which will be further discussed in the following section. 
 
1.2 DNA methylation and hydroxymethylation 
DNA methylation is an epigenetic mechanism that is widely studied in animals, 
plants and fungi (Feng et al. 2010). It occurs by the addition of a methyl (CH3) group 
at the carbon 5 of cytosine, resulting in 5-methylcytosine (5mC), and informally known 
as the "fifth base" of DNA. In mammals, methylation predominantly occurs at CG 
dinucleotides. CG dinucleotides are overall depleted in the mammalian genome except 
at short DNA sequences (on average 1 kb), termed ‘CpG' islands (which in mammals 
is globally depleted in methylation). CpG islands typically contain around 5-10 CpGs 
per 100 bp and often co-localise with gene promoters and regulatory regions (Auclair 
& Weber 2012; Jones 2012). The methyl groups of 5mC project into the major groove 
of DNA and thus can either inhibit transcription directly or indirectly by the recruitment 
of methyl DNA binding complexes (Guibert & Weber 2013; Rose & Klose 2014; 
Clouaire & Stancheva 2008). Gene silencing by DNA methylation is important in 
developmental processes such as cell differentiation, tumour suppression and 
reprogramming in plants and mammals (Feng et al. 2010). 
According to Song et al. (2016), 5-methylcytosine is generated by DNA 
methyltransferases (DNMTs) of which there are three conserved in mammals that 
regulate methylation. DNMT1 plays a role in the maintenance of DNA methylation and 
restoration of 5mC, after replication (Goll & Bestor 2005). DNMT3A and DNMT3B 
are de novo DNA methyltransferases and are essential during early development in 
mammals (Okano et al. 1999). DNMT1 is ubiquitously expressed in proliferating cells 
where it localises at replication foci and interacts with the proliferating cell nuclear 
antigen (PCNA) (Chuang et al. 1997; Leonhardt et al. 1992). Studies by Song et al. 
(2011) revealed that DNMT1 methylates hemi methylated cytosines at an initial rate 5- 
to 30-fold greater than unmethylated residues.  
Both DNMT3A and DNMT3B are responsible for de novo methylation in 
mammalian cells (Goll & Bestor 2005). Structural analyses revealed that DNMT1 and 
DNMT3 families have highly conserved C-5 methyltransferase motifs at their C 
termini but showed no similarity in N-terminal regions. In contrast to DNMT1, 
DNMT3A and DNMT3B are highly expressed in embryonic stem cells and during 
early embryo development but down-regulated in somatic tissues of postnatal animals 
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(Borgel et al. 2010; Okano et al. 1999). It has been shown by Chen et al. (2004) that 
the conserved PWWP domain of DNMT3A and DNMT3B, characterised by the 
presence of the highly conserved proline-tryptophan-tryptophan-proline motif, is 
involved in the functional specialisation of these enzymes. The disruption of this 
domain prevents their association with pericentric heterochromatin and abolishes their 
ability to methylate major satellite repeats (Chen et al. 2004). Double knockouts of 
DNMT3A and DNMT3B in ES cells have revealed a complete lack of de novo 
methylation activity which supports our understanding of their functional importance 
and redundancy in the process (Okano et al. 1999). 
Hydroxymethylation (5hmC) results from the conversion of 5mC to 5hmC by 
the ten-eleven translocation (TET) family of dioxygenases and is reported to be mostly 
enriched in ES cells (Stroud et al. 2011) and in the brain (Tahiliani et al. 2009; 
Kriaucionis & Heintz 2009; Khare et al. 2012). Analysis of chromosomal distribution 
in ES cells has shown that 5hmC is enriched at gene-rich genomic regions and in 
enhancers (Stroud et al. 2011). Further, 5hmC also has the tendency to localise at other 
protein-DNA binding sites, such as transcription factor binding sites (TFBs), and with 
the insulator binding protein, CTCF. 5hmC is also reported to be associated with GC-
skew, (where Gs residues are enriched over Cs residues at 5' ends and vice versa at 3 
ends) leading to the suggestion that sequence composition serves as a signal for the 
deposition of this epigenetic mark (Stroud et al. 2011). 
The most commonly used methods to study DNA methylation, such as 
methylation-sensitive restriction enzymes and sodium bisulphite treatment, cannot 
distinguish between 5mC and 5hmC (Gao & Das 2014). However, several 
chemical/enzymatic modifications to these methods in combination with bisulphite 
sequencing have made possible the base-resolution mapping of 5hmC and provided a 
more accurate picture of its global distribution (Kamdar et al. 2016; Song et al. 2016; 
Lister et al. 2013). For example, genome-wide sequencing following methyl-binding 
protein capture and hydroxymethyl-selective chemical labeling (hMeSeal-seq), 
conducted by Kamdar et al. (2016) on xenograft-derived prostate cancer cell lines, 
22Rv1, (in comparison with the normal prostate cell line, RWPE-1), has shown that 
5mC and 5hmC have different locus-specific distribution. The overall distribution of 
5mC and 5hmC marks, within each cell line, showed a peak increase in methylation 
and peak decrease in hydoxymethylation at promoter, exonic and DNAse I 
hypersensitive sites (DHS) in cancer. 
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The lack of significant intronic 5hmC differences between cell lines, coupled 
with the observation that in prostate cancer, intronic regions are the most likely to gain 
5hmC (Kamdar et al. 2016) suggests that intronic hydroxymethylation is both tightly 
regulated and potentially critical for basic cellular function (Kamdar et al. 2016). 
Similarly, the proportional gain of intergenic 5hmC and its status as the most likely 
feature to retain 5hmC in cancer may indicate either a lack of importance for intergenic 
5hmC marks or, conversely, a key regulatory function in oncogenic formation (Kamdar 
et al. 2016). 5hmC alterations are generally reported as being associated with various 
neurological disorders. This includes autism (5hmC enrichments are detected on autism 
related genes) (Wang et al. 2012; Khare et al. 2012; Zhubi et al. 2014); Rett syndrome 
(5hmC is globally decreased in the genome) (Szulwach et al. 2011); Angelman 
syndrome (5hmC is globally increased in the genome) (Szulwach et al. 2011); Fragile 
X syndrome (5hmC is enriched in FXS related genes) (Wang et al. 2012), Alzheimer’s 
disease (5hmC is increased or decreased in the genome) (Villar-Menéndez et al. 2013; 
Chouliaras et al. 2013; Condliffe et al. 2014; Coppieters et al. 2014; Bradley-Whitman 
& Lovell 2013); and Huntington’s disease (5hmC is globally decreased in the genome) 
(Wang et al. 2013). 
 
1.3 Post-translational modifications of histones (PTMs) 
A striking feature of histones, especially of their unstructured tails, is that they 
are extensively post-translationally modified (Grant 2001). The widely-reported 
modifications include acetylation (Sterner & Berger 2000), methylation (Zhang & 
Reinberg 2001), phosphorylation (Nowak & Corces 2004), ubiquitination (Shilatifard 
2006), sumoylation (Nathan et al. 2006), ADP-ribosylation (Hassa et al. 2006), 
deimination (Cuthbert et al. 2004; Wang et al. 2004)and proline isomerization (Nelson 
et al. 2006). Such chemical changes can be enzymatically added or removed. They 
regulate many aspects of an organism’s development including determination of a 
cell’s fate, differentiation, and, in many cases, disease onset (Pedersen & Helin 2010), 
by altering the chromatin architecture. Lysine is reportedly the most frequently 
modified amino acid residue and also contains the widest range of PTMs (Azevedo & 
Saiardi 2016). Lysine is a positively charged amino acid and has a similar structure to 
arginine. It contains a long flexible side-chain with three methyl groups and a primary 
positively charged ε-amino group. Arginine, on the other hand, has positively charged 
guanidinium groups. The primary reactive groups of the ε-amino group in lysine and 
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the guanidinium groups of arginine contribute to protein stability by forming ionic 
interactions and hydrogen bonds with proteins and DNA, in addition to acting as a 
general base in catalysis (Azevedo & Saiardi 2016; Patel et al. 2011). Although both 
lysine and arginine have side chains of similar reactivity, lysine is more prone to PTMs. 
The guanidinium group of arginine undergoes three-dimensional ionic interactions that 
allow arginine to drive protein folding and stability. Lysine polarity contributes to 
protein structure by way of its amine group that can form a single ionic interaction. 
Lysine residues are thus more flexible and more easily modified. This unusual chemical 
plasticity within the lysine residue eliminates steric hindrance and allows histone-
modifying enzymes, central to transcriptional regulation, to perform acetylation and 
methylation as well as subsequent deacetylation and demethylation (Patel et al. 2011). 
Over 100 different modification sites have been described to date on histones, 
and depending on the type of modification, they can function as docking sites for trans-
acting factors or influence the structural organization of chromatin and thus affect the 
accessibility of DNA (Rando & Chang 2009; Tan et al. 2011). PTMs of histones are 
essential for changing the dynamic state of chromatin in order to allow access of DNA 
binding complexes to the binding site. These dynamic changes include open/active 
states (associated with transcriptional activation) and closed/inactive states (associated 
with transcriptional repression). These modifications correlate with cellular processes 
such as transcription (Rando & Chang 2009). The elimination of histone-modifying 
enzymes can affect transcription rates, chromosome stability, and other chromosomal 
processes. Thus, mapping histone modifications has become an important way to 
characterize genome function and regulation (Rando & Chang 2009). 
PTMs are written by ‘writer’ enzymes, which serve as docking modules for 
proteins (usually as part of a complex) (‘readers’) that bind to the modification and are 
removed by ‘eraser’ enzymes (Pande 2016). One such modification that has been well 
characterised is histone methylation which is catalysed by lysine methyltransferase (the 
‘writer') and methylates lysine and arginine residues (Bannister & Kouzarides 2011). 
Examples of this include H3K36me3 and H3K4me3, both of which accumulate at the 
gene body and the TSS of actively transcribed genes and are commonly associated with 
transcriptional activation (Wozniak & Strahl 2014; Barski et al. 2007; Martin & Zhang 
2005). The ‘writer’ enzymes responsible for H3K36me3 and H4K4me3 are lysine N-
methyltransferase (SETD2) (Martin & Zhang 2005) and lysine methyltransferase 2 
(KMT2) (Eissenberg & Shilatifard 2010), respectively. Conversely, the demethylation 
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of these two sites is executed by lysine-specific demethylase 4A (KDM4A) (for 
H3K36me3) and lysine demethylase five families (KDM5) (for H3K4me3) (Kooistra 
& Helin 2012). The ‘reader' recognizes methylated histones, including PHD, chromo, 
WD40, Tudor, double/tandem Tudor, MBT, Ankyrin Repeats, zf-CW and PWWP 
(Yun et al. 2011). Li (2013) demonstrated the mechanism whereby H3K36me3 
interacts with the PWWP domain, in vivo and in vitro, by examining the regulation of 
human DNA mismatch repair (MMR) with MutSα. It was shown that the epigenetic 
mark H3K36me3 is required (in vivo) to recruit the mismatch recognition protein 
hMutSα onto chromatin, through direct interaction with the PWWP domain of hMutSα. 
The recruitment of hMutSα is cell cycle-dependent, such that H3k36me3 and the 
histone methyltransferase SETD2 are required for MMR, in vivo. The abundance of 
H3K36me3, in G1 and early S phase, ensures that hMutSα is enriched in chromatin 
before mis-pairs are introduced during DNA replication. They showed that cells with 
depleted SETD2 displayed microsatellite instability and elevated spontaneous mutation 
frequency, characteristics of MMR-deficient cells. Further, cells with depleted 
H3K36me3 fail to recruit hMutSα, and the restoration of H3K36me3 in SETD-depleted 
cells restored the localization of hMutSα to the chromatin, via its PWWP domain. 
Therefore, H3K36me3 and the PWWP domain regulate human MMR in vivo.  
Tan et al. (2011) recently identified histone crotonylation as another example 
of histone modification and a mechanism for epigenetic regulation. Lysine 
crotonylation (Kcr) marked active promoters and potentially enhancers in both mouse 
somatic and male germ cell genome (Tan et al. 2011). A report by (Li et al. 2016) 
showed that Kcr has high-affinity binding to AF9 YEATS domain via an extended 
aromatic sandwich pocket. Also, AF9 co-localises with crotonylation of H3 and 
positively regulates gene expression in YEATS domain-dependent manner. They 
proposed the YEATS domain as a family of a crotonyllysine readers and AF9 YEATS 
domain directly links Kcr to activate transcription.  
In addition to active transcription, PTMs have been widely linked to a silenced 
chromatin state.  A typical repressive histone mark is the trimethylation of lysine 9 and 
27 on histone H3 (H3K9me3 and H3K27me3) (Saksouk et al. 2015; Sienski et al. 
2012). H3K9me3 is usually enriched at constitutive heterochromatin, while 
H3K27me3 is enriched at facultative heterochromatin (Saksouk et al. 2015). The 
methylation of H3K9 relies on the action of H3K9-specific lysine methyltransferase, 
KMT1A/B (SUV39H1/2), which di- and tri-methylation occur specifically at 
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pericentric heterochromatin through direct interaction with chromodomain-containing 
protein (HP1) (Bannister et al. 2001). Meanwhile, the Polycomb repressive complex 2 
(PRC2) ensures trimethylation of H3K27 (Young et al. 2011). In ES cells, H3K27me3 
is enriched at the promoter region of the Polycomb group (PcG) protein associated 
genes, which includes the Hox genes as well as the inactive X chromosome (Boyer et 
al. 2006; Escamilla-Del-Arenal et al. 2013; Zhang et al. 2015). There is evidence that 
shows that in some instances a crosstalk through PRC2 is necessary for the coexistence 
of H3K9me3 and H3K27me3 in order for gene repression to occur (Boros et al. 2014; 
Cooper et al. 2014). For example, Boros et al. (2014) showed that binding of HP1α to 
H3K9me3 is significantly increased in the presence of H3K27me3 and that this is 
dependent on PRC2. In addition, they have shown that PRC2 is an indirect binder of 
H3K9me3. The knockdown of two PRC2 subunits, EZH2 and SUZ12, leads to the 
depletion of H3K27me3, a decrease in the total cellular level of HP1α and a slight 
reduction of H3K9me3. This is most likely due to a reduced ability to recruit 
SUV39H1/2 H3K9me methyltransferase to chromatin in response to HP1α loss. 
 
1.4 Non-coding RNA 
The developments in next-generation sequencing have increased our ability to 
sequence cDNA to an unprecedented scale. Transcriptome sequencing, such as RNA-
sequencing, coupled with computational analyses allowed researchers to obtain in-
depth sequence information that led to the identification and mapping of novel 
alternatively spliced transcripts and of non-coding transcripts. Protein coding genes 
account for approximately 1.5% of the genome, while more than 80% is transcribed 
into non-coding RNA (ncRNA) (Greco & Condorelli 2015). Non-coding RNA is 
classified according to its sequence length. There are two main categories that 
differentiate ncRNAs, small (< 200 bp) and long ncRNA (>200 bp). Small ncRNAs 
include microRNA (miRNA), piwi-interacting RNA (piRNA), and endogenous short-
interfering RNA (siRNA), while long ncRNAs (lncRNA) form a highly diverse class 
with less protein-coding potential (Wang & Chang 2011).  
Small ncRNAs impact gene regulation by acting as sequence-specific silencers of gene 
expression. They are cis-acting molecules that bind to mRNA, thus either interfering 
with its translational or inducing its degradation (reviewed by Collins et al. 2011). For 
instance, miRNA is perhaps the most well-known of the small regulatory ncRNA 
molecules. miRNAs are initially single-stranded RNA (ssRNAs) produced via 
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transcription or through splicing, which fold into stem-loop structures to form 
imperfect double-stranded RNA (dsRNA) molecules. These are then processed by 
RNase III endoribonuclease (generally Dicer) before being denatured. One of the RNA 
strands binds to the RNA-induced silencing complex (RISC), which later binds to a 
specific target of mRNA, containing a sequence complementary to the miRNA. The 
association induces either cleavage, degradation or blocks translation to protein 
(Collins et al. 2011). siRNAs, on the other hand, are produced as dsRNA and can enter 
the post-transcriptional gene-silencing (PTGS) pathway, which leads to mRNA 
degradation in the cytoplasm. Alternatively, siRNAs enter the transcriptional gene-
silencing (TGS) pathway, which involves chromatin modification. piRNAs and 
ssRNAs are produced in clusters and cleaved to individual mRNA by means of a yet 
unidentified processing mechanism(s) (Collins et al. 2011). 
Long non-coding RNAs (lncRNAs) are heterogeneous transcripts produced 
predominantly by RNA polymerase II. They are defined as RNA molecules of more 
than 200 bases in length with no protein-coding capacity (Aliperti & Donizetti 2016). 
lncRNA have been further categorized according to the anatomical properties of their 
gene loci. For instance, antisense lncRNA overlap with known protein-coding genes; 
intronic lncRNA are encoded within intronic regions of protein-coding genes; 
overlapping transcripts are those that overlap protein-coding genes; and lincRNA are 
encoded completely within the intergenic genomic space between protein-coding loci 
(Rinn & Chang 2012). In humans, estimates for the number of different types of 
lncRNA have ranged from 5,400 to 53,000, with only a small fraction being found at 
levels high enough to suggest evidence of functionality (Rinn & Chang 2012). The 
association of ncRNA with cellular development has been reported across many 
mammalian cell types and tissues, including human neuronal cells (Aliperti & Donizetti 
2016), mouse cardiomyocytes (Wang et al. 2014), human B-cells (Petri et al. 2015) and 
human keratinocytes (Kretz et al. 2012).  
One widely-cited function of lncRNA, specifically Xist and antisense transcript 
Tsix, is in X-chromosome inactivation (XCI) (Collins et al. 2011; Lee 2009). Xist is a 
17 kb RNA produced exclusively from the Xi (inactive X) and is thought to initiate 
chromosome-wide silencing as it accumulates and blankets the selected X 
chromosome, triggering extensive histone methylation as well as other chromatin 
changes (Collins et al. 2011; Lee 2009). Txis appears to restrict Xist activity on the 
active X chromosome, Xa, by two mechanisms: firstly Txis prevents the activation of 
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Xist allele in cis (even as cell differentiation signals trigger XCI on the selected X 
chromosome) by directing euchromatic modifications to the Xist locus; and secondly, 
Txis associates with Dnmt3a at the Xist promoter and facilitates de novo CpG 
methylation and stable silencing of active X chromosome Xist allele (Collins et al. 
2011; Lee 2009).  
In addition to gene silencing, lncRNA has been associated with regulation of 
the mitochondrial network (Wang et al. 2014). Specifically, a cardiac apoptosis-related 
lncRNA (CARL) was shown to suppress mitochondrial ﬁssion and apoptosis, by 
targeting miR-539 and PHB2. PHB2 is an oestrogen receptor (ER)-binding protein, 
which represses transcriptional activation and is negatively regulated by miR-539. 
CARL binds to miR-539 directly and participates in the regulation of mitochondrial 
network and apoptosis, through the miR-539/PHB2 pathway (Wang et al. 2014). One 
approach that has been used to predict lncRNA function was to co-express it with well-
characterized protein-coding genes (Petri et al. 2015). Co-expression alone may not be 
sufficient to assign a function to lncRNA, but the information obtained from 
embedding lncRNA in a transcriptional network associated with cellular development, 
provides a starting point for functional studies. To further determine the function of 
lncRNA, it will be necessary to perform knock out experiments (Palazzo & Lee 2015). 
 
1.5 Nucleosome positioning 
Before the era of genome-wide, next-generation sequencing, mapping of 
nucleosome occupancy through the whole genome was not feasible, and the question 
of whether nucleosomes are positioned randomly or at specific DNA sequences, 
remained an open question. In recent years, technologies like MNase-ChIP-seq, 
Hydroxyl-radical-seq and MNase exoII-seq have allowed us to map nucleosome 
positions to a base-pair resolution first in S. cerevisiae and then in D. melanogaster and 
to determine their influence(s) in gene regulation (Jiang & Pugh 2009). Given the large 
size of the mammalian genome, such base pair resolution has been challenging 
(Soboleva et al. 2014) 
According to Cui et al. (2014), nucleosome positioning is usually characterized 
by two parameters, "rotational positioning," which refers to the orientation of the DNA 
helix facing the nucleosome, and "translational positioning" of the nucleosome core 
particle along the DNA sequence i.e., which bp is at the central dyad (or midpoint) 
position of the core particle. Nucleosome positioning is a dynamic process, but 
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sequencing-based mapping approaches have been able to identify the positions of 
individual nucleosomes as a cell population average (Barski et al. 2007) and more 
recently in  single cells at a specific time (Struhl & Segal 2013).  
Genome-wide studies have provided a view of the nucleosome positions in a 
typical gene (Radman-Livaja & Rando 2010). Promoters and other functional regions, 
such as enhancers and replication origins, are depleted of nucleosomes relative to 
transcribed genes (Lieleg et al. 2015). These regions are known as "nucleosome-
depleted regions" (NDR) and are localized upstream of transcription start sites (TSS) 
(Radman-Livaja & Rando 2010). However, as shown by this laboratory, rather than 
being nucleosome depleted, NDRs may be occupied by unstable or fragile nucleosomes 
(Soboleva et al. 2014) 
Genome-wide mapping of the nucleosome has also provided insights into the 
organization of nucleosomes around protein-coding genes. The organization of 
nucleosomes is well documented in S.cerevisiae, which provides the clearest example 
of a consensus pattern of organization. The first predominant nucleosome located 
upstream of the TSS (designated   -1) covers a region from -300 to -150 (relative to the 
TSS) and can regulate the accessibility of the promoter in that region (Jiang & Pugh 
2009). During a transcription cycle, the -1 nucleosome experiences many changes that 
affect its stability, including histone replacement, acetylation, and methylation, as well 
as translational positioning and ultimately eviction after pre-initiation complex (PIC) 
formation to RNA polymerase II such as TFIID and SAGA. Further, in mammals, it 
has been reported that nucleosomes occupy exons more frequently than introns, 
providing that the exon has a higher guanine-cytosine (GC) content than its 
neighbouring introns. The nucleosomes positioned over exon sequences produce so-
called “speed bumps” that are believed to slow the rate of RNA pol II, promoting exon 
inclusion during pre-mRNA splicing. In addition to the -1 nucleosome, there exists a 
highly positioned nucleosome downstream of the TSS (the +1 nucleosome), which may 
also act as a barrier to the initial movement of RNA Pol II (Soboleva et al. 2014) 
Nucleosomes prevent gene expression from taking place by inhibiting the 
access of transcriptions factors that are recruited to bind to their DNA binding sites. 
However, some transcription factors are able to alter the nucleosome at a specific DNA 
location, i.e., near entry/exit point of a nucleosome, by transiently dissociating DNA 
from the octamer and exposing any underlying binding sites (Anderson & Widom 
2000). In fact, it was shown that there are five nucleosome positioning patterns found 
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in mouse C2C12 myoblast cells that appear around transcription factor binding sites 
which can be used to predict gene expression (Maehara & Ohkawa 2016).  This study 
also showed that the 5’ nucleosome positioning patterns act as functional units on 
chromatin and describe the transcriptional state of the transcription factors. This 
indicates that transcription factors are a major determinant of nucleosome positioning.   
Nucleosome positioning is strongly affected by DNA sequence (Struhl & Segal 
2013). There are two major sequences that determine nucleosome positioning. First, 
the intrinsic sequence property that refers to the variability of dinucleotide bending 
properties. Optimal nucleosome formation occurs when bendable nucleotides (AT and 
TA) occur on the face of the helix that directly interacts with histones (Struhl & Segal 
2013). Other than DNA sequence, nucleosome positioning is also determined by ATP-
dependent nucleosome remodelling enzymes. For instance, the combined action of 
nucleosome remodelling enzymes, ISW1 and CHD1 in yeast, are required to maintain 
the positioning of nucleosomes within the coding regions of eukaryotic genes and in 
alignment with transcriptional start sites (TSS) (Gkikopoulos et al. 2011).  In addition, 
a recent study also showed these two nucleosome spacing enzymes compete to set the 
spacing on most genes, such that CHD1 dominates genes with shorter spacing, and 
ISW1 dominates genes with longer spacing. In contrast, ISW2 (another yeast 
nucleosome enzyme) plays a minor role, limited to transcriptionally inactive genes 
(Ocampo et al. 2016).   
 
1.6 ATP remodelers 
ATP-dependent chromatin remodelling enzymes comprise a specialized class 
of enzymes involved in the epigenetic mechanisms that direct the compaction and 
decompaction of DNA in the nucleus (Runge et al. 2016; Kadoch & Crabtree 2015; 
Clapier & Cairns 2009). Remodelers are large multi-subunit complexes that contain an 
ATPase subunit that hydrolyses ATP to produce energy which is used to facilitate 
nucleosome sliding, to disrupt nucleosome conformation, for histone variant exchange 
(Latrick et al. 2016), and for promoter clearance on a genome-wide scale (Runge et al. 
2016). Remodelers bind to chromatin at enhancers, promoters and replication origins, 
to expose certain cis DNA elements in a regulated manner, thereby facilitating 
processes like transcription, DNA replication, DNA repair and DNA recombination 
(Clapier & Cairns 2009). Although some redundancy occurs, most remodelers are 
essential for cellular growth, development, or differentiation (Lans et al. 2012). 
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There are four major classes of remodelers, namely, i) Swi/Snf (switching 
defective/sucrose nonfermenting); ii) INO80 (inositol requiring 80); iii) CHD 
(chromodomain, helicase, DNA binding); and iv) ISW1 (imitation switch) (Clapier & 
Cairns 2009). They are considered derivatives of the SNF2 ATPase family which is 
evolutionarily conserved across eukaryotic organisms (all have a conserved ATPase 
domain), reflecting their conserved function and importance in gene regulation (Runge 
et al. 2016).  Swi/snf are well known remodelling complexes, composed of 8 to 14 
subunits (Clapier & Cairns 2009), and were initially identified in yeast (Winston & 
Carlson 1992). They are identiﬁed by their ability to activate transcription of the HO 
and SUC2 genes. Their mechanism of action, similar to many others that are regulated 
by this complex in yeast, involves binding in proximity to the promoter in order to 
assist the subsequent binding of speciﬁc transcription factors (Masliah-Planchon et al. 
2015). In mammals there are 15 subunits that make up the Swi/Snf complex. Among 
these subunits, only two ATPases, Brg1 or Brm, are sufficient to remodel nucleosomes 
in vitro (Phelan et al. 1999), while the others are likely providing specificity in vivo. In 
addition, there are reports suggesting that mutations in Swi/Snf subunits may contribute 
to various human malignancies, as evidenced by the high frequency of mutations, 
within genes encoding BAF subunit (mammalian Swi/Snf complex), occurring in 
>20% of human cancers (Kadoch & Crabtree 2015).  
 
1.7 Histone variants: Structure and versatility of function 
The DNA is packaged by an octamer of core histones, consisting of two H2A-H2B 
dimers and an H3-H4 tetramer (Figure 1.2) to form a 10-nm nucleosome as the primary 
component of chromatin. Histones are proteins comprising 100-140 amino acid long 
and structurally consist of 3 motifs: i) the histone fold, ii) the extra fold structured 
elements unique to the different histones, and iii) the labile termini, which vary from 
13 to 42 amino acids in length (Arents & Moudrianakis 1995; Luger et al. 1997). The 
10 nm polynucleosome arrays are folded and stabilized by linker H1 histones. As 
discussed above, histones are constantly modified, shifted, evicted and re-deposited as 
chromatin continues to remodel, in order to maintain proper organization and gene 
regulation (Marzluff et al. 2008). Major chromatin disruption requiring new histone 
synthesis also occurs during DNA/chromatin replication at S-phase. These continuous 
disassembly-reassembly of chromatin requires rapid transcription and translation of 
histone genes.  
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The core histone proteins are encoded by a family of replication-dependent genes. 
In eukaryotes, the mRNA of these genes is the only known cellular non-polyadenylated 
mRNA that has a unique 3' stem-loop (26 bp), crucial in modulating mRNA stability, 
transport, and translation. These mRNAs are rapidly expressed at the beginning of S 
phase and are maintained at high levels throughout the S phase to coincide with DNA 
replication (Marzluff et al. 2008).  
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Figure 1-2: Nucleosome core particle schematic diagram: half ribbon traces (73 
bp) of the 146-bp DNA phosphodiester backbones (brown and turquoise) and eight 
histone protein main chains (blue: H3; green: H4; yellow: H2A; red: H2B. Adapted 
from Luger et al. (1997). 
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Histone variants, unlike the core histones, are expressed and incorporated into 
chromatin throughout the cell cycle. The replication-independent gene and mRNA 
structure of histone variants also differ from core histones. The histone variant genes 
often contain introns, and the transcripts are often polyadenylated; features that are 
thought to be important in the post-transcriptional regulation (Kamakaka & Biggins 
2005).  The most prominent sequence divergence is found in H2A and H2B, with H2A 
having the most variants. In contrast, H4 has no reported variants, and H3 variants have 
only minimal sequence variations (Mattiroli et al. 2015).   
Histone variants have evolved to contribute to the complexity of chromatin and 
have specialized functions in regulating chromatin dynamics. Their sequence 
divergence can alter chromatin states and the fate of cell decisions (Weber & Henikoff 
2014). The role of histone variants in regulating transcription has been widely reported. 
It was initially understood that in order for transcription to take place, a nucleosome-
depleted region (NDR) must form at the TSS, to allow binding of transcription 
machinery. Based on experimental evidence, the accessibility of micrococcal nuclease 
supported this notion, however, this has been disputed upon finding that nucleosomes 
containing labile H2A variants flanked the NDR. Jin et al. (2009) used chromatin 
immunoprecipitation (ChIP) and re-ChIP, followed by high throughput Solexa 
sequencing on HeLa cells expressing Flag-tagged H3.3 histone to reveal that hybrids 
of H3.3-H2A.Z nucleosome core particle (NCP) localized to TSS of active genes. 
Subsequently, this laboratory has shown that heterotypic H2A.Z-H2A nucleosomes 
occupy the TSS in stem cells thus raising the possibility that H3.3-H2A.Z nucleosomes 
are in fact heterotypic with respect to H2A.Z (Nekrasov et al. 2012; Soboleva et al. 
2014). As mentioned above, we also found that H2A.Lap1-containing nucleosomes are 
found at the TSS of active genes in the testis (Soboleva et al. 2012; Soboleva et al. 
2014). These unstable nucleosomes may serve as a ‘place holder’ to prevent the region 
from being covered by adjacent stable NCP and/or nonspecific factors, when the region 
is nucleosome-free. Moreover, these fragile nucleosomes could be more easily 
displaced by transcription factors because of its instability (Jin et al. 2009). 
Histone variants have also been reported to participate in their own epigenetic 
inheritance, maintaining correct localization on newly synthesized daughter strands 
following DNA replication. For instance, during the cell cycle of mouse trophoblast 
stem cells, a decrease in the level of H2A.Z, at promoters, during S phase occurred. 
This coincided with the H2A.Z-H2A.Z nucleosome, flanking the TSS, becoming 
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heterotypic. This nucleosome persisted as heterotypic until M phase (Nekrasov et al. 
2012). The depleted expression of H2A.Z at promoter, after DNA replication, is 
possibly due to its redistribution to constitutive heterochromatin and/or at the 
centromere. This cell cycle-dependent possible dynamic movement of H2A.Z suggests 
its functional importance in providing transcriptional memory, that is, active marks 
established at the G1 phase and remaining at M phase may facilitate the reestablishment 
of gene transcription after cell division (Nekrasov et al. 2012). 
Histone variants have also been linked to the response to DNA damage, following 
exposure to gamma-radiation (Volle & Dalal 2014). H2A variants, γH2A.X. H2A.Z 
and macroH2A, specifically, have been implicated in this role. The various functions 
of histone variants in eukaryotes are briefly presented in Table 1. 
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Table 1-1: List of reported functions of histone variants in eukaryotic organisms 
(Yuan & Zhu 2012) 
Histone variants Function 
CENP-A or cenH3 Epigenetic marker of the centromere 
H3.3 Involved in transcription 
 Enriched at transcriptionally active regions, 
telomerase, and pericentric regions 
H3.Z  Regulation of cellular response to outside stimuli 
H3.Y Regulation of cellular response to outside stimuli 
H2A.Z Transcriptional control rheostat 
Heterochromatin formation and maintenance 
H2A.X Double strand break repair  
Meiotic remodelling of sex chromosome 
macroH2A Gene silencing 
X-chromosome inactivation 
H2A.Bbd/H2A.B or 
H2A.Lap1 
Epigenetic mark of active chromatin. Found at the 
TSS and intron-exon boundaries. 
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1.8 Histone H2A.Z variants: The structure and function  
H2A.Z is the most widely studied of the histone variants, with respect to 
structure and function (Chakravarthy et al. 2005; Sarma & Reinberg 2005; Yuan & Zhu 
2012; Suto et al. 2000). It is an essential histone found in all higher eukaryotes and 
there is approximately 90 % sequence homology between species (Suto et al. 2000; 
Chakravarthy et al. 2004; Yuan & Zhu 2012). The H2A.Z sequence differs by 
approximately 60 % from canonical H2A and the other H2A variants, mainly in its 
“docking” domain in the C-terminus and in the L1 loop where two H2A molecules 
contact each other at the back face of the nucleosome (Suto et al. 2000).  The docking 
domain of the H2A.Z histone variant contains several negatively charged amino acid 
residues that come together on the surface of the nucleosome to create an ‘acidic patch’ 
(Luger et al. 2012). The larger acidic patch of H2A.Z-H2B displays higher affinity with 
H4 N-terminal tail than that of the H2A-H2B dimer, resulting in the compaction of 
chromatin by facilitating intra-nucleosome-nucleosome interactions. Specifically, the 
acidic patch of a H2A.Z-containing nucleosome interacts better with the basic histone 
H4 tail originating from a neighbouring nucleosome thus driving intra-nucleosome 
interactions (Fan et al. 2004; Luger et al. 2012). Hence, DNA accessibility is 
suppressed and transcription is inhibited in vitro from a chromatin template that is 
enriched with H2A.Z to a greater extent than a H2A-containing chromatin template 
(Zhou et al. 2007) 
H2A.Z has been shown to be crucial in metazoan development, as the absence of 
this variant has been reported to be lethal to Tetrahymena thermophile (Liu et al. 1996), 
Drosophila (Clarkson et al. 1999) and in blastocysts of the mouse embryo (Faast et al. 
2001). Immunofluorescence staining of differentiating inner cell mass (ICM) in mice 
showed that H2A.Z is enriched at the pericentric heterochromatin, but absent from 
totipotent ICM. Interestingly, initially H2A.Z enrichment occurred at pericentric 
heterochromatin before shifting to other regions of the nucleus. This suggested a novel 
role for H2A.Z in providing a signal for the assembly of an architecturally distinct 
structure at pericentric heterochromatin (Rangasamy et al. 2003). Indeed, findings by 
Greaves et al. (2007) showed that H2A.Z has a major structural role in maintaining the 
integrity of pericentric heterochromatin in a variety of mammalian cell lines, as down 
regulation of H2A.Z impairs mitotic division and leads to chromosomal segregation, 
defects in cytokinesis and the loss of HP1α from pericentric heterochromatin (Greaves 
et al. 2007). In addition, H2A.Z in combination with either H3K9me3 or H3K4me2 
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contribute to the specialised 3-D organization of a centromere at metaphase (Greaves 
et al. 2007). H2A.Z also has a unique and specific role in assembling the X 
chromosome into a silenced heterochromatic state, following meiosis (Greaves et al. 
2006)  
In both yeast and mammals, H2A.Z has been shown to associate with 
transcription activation. Genome-wide chromatin immunoprecipitation (ChIP) showed 
that H2A.Z localizes primarily to the promoter region (Zhang et al. 2005; Barski et al. 
2007) Formaldehyde crosslinking followed by ChIP experiments on budding yeast S. 
cerevisiae showed that H2A.Z is enriched at intergenic regions upstream of PHO5 and 
GAL1, even under repressed conditions (Santisteban et al. 2000). Subsequent genome-
wide studies showed that H2A.Z is enriched at the promoter-proximal +1 and -1 
nucleosome (Albert et al. 2007). The presence of H2A.Z nucleosome surrounding most 
yeast promoters, in the absence of transcription, led to the proposal that H2A.Z-
containing nucleosomes helped poise genes for transcription (reviewed by Luk et al. 
2010).  
 Evidence is accumulating to associate H2A.Z with cancers, such as melanoma 
(Vardabasso et al. 2015), prostate (Baptista et al. 2013), bladder (Kim et al. 2013) and 
breast (Hua et al. 2008; Svotelis et al. 2010). It was observed by Svotelis et al. (2010) 
that H2A.Z mRNA is elevated in breast cancer biopsies. This correlates with increased 
levels of oestrogen receptor gene α (ERα) in low-grade breast tumours, and elevated 
levels of H2A.Z in high-grade tumours. ERα was shown to regulate H2A.Z in breast 
cancer by way of a positive feedback loop that appears important for ERα signalling 
under normal and pathological conditions. This study correlates elevation of H2A.Z 
expression with cellular proliferation, when E2 (ligand for oestrogen receptor) levels 
are low and during tamoxifen (drug used widely to treat breast cancer due to its capacity 
bind to ERα) treatment. H2A.Z therefore could be an important factor in the 
transformation of breast cancer cells and in the establishment of endocrine resistance, 
which is of major clinical importance in breast cancer treatment.  
 
1.8.1 H2A.Bbd (human) and the recently discovered mouse histone H2A.Lap1 
The importance of the acidic patch is exemplified by the fact that in addition to 
H2A.Z having an extended acid patch, the human histone variant H2A.Bbd and the 
mouse orthologue H2A.Lap1 (recently re-named H2A.B) have a reduced acidic patch 
(missing three acid amino acid residues). Not surprisingly then, H2A.Bbd nucleosome 
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arrays cannot compact and de-represses chromatin mediated repression in vitro (Zhou 
et al. 2007). Further, restoration of the acidic residues in H2A.Bbd was shown to restore 
the intranucleosomal interactions, needed for the folding of a nucleosomal array, and 
repression of transcription (Zhou et al. 2007). In addition, H2A.Bbd has a truncated C-
terminus/docking domain making this nucleosome highly unstable leading to 
unwrapping of the DNA from the octamer surface (Bao et al. 2004; Doyen et al. 2006). 
Specifically, this domain is responsible for the interaction with the N-terminus H3, 
which guides the DNA at the entry and exit points. Therefore, micrococcal nuclease 
digestion of H2A.Bbd-NCP (nucleosome core particle) revealed that only 118 ± 2 bp 
of DNA, compared with 145 bp for the wild type nucleotide, was protected (Bao et al. 
2004). 
H2A.Bbd was first discovered in humans and shown to be excluded from the 
female X-chromosome (Chadwick & Willard 2001), a feature that gave this variant its 
name, Barr body deficient (Bbd). H2A.Bbd protein consists of 115 amino acids with a 
molecular weight of 12.7 kDa and is only 48 % identical to the core H2A histone, 
making it the most evolutionary divergent histone variant known to date (Chadwick & 
Willard 2001; González-Romero et al. 2008). It has been proposed that the major 
hallmarks of Bbd, compared to core H2A (Bao et al. 2004; Doyen et al. 2006), are: i) 
the presence of a continuous stretch six arginine residues and the conspicuous absence 
of lysine in the N-terminal tail; ii) the absence of a C-terminus including the last 
segment of the docking domain that is responsible for the interaction with H3 in major 
NCP; iii) major sequence differences in the docking domain of H2A (residues 81-119); 
iv) the presence of only one lysine in H2A.Bbd (compared to 14 in major H2A); and 
v) the absence of ‘acidic patch as discussed above. 
To establish the function of histone H2A.Bbd in vivo, our laboratory turned to 
the mouse model. An extensive analysis of the mouse genome database revealed, 
however, that several H2A.Bbd ‘like’ genes exist but the most similar to H2A.Bbd was 
a new histone variant, which we designated, H2A.Lap1 (Lack of acidic patch) (see 
below). H2A.Lap1 is a multi-copy gene, coded by at least three genes, H2Afb3 
(henceforth referred to as mH2ALap1a) which is a major form, Gm14920 
(mH2ALap1b) and EG624153 (mH2ALap1c) (Soboleva et al. 2012). Although 
recently, H2A.Lap1 has been re-designated as H2A.B.3, in this thesis, I will refer to 
the histone as H2A.Lap1 for ease of distinction from the human H2A.Bbd. H2A.Lap1 
encoded genes are over 90% identical in DNA sequences (Figure 1.3). We found that 
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mice have a family of four H2A.Lap1-like variants (which we designated H2A.Lap 1-
4), all multi-copy genes, related to a human variant, H2A.Bbd. The H2A.Lap1 is the 
closest variant, being 68% similar to the human H2A.Bbd and the focus of this study.  
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  Figure 1-3: The alignment of partial sequence of H2A.Lap1 genes. 
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1.8.2 H2A.Lap1 is a tissue-specific histone 
1.8.2.1 H2A.Lap1 in spermatogenesis 
 In mammals, germ cells move from the periphery to the lumen of a 
seminiferous tubule and are subsequently transported to the epididymis, a long tubule 
that stores mature sperm. Mammalian spermatogenesis takes place in the seminiferous 
tubules of the testes. 
Spermatogenesis consists of three stages (Figure 1-4), i) somatic diploid cell, 
or spermatogonia (2n): establishment of primordial germ cell (PGC) in the embryo, and 
mitosis of spermatogonial cells; ii) tetraploid cells (4n) or spermatocytes: meiosis of 
diploid cells which involves reductional divisions in primary and secondary 
spermatocytes to produce haploid cells. The primary spermatocytes undergo 
differentiation through preleptotene (in Prophase I)leptotenezygoteneearly 
pachytene mid-pachytenelate pachytene. Secondary spermatocytes undergo 
further meiosis divisions to produce haploid spermatids. In the final stage, iii) haploid 
(n) spermatids that are represented by round, elongating and condensing stage of 
differentiation resulting in final stage, mature haploid spermatozoa (Clermont 1972).  
A characteristic feature of spermatogenesis is that transcription stops at a 
defined point during the differentiation of germ cells, at the beginning of elongating 
spermatid stage. Thus, prior to this stage (the round spermatid stage), high levels of 
transcription occur to produce a store of mRNA, e.g. mRNA encoding protamines and 
other key proteins essential for the completion of spermatid development. The 
translation of those mRNA species is uncoupled from transcription and happens in 
elongating-condensing spermatids. Mammalian spermiogenesis involves a dramatic 
reorganization of chromatin from a histone-based nucleosome structure to a structure 
primarily based on protamines, which condense the DNA for packaging within the 
sperm head. Gradual replacement of histones with protamines requires first, the 
utilization of transitional proteins (TP; in mammals contain two major types, TP1 and 
TP2), followed by incorporation of protamine dimers, Prt1/2. 
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Figure 1-4: Stages of spermatogenesis in mammals. Adapted from 
Clermont (1972) 
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Many histone variants of H2A and H2B are specifically expressed in the testis. 
For instance, TH2A and TH2B have been detected in post-meiotic spermatids. During 
the condensation of spermatid nuclei, TH2A and TH2B gradually decrease, before 
being degraded during DNA compaction (Moss et al. 1989). An increase in histone 
acetylation in elongating spermatids serves as a signal for the recruitment of specific 
machinery acting on acetylated histones needed for the histone-protamine exchange 
(Govin et al. 2004). Investigation of nucleoproteins on condensing spermatids has led 
to the identification of five more H2A and H2B histone variants that are expressed 
mainly in testes, namely H2A.L1 (H2A.Lap2), H2A.L2 (H2A.Lap3), H2A.L3 
(H2A.Lap4), H2B.L1 (of which mRNA is strongly enriched at round and elongating 
spermatids) and H2B.L2 (which has very low mRNA present at meiotic and post-
meiotic stages). Immunostaining using antibodies that recognize H2A.L1 and H2A.L2 
(H2A.L1/H2A.L2) or H2B.L1 showed an accumulation of H2A.L1/L2 and H2B.L1 in 
condensing spermatids, similar to that of transition proteins and protamines (Govin et 
al. 2007). 
Further investigation to identify testis-specific histones has led to the in-depth 
characterization of the function of H2A.Lap1 variant in vivo, by Soboleva and 
colleagues (2012) in our laboratory. Mechanistically, and similar to H2A.Bbd, 
H2A.Lap1 inhibited chromatin compaction in vitro (Soboleva et al. 2012). In vivo, 
H2A.Lap1 expression begins at the pachytene stage and peaks in the round spermatid 
stage coincident with the highest levels of transcription. In elongating spermatids, 
H2A.Lap1 is exported out of the nucleus (Soboleva et al. 2012). ChIP-Seq and RNA-
Seq analysis revealed that H2A.Lap1 is targeted to the TSS of active genes including 
those few genes on the X chromosome that escape the X chromosome inactivation 
process (Soboleva et al. 2012).  
Most recently, H2A.Lap1 has also been shown to be incorporated into the 
intron-exon boundary of active genes suggesting that, in addition to a role in 
transcriptional initiation, it also has a specific function in pre-mRNA splicing 
(Soboleva et al. 2017). To explore this further, CLIP (Cross-Linking and 
Immunoprecipitation) experiments were conducted and was it demonstrated that 
H2A.Lap1 associated with mRNA. Finally, a mass spec analysis revealed that 
H2A.Lap1 directly interacts with splicing factors (Soboleva et al. 2017). Taken 
together, this indeed provides support for the notion that H2A.Lap1 is a novel 
epigenetic regulator linking transcriptional initiation with RNA splicing. 
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1.8.2.2 H2A.Lap1 in the brain. 
The role of H2A.Lap1 in the mouse brain remains unknown, but similar to the 
testis, H2A.Lap1 ChIP-Seq and RNA-Seq in the hippocampus revealed that H2A.Lap1 
is also found at the TSS and intron-exon boundaries of active genes (Soboleva et al. 
2017). An immunohistochemical staining of mouse brain tissues showed that 
H2A.Lap1 is expressed in neurons throughout the adult mouse brain, including the 
hippocampal areas of dentate gyrus (DG), CA1 and CA3 (unpublished data). In 
cerebellum, H2A.Lap1 localized specifically in the Purkinje neurons, while H2A.Z is 
expressed in the granular layer (unpublished data). Further, H2A.Lap1 expression was 
found to coincide with the maturation of the Purkinje neurons, implicating H2A.Lap1 
in Purkinje neuron development (unpublished data).  
In spite of these successes in characterizing many aspects of H2A.Lap1 function 
in mouse brain and testes, the ultimate approach to deciphering a function of a gene is 
to create and characterize a biological system where the function of the gene of interest 
is disrupted. Therefore, the overall aim of this thesis was to generate a mouse model in 
which all three H2A.Lap1-coding genes are knocked-out.  
 
1.9 Targeting H2A.Lap1 encoded genes 
The purpose of gene targeting is to discern a particular gene’s biological 
function. There are two ways to achieve this, either by overexpression of the gene of 
interest, or by down regulation of its expression. Overexpressing a gene can be 
employed by transgenic technology, whereas, homologous recombination is typically 
employed to create a mutation that leads to ‘loss-of-function' (Hall et al. 2009). Where 
overexpression can violate balanced gene dosage, affecting protein folding, complex 
assembly and downstream regulation (Gibson et al. 2013), most researchers opt for a 
knockdown or knockout targeting strategy to disrupt a gene’s open reading frame and 
block its expression, as a direct means to delineate its function (Hall et al. 2009). 
Since H2A.Lap1 is a multicopy gene (three genes and one pseudogene), the 
conventional knockout approach that only able to target one gene at a time is not a 
suitable tool to target H2A.Lap1 for knockout. However, new methodologies in 
genome editing, which rely on recognition of specific DNA sequences by either 
proteins or complementary RNA, have allowed researchers to induce a custom 
modification, in cells and model organisms. 
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1.9.1 Genome editing approach to disrupt genes 
1.9.1.1 ZFN, TALE or CRISPR 
Zinc finger nuclease (ZFN) 
Specificity of targeting remains the focus in disrupting a gene of interest. A 
recent approach called ‘genome-editing' has enabled scientists to target virtually any 
sequence. This approach uses engineered nucleases which consist of a specific 
sequence of DNA binding domain fused to a non-specific DNA cleavage motif (Gaj et 
al. 2013; Boettcher & McManus 2015; Cermak et al. 2011). The first genome editing 
introduced was zinc finger nucleases (ZFN). A zinc finger nuclease contains a DNA-
binding domain composed of at least three tandem arrays of Cys2His2 zinc fingers, 
commonly found in eukaryotes and representing the second most frequently encoded 
protein domain in the human genome. This motif is fused with a nonspecific DNA 
cleavage domain derived from the endonuclease FokI which requires dimerization for 
enzymatic activity (Gutschner et al. 2011; Gupta et al. 2011) (Figure 1-5). The 
specificity of targeting lies in the DNA binding domain that can be customized by the 
researcher. One zinc finger recognizes three base-pairs on one DNA strand. For 
example, a protein comprising of three zinc fingers recognizes a 9- to 10-base-pair 
segment. But the zinc-finger triplet also means you have less flexibility in how the 
recognition sequence must be read i.e. although there are hundreds of zinc-finger 
modules, not every possible sequence is represented (DeFrancesco 2011). 
Zinc finger nucleases generate sequence-specific, double-strand breaks that are 
repaired mainly by error-prone nonhomologous end joining (NHEJ) or by high-fidelity 
homologous recombination (Cui et al. 2011) (Figure 1-6). Zinc finger nucleases have 
reportedly been used to create knockouts in rats (Geurts et al. 2009), mice (Carbery et 
al. 2010) and zebrafish (Gupta et al. 2011) with remarkable germ line transmission rates 
and efficiency (Cui et al. 2011). However, mutations are unpredictable owing to the 
variable nature of DNA repair by NHEJ and are limited to knockouts (Cui et al. 2011). 
Although ZFN has demonstrated flexibility in the specificity of the targeted sequence, 
this modular assembly requires the use of a preselected library of zinc-finger motifs 
generated by selection of large combinatorial libraries or by rational design (Cui et al. 
2011). Further, off-target effects resulting from the application of ZFN are widely 
reported across all eukaryotic organisms. Also, Pattanayak et al. (2011) identified 37 
sites and 2,652 sites in the human genome that can be cleaved by ZFN CCR5-224 and 
VF2468 that were designed to target only the CCR5A and VEGF genes. Further, Sander 
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et al. (2013) revealed that transient transfection and using a strong constitutive CMV 
promoter may induce an even greater number of undesired cleavage sites by ZFN. 
Numerous efforts have been made to improve the design and specificity of ZFN. Prior 
to the introduction of the TALEN system, another limitation of the ZFN approach is 
the complexity involved in designing ZFN to recognise specific DNA sequences. 
TALEN and CRISPR were subsequently developed as an alternative to ZFN. These 
systems are characterized by their simplicity of design and high functional efficiency 
at enabling various genomic manipulations.  
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Figure 1-6: FokI will only start the enzymatic cleavage activity when ZFNs bind
to both sense and antisense strand. This creates double-strand breaks (DSB) in the 
genomic strand which will be naturally repaired by NHEJ or HR.   
Figure 1-5: ZFN recognize nucleotide in triplet manner. The engineered zinc 
finger nuclease which consists of DNA binding domain (tandem repeat of Cys2His2).
Since FokI works as a dimer, two constructs are required, one to target the sense 
strand and the other one for the antisense. Adapted from Durai et al. (2005) 
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Transcription activation-like effector nuclease (TALEN) 
In 2011, Nature Methods named the methods of precise genome editing, 
including the TALEN system, as the method of the year. TAL effector is a newly 
described class of DNA binding proteins, a family of virulence factors produced by 
plant pathogen Xanthomonas spp, which when injected into a host plant, bind to a 
specific host promoter sequence that regulates genes affecting disease processes, both 
negatively and positively (Cermak et al. 2011; DeFrancesco 2011). TAL effectors 
contain tandem, 33-35 polymorphic amino acid repeats, which independently specify 
single, contiguous nucleotides in the DNA target.  The targeting specificity is 
determined by the amino acids 12-13, referred to as repeat variant di-residues (RVDs), 
which are HD, NG, NI and NN corresponding to the nucleotide C, T, A and G/A 
respectively (Cermak et al. 2011; Bogdanove & Voytas 2011) (Figure 1-7). 
TALEN has been shown to act similarly to the zinc finger nuclease. However, 
in contrast to the zinc finger domain which predominantly recognizes nucleotide 
triplets, the TAL effector domain consists of monomers with the ability to recognize a 
single nucleotide, which has dramatically improved DNA targeting (DeFrancesco 
2011). The targeting domain of TAL can be fused with the catalytic domain of the FokI 
nuclease generating a fusion protein that creates site-specific DNA double-strand 
breaks (DSB). This protein functions as a dimer, hence, TALENs are designed in pairs 
for both strands of DNA separated by a spacer, allowing the FokI monomer to come 
together and cleave. The creation of DSB in turn triggers an in vivo DNA repair 
pathway, which can be harnessed to create specific DNA sequence modifications at the 
break site. In non-homologous end joining (NHEJ), the broken chromosome may be 
re-joined imprecisely, resulting in small insertions or deletions at the break site. In 
homologous recombination, the DNA surrounding the break site is replaced with a 
repair template of a similar sequence, which can be modified or amended to introduce 
specific mutations, or different DNA sequences. Unlike ZFN, TALEN has been 
reported also to have low cellular toxicity and higher target specificity (Mussolino et 
al. 2014). Reports regarding off-target sites by TALEN are not as common as they are 
for ZFN (and CRISPR, see below). The only limitation of the TALEN design is in the 
selection of the TALEN nuclease site that is needed for nucleotide thymine -before the 
5'- end of the target sequence (Nemudryi et al. 2014). Based on crystal structure 
analysis of TALE effector by Mak et al. (2012), the W32 residue in the N-terminal 
region of the DNA-binding domain was demonstrated to interact with 5'-T, affecting 
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the efficiency of TALEN binding to the target site (Nemudryi et al. 2014). However, 
this limitation was fixed by selecting TALEN N-terminal mutant variants with the 
capability to bind A, G, or C (Nemudryi et al. 2014). Despite the specificity shown by 
TALENs design, the TALEN approach has been super ceded by the CRISPR-Cas9 
system.  
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Figure 1-7: The design of TALEN is much more flexible than ZFN. The
DNA binding domain consists of repeat di-residue of amino acid that able to
recognize one nucleotide, providing more specificity and flexibility for
targeting in comparison to ZFN. Adapted from Kim & Kim (2014) 
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Clustered regularly interspaced short palindromic repeats -Cas9 (CRISPR-Cas9) 
About two years after the discovery of chimeric TALEN proteins, a new 
genome-editing tool called CRISPR-Cas was introduced. Unlike ZFN and TALEN that 
used protein motifs to recognize DNA sequences, CRISPR uses antisense RNA to bind 
to the targeted RNA-guided nuclease, (RGN).  Since it was first described in 1987, 
CRISPR was not further developed for genome editing purposes until 2010 (Doudna 
& Charpentier 2014). Briefly, the Cas9 protein, found in bacteria and algae, serves as 
an adaptive immune response against invading viruses and plasmid DNA by degrading 
complementary DNA sequences (Chandrasegaran & Carroll 2016). Targeting of Cas9 
to specific genomic sites is mediated by a 20-nucleotide guide sequence, within an 
associated CRISPR RNA (crRNA), and requires trans-activating crRNA (trcrRNA) 
that recruits the crRNA into the Cas9 complex. Recognition of cleavage sites is 
determined by crRNA-DNA base pairing and protospacer-adjacent motif (PAM), a 
three-nucleotide sequence (NGG) juxtaposed to the complementary DNA region 
(Doudna & Charpentier 2014). It is notable that a single guide RNA (gRNA) that 
mimics the trcrRNA-crRNA complex recruits Cas9 to targeted genomic sites and 
generate DSBs in DNA (Doudna & Charpentier 2014). 
Despite its simplicity for targeting, and with improvements continually being made 
(Doench et al. 2016; Kleinstiver et al. 2016; Shin et al. 2017), one major drawback of 
the CRISPR-Cas9 system that has been widely discussed is its high probability of 
producing off-target mutations, which has been clearly illustrated when a direct 
comparison between CRISPR and TALENs were made (Duan et al. 2014; Kim et al. 
2016; Schaefer et al. 2017; Xu et al. 2015). As noted above, one attractive feature of 
TALENs, which enables a higher level of specificity, is that the FokI nuclease domain 
will only cleave DNA when dimerized, which occurs when the two TALE-domains 
bind to DNA (on opposite strands) in close proximity to each other. Therefore, we used 
the TALEN approach to knockout H2A.Lap1 (and when I started this project, CRISPR 
was still in its infancy). 
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Figure 1-8: A mechanism of CRISPR-Cas9 action in bacterial cells. Adapted 
from Nemudryi et al. (2014) 
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1.10 Project objectives and chapters summary 
The availability of a H2A.Lap1 knockout would be an invaluable tool for 
investigating the importance of this histone variant, however, as the H2A.Lap1 protein 
is expressed from three different genes, this is a technically challenging feat. Our aim 
was to devise the most efficient and specific strategy to inhibit the function of all three 
genes. In this thesis, we report a simplified TALEN approach that achieves this goal. 
Specifically, we used only one pair of TALENS to do this. To our knowledge, this has 
not been done before.  
The aims of the project were to: 
1- Generate an H2A.Lap1 knockout (KO) mouse colony using the TALEN 
system. 
2- To determine the specificity of the TALEN approach by investigating, whether 
there were any off-target effects.  
3- Perform an initial characterisation of the genotype and phenotype of H2A.Lap1 
knockout mice. 
In chapter 3, in collaboration with Phillip Gregory and Lei Zhang of Sangamo 
Biosciences, we present the design of the TALEN plasmids that specifically target the 
H2A.Lap1 encoding genes. We screen their activity efficiencies in transiently 
transfected cells: this includes a list of plasmids designed, a description of the Dual-
Luciferase Single Strand Annealing Assay (DLSSA) to test plasmids' activities in cells, 
and the surveyor nuclease assay to detect mutations in cells. Next, we show how the 
plasmids’ cleavage activities were validated in our cell lines, and how we developed 
our screening methods for mutations using a surveyor nuclease assay, T7 endonuclease 
I assay, and the use of the PCR cloning sequencing assay (which we simplified) for 
efficient high-throughput genotype screening in mice. Next, the microinjection of 
H2A.Lap1TALEN mRNA into single cell embryos of FVB/NJArc strain mice, which 
were implanted it into pseudopregnant females to generate H2A.Lap1KO founder mice 
is described (in collaboration with Prof Peter Koopman, the University of Queensland). 
Nineteen founders were born and transported to JCSMR so we could determine their 
genotype. In all 19 founders that we have screened, we have shown that H2A.Lap1 
encoded genes were successfully disrupted by frame shift mutations which led to the 
loss of H2A.Lap1 protein. We also demonstrate how we continued to successfully 
breed the founders to produce KO pups. In this chapter, I also describe how we further 
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characterized the genotype of the pups that stably carried their parents' mutation 
throughout several generations. Our findings also include the discovery of chimera 
mice resulting from genomic rearrangement. 
In Chapter 4, I asked the question: “Do TALENs cause any off-target 
mutations?” To answer this, we conducted exome sequencing on H2A.Lap1KO mice 
from 3 generations (G0, G1 and G2). By using bioinformatics analysis on the exome 
sequencing data, we hypothesized that if there were any off-target effects, the number 
of variants picked up by bioinformatics analysis would be diluted by half, from one 
generation to the next, when heterozygous female (+/-) bred with wild-type (wt) (+/Y) 
partner (Mendelian law of segregation). We were able to show, in collaboration with 
our Bioinformatics collaborators (Dr. Matthew Field and Dr. Sebastian Kurscheid, 
JCSMR) that the variations observed showed no dilution effects in all three generations 
of mice, providing evidence of TALEN's specificity. However, their analysis identified 
19 putative indels that were consistently present in all 3 generations. We validated these 
variants experimentally, using PCR and Sanger sequencing analysis, and proved that 
the indels were mouse strain variation specific to our inbred colony and not the result 
of TALEN off-target activity. This proved the remarkable specificity of a single pair 
of TALENs as genome editing tools on multicopy genes. 
 In Chapter 5, I then characterized the phenotype of our H2A.Lap1KO mice 
colony. Since H2A.Lap1 is highly expressed in testes, we explored the ability of the 
KO mice to reproduce. Here we show that male H2A.Lap1 KO mice are subfertile and 
that their subfertility is likely due to aberrant nuclear morphology epigenetic landscape 
in the round spermatids of the KO mice. Since, the differentiation of the germ cells 
underwent significant epigenetic and chromosome organisation changes, we examined 
whether the absence of H2A.Lap1 affected the localisation and abundance of important 
active and repressive chromatin marks. Finally, we observed a connection between loss 
of H2A.Lap1 and aberrant function of somatic Sertoli cells that do not express 
H2ALap1. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1  Reagents 
Name Supplier 
1,4-Dithiothreitol (DTT) Life Technologies 
2-mercaptoethanol Sigma 
30 % Acrylamide:Bis (29:1) Biorad 
AEBSF Enzo life science 
Agarose Powder Amresco 
Agencourt AMpure XP beads Beckman Coulter 
Ammonium chloride Sigma 
Ampicillin Sigma 
BigDye system ABI 
Bolt® LDS sample buffer Life Technologies 
Bolt® Bis-Tris Polyacrylamide gel (4-12 %) Life Technologies 
Bolt® buffer system for protein gel (20x) Life Technologies 
BSA (Bovine serum albumin) Sigma, Biomatik 
Calcium chloride AnalaR, Merck BDH 
Complete protease inhibitor Roche 
Cel1 Surveyor ` Mutation Detection Kit Transgenomic 
DAPI Roche 
Dynabeads® Protein G Life Technologies 
RPMI Sigma 
di-Sodium hydrogen phosphate Merck 
DMSO Sigma 
dNTP mix Life Technologies 
EDTA Life Technologies 
EGTA Sigma 
Ethidium bromide Amresco 
FBS (fetal bovine serum) Life Technologies 
Flourescent mounting medium (Vectashield) Vector laboratories 
Formaldehyde Chem-supply 
Gel extraction kit Qiagen 
Glycerol Sigma 
HEPES Sigma 
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Isopropyl β-D-1-thiogalactopyranoside (IPTG) Sigma 
Lipofectamine 2000 Invitrogen 
L-glutamine Life Technologies 
Magna ChIP ™ Protein A magnetic beads Milipore 
Magnesium sulphate Merck 
N,N-dimethylformamide Sigma 
Nonidet P-40 Fluka 
Nuclease-free water Ambion 
Paraformaldehyde  Life Technologies 
pGEMT-easy vector Promega 
Plasmid mini purification kit Promega 
Potassium chloride Merck 
Potassium hydrogen carbonate Merck 
Power Syb Green kit ABI 
Propidium iodide Sigma 
Proteinase  K Sigma 
PureYield ™ plasmid midiprep Promega 
Qubit® fluorometer protein kit Life Technologies 
Quick extract DNA solution Epicenter 
Recombinant Taq DNA polymerase Life Technologies 
RNase A Qiagen 
RPMI 1640 Life Technologies 
SDS Sigma 
Sodium di-hydrogen phosphate Merck 
Sodium DL-lactate Sigma, Santa Cruz 
Sodium pyruvate Life Technologies 
SureSelect XT2 Mouse All Exon Kit Agilent 
Sucrose  Merck 
SuperScript III first strand synthesis system Life Technologies 
T4 DNA ligase and buffer Promega 
Tris Sigma 
Triton® X-100 Sigma 
Trizol reagent Ambion 
Trypan blue stain (0.4 %) Invitrogen 
Trypsin-EDTA 0.25 % Life Technologies 
Tween® 20 Sigma 
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2.2  Antibodies 
Specific 
antigen 
Species 
antibodies 
were raised 
Isotype Conjugated 
to 
Clone & source/ 
manufacturer 
Catalogue 
number 
Mouse 
H2A.Z 
Sheep IgG - Polyclonal, 
South Australia 
Health & Medical 
Research Institute 
(SAHMRI) 
Antibody 
Production 
Services, SA, 
Australia. 
- 
Mouse 
H2A.Lap1 
Sheep IgG - Polyclonal, 
SAHMRI, 
Antibody 
Production 
Services, SA, 
Australia. 
- 
Mouse 
H2A.Lap2 
Rabbit IgG - Polyclonal, 
SAHMRI, 
Antibody 
Production 
Services, SA, 
Australia. 
- 
Mouse 
H3K9Me2 
Rabbit IgG - Abcam ab7220 
Mouse 
H3K9me3 
Rabbit IgG - Abcam ab8898 
LectinPNA 
Alexa Fluor® 
488 
conjugate 
- - FITC Invitrogen L21409 
Sheep IgG Donkey  Cyanine 
Cy™3 
Polyconal, 
Jackson 
ImmunoResearch 
713-165-
003 
Rabbit IgG Donkey      - Cyanine 
Cy™3 
Polyclonal, 
Jackson 
ImmunoResearch 
713-165-
152 
Goat/Shee
p IgG 
Donkey      - HRP Polyclonal, 
Millipore 
AB324P 
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2.3 Methods 
2.3.1 Purification of antibody 
2.3.1.1 Thrombin digest of 6-His tagged protein 
To remove a Histidine tag from a 6xHis-tagged H2A.Lap1 and 6xHis-H2A.Lap2 
proteins, a 0.1 u/µl of Thrombin was prepared by diluting with Thrombin cleavage 
buffer (TCB) which contains 200 mm of Tris, pH 8.4, 1.5 M NaCl, 25 mM of CaCl2. 
In 200 µl reaction, 0.2-0.5 mg of protein was cleaved with 3 U of 0.1 u/µl of 
Thrombin. The reaction consists of 75 µl of 8 M urea in H2O, 0.2-0.5 mg protein, 30 
µl of 0.1u/µl Thrombin, 20 µl of 10x TCB and H2O. The reagents were mixed well 
and dispensed into equal amount of 8 PCR tubes. Then the reaction was incubated at 
25 °C for 16 hrs. Following incubation, 6 µl of 4x Bolt sample buffer was added to 
the tube and boiled for 3 minutes. Then, after a brief spin, the sample was loaded into 
10-well 4-12% gradient acrylamide gel, with 1 well loaded with uncut sample and 
one well for protein marker. The proteins were separated on the gel at 200V for 28 
minutes. Alternatively, the cleaved sample were stored at -20 °C until use. 
 
2.3.1.2  Affinity purification of antibody 
Separated proteins were transferred into PVDF membrane as mentioned in section 
2.3.5.3. The transfer was done at 30 V overnight. Following that, the PVDF 
membrane was stained with 0.2 % Ponceau S containing 1 % acetic acid. Once the 
protein is visible, the membrane was rinsed several times with mili Q H2O. Then, the 
strip containing the desired protein was cut off using a scalpel blade. After that, the 
cut strip containing protein of interest was blocked using 3 % BSA at room 
temperature for 1 hr. Next, the serum containing the appropriate IgGs was diluted 1:1 
with the blocking solution and incubated with the pre-blocked strip at room 
temperature for 5 hrs with rotation.Following that, the strip was washed with 10 ml 
of 1x PBS twice, 10 minutes each, at room temperature with rotation. To elute the 
antibody, a small boat was made out of paraffin film and stuck onto a petri dish. Inside 
the petri dish, wet tissues were placed around the paraffin boat to create humidity. 
Then, the strip was placed gently into the paraffin boat and 200 µl of elution buffer 
containing 0.2 M glycine pH 2.8 and 1mM EGTA was added. The Petri dish was 
agitated at 280 rev/min for 20 minutes. Then, immediately, the eluted antibody was 
transferred into microcentrifuge tube and 0.1 volume of Tris (unpHed) was added to 
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the tube. The pH of the eluted antibody was measured by dropping 5 µl onto pH 
paper. Then, 0.1 volume of 10x PBS was added. The antibody was stored at 4 °C. 
 
2.3.2 Preparation of gDNA 
2.3.2.1 Preparation of gDNA for exome capture and for Next Generation 
Sequencing (NGS) 
Three to five ear punches or 5 mm of tail were collected from each selected mouse. 
The tissues were snapped frozen in dry ice immediately after punches. Then, 500 μl 
of tissue lysis buffer (50mM Tris pH 8.0, 100 mM EDTA, 0.5 % SDS) and 2.5 μl of 
20 mg/ml of Proteinase K were added to the tissues. The sample was incubated at 55 
°C for 1 hour until fully digested. In every 10 minutes interval during the incubation, 
the tissues were passed through 19 G and 23 G needles 10 times to further aid the 
lysis. After that, 5 μl of RNase A (100 mg/ml) were added to the reaction tube and 
mixed several times by inversion. The tissues were further incubated at 37 °C for 30 
minutes. Following the incubation, the digested sample was centrifuged at 16,000 g 
for 10 minutes at room temperature. Then the supernatant was transferred to a new 
tube and 2.5 M of NaCl were added to the tube. The sample was mixed by inversion 
and left at room temperature for at least 5 minutes. After that, the sample was 
centrifuged at 16,000 g for 10 minutes at 4 °C, and after that the supernatant was 
transferred to a new tube. This step was repeated another time to remove the white 
precipitate in the supernatant. Following that, an equal amount of ice-cold 
isopropanol was added to the supernatant and the tube was mixed by inversion, 
followed by incubation at -20 °C overnight to precipitate the DNA. The following 
day, the tube was centrifuged at 16,000 g for 20 minutes at 4 °C. The supernatant was 
carefully removed without disturbing the pellet. Then, the pellet was washed with 1 
ml of freshly prepared ice-cold 70% ethanol followed by brief gentle vortexing to lift 
the pellet of the wall. After that, the tube was centrifuged at 16,000 g for 10 minutes. 
The washing step was repeated with 500 μl of cold 70% ethanol and spun for another 
5 minutes. The supernatant was carefully removed without disturbing the pellet. Then 
the pellet was air dried to remove any remaining ethanol residue. The pellet was 
dissolved in pre-warmed dH2O and incubated further at 55 °C for 10 minutes to 
completely dissolve the DNA. The concentration was measured using Nanodrop and 
the visualisation of DNA was done using 1 % agarose gel, post-stained with EtBr. 
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One µg of was used for the preparation of indexed gDNA libraries using SureSelect 
XT2 Mouse All Exon kit as per the manufacturer protocol. Prior to exome enrichment, 
the DNA was iniatially sheared and the quality of DNA was assessed using 2100 
Bioanalyzer DNA Assay to ensure the average DNA fragments is around 150 to 200 bp.  
To capture the exome using the SureSelect XT2 Mouse All Exon Kit, the DNA ends 
were initially repaired and then purified using the AMPure XP beads. Then the 3´ ends 
of the DNA fragments were adenylated. Following that, the A-tailed DNA fragments 
were ligated to the indexing adaptor and subsequently purified using the AMPure XP 
beads. Then, the indexed libraries were purified via PCR program as described in the 
kit. After that, the amplified libraries were purified using AMPure XP beads followed 
by quality assessment using the 2100 Bioanalyzer DNA Assay. Then the sample was 
ready to be sent for sequencing using Illumina HiSeq 2000 as 100 bp paired-end reads. 
The output result was sent for bioinformatics analysis. 
 
2.3.2.2 Preparation of gDNA for standard PCR. 
One to three ear punches from each selected mouse were placed in a 1.5 ml tube 
containing 50 μl of Epicentre Quick Extract Solution 2.0. For gDNA from cell lines, 
about 1 x106 cells were washed with 1x PBS and harvested using 0.25 % trypsin-EDTA 
at 37°C for 5 minutes and spun at 1,200 rpm for 5 minutes in 15 ml tube. After that that 
the cell pellet was resuspended with 1 ml the culture media and transferred into 1.5 ml 
tube and lysed with 100 µl of Epicentre Quick Extract Solution. Then, the tube was spun 
at 10,000g for 1.5 minutes. Following that the tube was incubated at 65 °C for 15 minutes 
with agitation and centrifuged briefly and further incubated at 98 °C for 8 minutes. 
Subsequently, the tube was vortex for 10 seconds and centrifuged at 10,000 g for 3 
minutes to pellet the digested tissues. The supernatant containing DNA can be used 
directly in a standard PCR setup. 
  
2.3.3 PCR 
2.3.3.1 Standard PCR for genotyping purpose 
For each mouse, all three genes of H2A.Lap1 were amplified to determine the 
genotype (wild type (WT), homozygous, heterozygous or hemizygous). For each primer, 
the reagents in Table 1 were prepared in master mix and aliquoted in a 96-well plate. 
The PCR condition was set to 1 cycle of initial denaturation at 95 °C for 10 minutes, a 
28 cycle of denaturation at 95 °C for 30 secs, annealing at 60 °C (for H2A.Lap1a), 65°C 
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(for H2A.Lap1b), 56 °C (for H2A.Lap1c) for 30 secs, extension at 72 °C for 1 minutes 
and 1 cycle of final extension at 72°C for 4 minutes. For gDNA PCR reaction on other 
than genotyping purpose, the annealing temperature was adjusted and optimised 
according to the primer’s melting temperature. 
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Table 2-1: List of PCR ingredients. 
   
   
 
 
 
 
 
 
 
 
 
  
Ingredients 1x Volume  
(µl) 
10x Normal Platinum Buffer 2.5 
50 mM MgCl2 1.0 
10 mM dNTP 0.5 
10 µM Forward Primer  0.5 
10 µM Reverse Primer  0.5 
Platinum Taq polymerase 5 u/μl 0.1 
gDNA 1.0 
H2O 18.9 
TOTAL 25.0 
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2.3.3.2 Amplicons visualisation. 
To visualise the amplicons, we used native polyacrylamide gel electrophoresis in 
order to detect small deletions such as 5 bp. The gel was prepared by adding the reagents 
in Table 2 in a 50 ml polypropylene tube. The mixture was homogenised by inverting 
the tube 4 times. Then immediately casted into 1 mm cassette. Twelve-well comb was 
placed on top of the cassette slowly from left to right to prevent bubble trap. The gel was 
left at room temperature for 15 minutes to polymerise. Higher gel concentration will 
solidify faster, hence, the mixing needs to be done quickly. Once the gel solidified, it 
was placed in Bolt® electrophoresis tank filled with 0.5 % TBE buffer (diluted with 
dH2O from 5x TBE which consists of 54 g Tris base, 27.5 g boric acid and 20 ml of 0.5 
M EDTA). While waiting for the gel to solidify, the PCR product was diluted to 20 times 
with 1 x TBE sample buffer (5x TBE buffer, 20 % glycerol, 0.004 % bromophenol blue 
and 0.004 % xylene cyanol, and H2O). Then 5 µl of the diluted amplicons were loaded 
in to the well and run at 200 V for 60 minutes (for H2A.Lap1a, c) and 90 minutes (for 
H2A.Lap1b). Then, the visualisation was done by post-stain the gel in 0.5 µg/ml of EtBr 
for 10 minutes and viewed under UV. 
For amplicons documentation other than genotyping, the presence of PCR products 
was visualised using 2 % agarose gel, pre-stained with 0.5 µg/ml of EtBr. 
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 Table 2-2: List of ingredients for native PAGE gels 
Ingredients 10 % 12 % 14 % 
30% Acrylamide: Bis (29:1) 4.0 ml 4.8 ml 5.6 ml 
sdH2O 5.6 ml 4.8 ml 4.0 ml 
5x TBE 2.4 ml 2.4 ml 2.4 ml 
10 % APS (fresh)  200 µl 200 µl 200 µl 
10 µl Temed 10 µl 10 µl 10 µl 
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2.3.3.3 Purification of PCR products using Agencourt AMPure XP kit 
10 µl of PCR product were transferred from plate into 0.2 ml tube. Then, 20 µl of 
H2O was added to the PCR product. After that, 1.4x (40 µl) of AMPure XP solution was 
added into the reaction tube. The mixture was homogenised thoroughly by pipetting 20 
times. The sample was incubated at RT for 5 minutes. Then the tube was placed onto a 
magnet plate for 2 minutes. Beads were separated from solution to the wall of the tube. 
Whilst tube still on magnet plate, the cleared solution from tube was aspirated and 
discarded (Carefully not to disturb beads). Whilst tube still on magnet plate, 200 µl of 
70 % EtOH was dispensed into the reaction tube and incubated for 30 seconds. Then the 
EtOH was aspirated and discarded. The washing step was repeated 2 times. Off the 
magnet plate, 30 µl of elution buffer was eluted into reaction tube and mixed for 10 
times until homogenise. The tube was placed back onto the magnet plate and incubated 
at RT for 1 minute to separate beads. The eluent was transferred to a new tube. The 
purity of the amplicons was measured using nanodrop and then visualised using 2 % 
agarose gel that was pre-stained with EtBr. 
 
2.3.3.4 Ligation of amplicons into pGEMT vector  
Cloning and sequencing was done to confirm the sequence of the amplicons. To 
distinguish heterozygous mutations, individual PCR products were cloned into and at 
least 8-10 clones for each gene were sequenced by Sanger method. 
The ligation was done according to the manufacturer protocol of pGEMT-easy 
vector. Briefly, in a 1.5 ml tube, the following reagents were added:  5 µl of 2x rapid 
ligation buffer, 1 µl of pGEMT-easy vector plasmid, 1 µl of T4 DNA ligase, 2 µl of 
purified PCR product and H2O to 10 µl of total reaction volume. The mixture was 
homogenised by pipetting. Then it was left at room temperature for at least 2 hrs. 
Alternatively, the reaction can take place at 4 °C overnight. 
 
2.3.3.5 Transformation 
Following ligation, the recombinant vector was transformed into E.coli TOP10 
competent cells. The tube with ligation reaction was centrifuged briefly. Then, 1 tube of 
TOP10 competent E. Coli cells was thawed on ice. For each ligation,100 µl of competent 
cells was added into 5 µl ligation followed by gentle flick to mix. And then the mixture 
was left on ice for 20 minutes. Following that, a heat shock treatment was done by 
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placing the tube in a water bath at 42 °C for 45-50 seconds followed by immediate 
cooling of the tube on ice for 2 minutes. Then the 900 µl of pre-warmed LB was added 
into reaction tube and incubated at 37 °C with shaking for 1.5 hours. After that, the 
reaction tube was centrifuged at 8,000 rpm to pellet the bacterial cells. Then 800 µl of 
medium was aspirated and discarded. Then the bacterial pellet was resuspended in the 
remaining 200 µl medium. A100 µl onto of the bacterial suspension was spread on to 
LB plate which contains 100 µg/ml of ampicillin, 80 µg/ml of X-gal and 0.5 mM of 
IPTG. The plate was incubated at 37 °C for 16-20 hrs.  
 
2.3.3.6 DNA amplification from E. Coli colonies by PCR 
The following day, only white colonies (which contain the insert) were picked from 
the plate and placed into 96-well plate containing 20 µl of H2O. The suspension was 
subjected to PCR reaction to screen for the inserts. Briefly, in 96-well plate reaction, 
each well contains 5 µl of the bacterial suspension, 20 mM of universal T7 primer, 20 
mM of SP6 primer, 10 µl of Immomix and H2O to 20 µl of total reaction volume. Stand 
The standard PCR condition was set to 1 cycle of initial denaturation at 95 °C for 10 
minutes, a 28 cycle of denaturation at 94 °C for 30 secs, annealing at 50 °C for 30 secs, 
extension at 72 °C for 1 minutes and 1 cycle of final extension at 72°C for 5 minutes. 
Following that, the PCR product was purified using Agencourt AMPure XP beads as 
described in section 2.3.3.3.  
 
2.3.3.7 Sanger sequencing 
The plasmids containing inserts were subjected to Sanger sequencing. Briefly, in 96-
well plate, 5 µl of BigDye buffer was added with 3 pmole/µl of universal T7primer, 200-
500 ng of plasmid, 1 µl of BigDye fluorophore and H2O to 20 µl of total reaction. The 
mixture was subjected to PCR using the following parameters. Single cycle of initial 
denaturation at 94 °C for 5 minutes, 30 cycles of denaturation at 96 °C for 10 secs, 
annealing at 50 °C for 5 secs and extension at 60 °C for 4 minutes. Then the PCR product 
was subjected to purification: 5 µl of 125 mM EDTA was added at the bottom of the 
well, followed by the addition of 60 µl of 100 % EtOH. The plate was covered with 
aluminium seal and inverted 4 times to homogenise the mixture. Then the plate was 
subjected to centrifugation at 2,500 g for 30 minutes. Then, the supernatant was removed 
by inverting and centrifuged for up to 185 g for 1 minute. The washing step was repeated 
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with 100 µl of EtOH. The pellet was left to dry for 1 minutes before it was sent to the 
Biomolecular Research Facility, JCSMR for sequencing. 
 
2.3.4 Preparation of cDNA 
2.3.4.1 Extraction of RNA  
RNA extraction from tissues and cell lines was performed using the TRIzol® reagent.  
Firstly, 1 ml of TRIzol® reagent was added to the frozen tissue sample. The tissues were 
passed through 19 G and 23 G needles attached to a 1mL syringe 10 times to 
homogenize. Then, the homogenized sample was incubated for 5 minutes at room 
temperature to permit complete dissociation of the nucleoprotein complex. Following 
the incubation, 2 ml of chloroform per 1 ml of TRIzol® reagent was added to the tube. 
The tube was securely capped and shook vigorously for 15 seconds. Then the tube was 
incubated at room temperature for 2-3 minutes. After that, the tube was centrifuged at 
12,000 xg for 30 minutes at 4°C. Then the aqueous phase was transferred to a new tube. 
10 μg of glycogen (used as an RNA carrier) was added to the aqueous phase and mixed 
by pipetting. Then, RNA was precipitated by addition of 0.5 ml of 100% isopropanol 
and mixed by inverting 6 times. Following that, the RNA was left to precipitate 
overnight at -20 °C. The next day, the tube was centrifuged at 12,000 xg for 30 minutes 
at 4°C. Then, the supernatant was removed by pipetting. The pellet was washed with 
freshly made 75 % ethanol. After that the tube was centrifuged at 10, 000 xg for 10 
minutes at 4 °C. After that, the supernatant was removed by pipetting leaving about 5-
10 μl of ethanol. Then, the tube was briefly centrifuged using tabletop microcentrifuge 
to bring down all solution residues. Following that, using 10 μl tips, the remaining 
ethanol was carefully aspirated and the pellet was left to dry for 1-2 minutes. The pellet 
was dissolved and mixed in pre-warmed nucleus-free water and incubated at 55 °C for 
10 minutes. The concentration was measured by Nanodrop. 
 
2.3.4.2 DNAse treatment of purified RNA 
Following RNA extraction, 8-10 μg of RNA was subjected to DNAse treatment to 
eliminate remaining DNA. In 1.5 ml tube, 200 ng/μl of RNA was treated with TURBO 
2 units of DNAse Turbo in 1x Turbo buffer in a 50 ul reaction at 37 °C for 30 minutes. 
Then, extra 2 units of Turbo DNAse were added and mixed by pipetting. The tube was 
further incubated another 30 minutes. The reaction was inactivated by mixing  with 1/10 
volume of DNAse inactivation reagent and left at room temperature for 5 minutes with 
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occasional mixing. Then the tube was centrifuged at 10,000 xg for 1.5 minutes. The 
supernatant containing treated RNA was transferred to a new tube and stored at -80 °C. 
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2.3.4.3 First strand cDNA synthesis using SuperScript III reverse transcriptase 
The first strand cDNA synthesis was performed in a 200 μl PCR tube using 1-2 μg of 
Turbo DNase treated RNA (making sure that the volume does not not exceed 40% of 
total volume), 3 μl of 5x first strand buffer, 1 μl of 10 mM dNTPs mix, 0.5 μl of 50 μM 
oligo (dT) primer, 0.5 μl of random primer and nuclease-free H2O to 15 μl. The mixture 
was mixed by pipetting followed by a quick spin and incubated at 65 °C for 5 minutes. 
Following the incubation, the tube was immediately coolled on ice for 2 minutes then 
spun briefly. Then, the rest of the reagents were added: 2 μl of 0.1 M DTT, 1 μl of first 
strand buffer, 0.4 μl (per μg of RNA) of 200u/μl SuperScript III reverse transcriptase 
and nuclease-free H2O to 20 μl. The mixture were mixed and centrifuged briefly. The 
reaction tube was further incubated at 50 °C for 50 minutes followed by inactivation at 
70 °C for 15 minutes. The synthesised cDNA was stored at -20 °C until used. 
 
2.3.5 Real time PCR 
The expression of genes was assessed using relative quantification and comparative 
Ct method. In a total reaction of 10 µL, 2.5 µM of forward and reverse primer 
(mixed), 5 µl of Power Syber green, 5-10 ng of cDNA and nuclease-free water were 
mixed. The PCR reaction took place in a 384-well plate in an ABI SDS 7900 real-time 
PCR machine using the following parameters: initial denaturation at 95 °C for 10 
minutes, a total of 40 cycle of denaturation at 95 °C for 15s and annealing/extension at 
60 °C for 1 min. 
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2.3.6 Preparation of protein 
2.3.6.1 Preparation of total tissue lysate for Western blot 
To prepare protein samples for PAGE, 2 different lysis buffers was used based on the 
type of tissues. The buffers are as listed in Table 2-3. Following extraction, the 
concentration of the protein was determined using nanodrop at absorbance 280 nM or 
Qubit Fluorometer® Protein Kits  
  
2.3.6.2 Polyacrylamide gel electrophoresis (PAGE) 
For comparison of expression, total protein concentration was standardised and 
lysates were mixed with 4x Bolt® sample loading buffer in reduced conditions by adding 
of 2.5 μl of 14.3M β-mercaptoethanol for every 20 μl of sample buffer.  The sample was 
boiled for 5 minutes and instantly place on ice before loading into 4-12 % Bis-Tris 
polyacrylamide gel. Electrophoresis was performed in 1X Bolt® MOPS SDS Running 
Buffer at 200 V for 28 minutes. 
 
2.3.6.3 Western blot transfer 
In all western blot experiments, wet transfer was applied. All sponges and papers 
were pre-wet in 1x western transfer buffer (WTB, 25 mM Tris-HCL, 192 mM glycine, 
10 % v/v methanol, pH8.3). PVDF membrane was pre-wet in 100 % methanol for 15 
secs, rinsed in mili Q water for 2 minutes and in ice-cold 1x WTB for 5 minutes. Briefly, 
the gel and membrane are sandwiched between sponge and paper 
(sponge/paper/gel/membrane/paper/sponge) and all are clamped tightly together after 
ensuring that there is no air bubble between layers. The sandwich was submerged in 1x 
WTB and placed in an electrophoresis tank. The transfer process was done at 30 V for 
overnight in a cold room. Alternatively, it was carried out at 30v for 2 hours in a cold 
room. 
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Table 2-3: List of lysis buffer used for protein extraction 
 
  
Sample Lysis Buffer Components 
Nero2a,  
Neuroblastoma 
cell line   
RIPA 50 mM Tris, pH 8.0, 1 % NP-40, 0.5 % 
sodium deoxycholate, 0.1 % SDS, 150 mM 
NaCl, 2 mM EDTA
Mouse germ 
cells (for IP)
iCLIP 50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 1% 
NP-40, 0.1% SDS, 0.5% sodium deoxycholate
Mouse germ 
cells for 
western blot
1x LSB 60 mM Tris-HCL pH 6.8, 2 % SDS, 10 % 
glycerol, 2.5 % β-mercaptoethanol 
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2.3.6.4  Incubation with primary and secondary antibody 
All incubation and washing steps were done with agitation. Following transfer 
process, the membrane was instantly blocked with 3 % BSA (in 1x PBS and 0.05 % 
Tween 20) for 1 hour at room temperature. The remaining gel from the transfer was 
stained in Instant blue stain (Expedeon, cat. no. ISB1L) for 1 hour to assess the efficiency 
of the transfer process. Then, the membrane was incubated with primary antibody 
(H2A.Lap1- 1:5000) diluted in 1 % BSA/ PBS/0.05 % Tween at room temperature for 
1 hour with agitation. Alternatively, the incubation was also done at 4 °C overnight. 
Following primary antibody incubation, the membrane was washed with PBST (1x PBS, 
0.5 % Tween, 0.5 M NaCl) for 50 minutes at room temperature. After that, the membrane 
was washed with PBS/ 0.5 % Tween for 10 minutes at room temperature. Then, the 
membrane was incubated with secondary antibody (anti-sheep HRP- 1: 15,000) which 
was diluted in 1 % BSA/PBS,/0.05 % Tween) for 1 hour at room temperature. Following 
that, the membrane was washed 3 times with PBS/ 0.05 % Tween for 5 minutes at room 
temperature.  
 
2.3.6.5 Image development 
For HRP-conjugated antibodies, Immobilon Western Chemiluminescent HRP 
substrate was used. Working HRP substrate was prepared by combining equal volumes 
of Luminol Reagent and Peroxide Solution. The substrate was spread onto the membrane 
by pipetting and left for 5 minutes. Then the membrane was exposed to 
chemiluminescence in LAS 400 machine with various time of exposure (from 10 s to 3 
minutes) depending on the strength of the signal. Alternatively, for a more sensitive 
signal detection, X-ray film was used. 
 
2.3.7 Preparation of protein for immunoprecipitation (IP) 
2.3.7.1 Beads preparation 
To assess H2A.Lap1 protein from testes, 1 whole testicle was used in preparing the 
total cell lysate. Firstly, the procedure was begun by preparing the protein A and protein 
G beads for coupling to H2A.Lap1 antibody. Fifty μl of Magna ChIP™ Protein A 
Magnetic Beads (Milipore, cat. no. 16-661) and 50 μl of Dynabeads® Protein G (Life 
Technologies, cat. no. 10004D) were mixed in a 1.5 ml tube. The beads were washed by 
adding 900 μl of iCLIP buffer (50 mM Tris-HCl, pH 7.4; 100 mM NaCl; 1% NP-40; 
0.1% SDS; 0.5% sodium deoxycholate) followed by inverting the tubes 10 times. To 
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remove the buffer, the tube was place in a magnetic holder and the supernatant was 
removed by pipetting. The washing step was repeated 3 times. Then the beads were 
resuspended with 200 μl of iCLIP buffer and 20 μl of sheep anti-H2A.Lap1 antibody. 
The mixture was mixed at RT for 1 hour on a rotator to allow conjugation of the protein 
to the antibody. Following the incubation, the beads were washed for 5 minutes with 
900 μl of iCLIP buffer on a rotator. The washing step was repeated 3 times. Then, the 
beads were resuspended with 200 μl of iCLIP elution buffer (iCLIP buffer added with 
1x Protease Inhibitor cocktail (Roche, cat. no. 05892791001) and 1 mM of AEBSF 
(Enzo Life Science, cat. no. ALX-270-022-G001)). The beads were kept at 4 °C until 
use. 
 
2.3.7.2 Total cell lysate preparation 
A cell pellet from 1 whole testicle was resuspended in 900 μl of iCLIP elution buffer 
in a 1.5 ml tube by pipetting on ice for 20 minutes. To facilitate the lyse, the cell pellet 
was passed through pre-chilled 1 ml syringe with 25G and 23G needle for 10 times. 
Then, to lyse the DNA from the cell, 4 μl of 2U/ μl TURBO DNase (Ambion, cat. no. 
AM1907) was added to the tube and mixed well prior to incubation at 37 °C for 10 
minutes. Following the incubation, the reaction tube was centrifuged at 16,000 xg at 4 
°C for 30 minutes. The supernatant was transferred to a new 1.5 ml tube and kept on ice. 
The pellet containing unbroken nuclei was resuspended with 200 μl of iCLIP elution 
buffer. The pellet was sonicated on ice for 5 minutes with 15 seconds pulse. Then the 
cleared supernatant was combined and centrifuged at 16,000 rpm for 15 minutes at 4 °C 
to pellet any remaining debris. The supernatant containing the total cell lysate were 
transferred to a new tube and the OD is measured at 280 nM. The sample was kept at -
20 °C until use. 
 
2.3.7.3 Immunoprecipitation assay 
The total cell lysate (about 950 μl) were combined with 100 μl of antibody-conjugated 
beads (from section 3.1.1). The sample was mixed for 4 hours on a rotator at 4 °C. 
Following the incubation, the tube was placed on a magnetic holder and the flow through 
was transferred to a fresh 1.5 ml tube and kept at -20°C until use. The beads were washed 
for 5 minutes with high salt wash buffer (50mM Tris-HCl, pH7.4; 1M NaCl; 1mM 
EDTA; 1% NP-40; 0.1% SDS; 0.5% sodium deoxycholate) 2 times on a rotator at 4 °C. 
Following the high salt buffer washing step, the beads were washed twice with wash 
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buffer (20 mM Tris-HCl, pH 7.4; 10 mM MgCl2; 0.2% Tween-20) for 5 minutes on a 
rotator at 4 °C. Then, the buffer was removed. The beads were resuspended with 20 μl 
of reduced 1x Bolt® LDS Sample Buffer (which included 12.5 mM β-mercaptoethanol). 
The beads were heated at 80 °C with shaking at 800 rpm for 10 minutes. Following the 
heating, the tube was immediately placed on a magnetic holder and the eluate was 
collected and transferred to a new 1.5 ml tube and instantly placed on ice. The sample 
was kept at -20 °C until use. 097714898 
 
2.4   Extraction of mouse tissues  
2.4.1 Extraction of germ cells from testes for hypotonic spreads and fixation 
All procedures that involved extraction of tissues were done under the approval of 
Biomedical Animal Ethics Protocol number A2014/33. All procedures of extraction 
were conducted in Containment Suite #3, JCSMR building. 
A day before the tissues extraction, the following buffers were prepared and stored at 
4 °C. For testes collection, the PBSGL buffer was used which consisted of 1x PBS, 5.6 
mM glucose, 5.4 mM sodium DL-lactate, EDTA-free 1x protease inhibitor cocktail (was 
freshly added to the 1x PBSGL just prior to extraction).  
The method is based on the well-known protocol (Peters et al. 1997). Briefly, mouse 
was ethically culled using cervical dislocation method. Once the mouse was confirmed 
dead, it was placed on its back on a paper towel. The abdominal part was cleaned with 
70 % EtOH and an V section was made at about 1 cm above genitals. The skin was torn 
open and a cut was made in the muscle tissue. A long cut was made to expose the fat 
pads and the testicles. Then, the testes were pulled out and placed in a well of 12-well 
plate containing 2 ml PBSGL. Then, a small incision was made in the tunica albuginea 
and the seminiferous tubule was squeezed and transferred into a petri dish on ice 
containing 1 ml of PBSGL. The tubules were rinsed to remove blood and interstitial cells 
and cut for 1 minutes (on ice) with scissors to release the germ cells. Then, when the 
media became cloudy, all of the mixture was mixed gently by pipetting 10 times before 
transferring it into 1.5 ml tube. Then, the mixture was centrifuged at 1200 rpm for 5 
minutes at 4 °C. The supernatant was aspirated and discarded, leaving about 20 µl of 
media in the tube. The cell pellet was resuspended gently by flicking the tube and 80-
160 µl (depending on the size of the pellet) of hypotonic buffer (100mM sucrose, 3mM 
Tris-HCL pH 8.) was added. Then, the cells were left on ice for 5 minutes to swell up. 
Whilst waiting for the cells to swell up, hydrophobic circles were drawn on the slide. 
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Then, a thin layer of 2 % PFA in water, containing 0.05 % Triton, pH at 9.2, was spread 
inside the circle. Then, about 5-10 µl of the hypotonic cells was drop onto the slide and 
spread by rotating the slide. The cells were fixed in a humidity chamber for 2 hrs at room 
temperature. After that, the lid of the chamber was lifted off to let the slides to dry 
completely. The slides were stored in -80 °C.  
For whole testicle fixation for IHC analysis, 10 % Neutral-Buffers Formalin was used 
(NBF), which consists of 9.2 M NaH2PO4, 33.3 mM Na2HPO4, 3.65% formaldehyde. A 
whole testicle was placed in a 15 ml tube containing 10 ml of 10% NBF. The tissue was 
left in the fixation solution and incubated at room temperature on a wheel with rotation. 
After 1 hour, the solution was carefully removed and a fresh 10 % NBF was added. The 
tissue was left to fix with rotation for 4-24 hours. Then, tissue was washed 3 times with 
fresh 70 % ethanol, 10 minutes for each wash. Finally, the fixed tissue was sent to the 
Histology lab of JCSMR Imaging and Cytometry Resource Facility for processing and 
paraffin embedding. 
 
2.4.2 Sperm extraction from mouse cauda epididymis for sperm swim-up 
Before the extraction, 4 ml of Donners medium (135 mM NaCl, 5 mM KCl 1 mM 
MgSO4, 2 mM CaCl2 , 30 mM HEPES, pH 7.4, 25 mM NaHCO3, 20 mg/ml BSA, 1 mM 
sodium pyruvate and 0.53 % (v/v) sodium DL-lactate) was placed in a 5 ml round bottom 
tube. The caudal epididymis was dissected using fine scissors and forceps. Then, 2-3 
cuts were made in each epididymis. After that, the epididymis was gently placed at the 
bottom of round-bottom tube. Then, another 3 ml of Donners medium was added along 
the wall of the tube. Following that, the tube was incubated at 37 °C for 1 hr to allow 
sperm to swim up to the upper phase of the medium. After incubation, 2.5 ml of the 
upper phase was removed into 15 ml tube. Then, 10 µl of the suspension, was diluted 
1:1 with 0.4 % trypan blue stain and viewed under microscope for morphological 
observation and cell count. 
 
2.5 Immunofluorescence staining  
Slides that were stored at -80 °C was equilibrated in a cold room for 10-15 minutes. 
Then, slides were placed in glass chamber containing ice cold PBS and placed at room 
temperature for 15-20 minutes to warm up. Alternatively, for wet-prep slide, after 2 hr 
fixation with 2 % PFA, the excess tissues were washed with water in the upright glass 
chamber gently. Then, the antigen blocking step was conducted by pipetting onto the 
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slide 3 % BSA/PBS for 2 hrs at room temperature in humidity chamber. In the meantime, 
primary antibody mix were prepared in 1 % BSA/PBS containing 0.1 % Tween®20. 
Then, the blocking mixture was removed by tapping the slides on a tissue. Immediately, 
primary antibody was pipetted onto the slide. The incubation was done at 4 °C overnight 
in humidity chamber. Alternatively, the slide was also incubated at 37 °C for 1 hr. After 
primary antibody incubation, the secondary antibody was prepared the same way as the 
primary. Then, after the removal of primary antibody, the slide was washed 3 times with 
1x PBS 5 minutes for each wash. Then, the slide was incubated with secondary antibody 
which was prepared in the same buffer as the primary antibody and incubated for 1 hr at 
room temperature in dark. Following secondary antibody incubation, all steps were 
conducted in dark. The slide was washed 2 times with 1x PBS. Then, in the upright glass 
chamber, the side was stained with 0.2 mg/ml DAPI in water for 2-5 minutes. Then, the 
slide was washed with water for 1 minute. To protect the fluorescence signal, 10-20 µl 
of mounting medium (Vectashield) was dropped onto a coverslip, placed on the slide to 
cover the cell-containing area and sealed with nail polish. The slide was stored in the 
dark at 4 °C. Visualisation and documentation was done using Leica SP5 confocal 
microscope.  
 
2.6 Mammalian cell culture and transfection 
2.6.1 Mouse neuroblastoma 2a (Neuro2a) cell culture 
Mouse Neuro 2a cells were cultured at 37 °C in a humidified atmosphere with 5 % 
CO2 in RPMI medium supplemented with 10 % FBS and 2 nM L-glutamine 
supplemented with penicillin (100 U/ml) and streptomycin (100µg/ml). 
 
2.6.2 Transfection with Lipofectamine 2000 
A day before transfection, 5 x 105 of cells per well were seeded in a 6-well dish. Then, 
transfection was done according to manufacturer’s protocol. The plasmid DNA 
concentration was adjusted to 0.5 µg/µl and a total of 250 ng of DNA were transfected 
into the cells in a serum-antibiotic-free condition. After 5 hrs, the medium was changed 
to normal growth medium. The cells were allowed to grow for another 24-48 hrs, prior 
to collection for further experiments. 
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2.6.3 Cel1 assay 
Forty-eight hours post-transfection, the cells were harvested and subjected to gDNA 
extraction as described in section 2.3.2.2. Then, the PCR amplification was conducted 
to amplify all 3 H2A.Lap1 genes as described in section 2.3.3.1. After confirming the 
presence of amplicons in 2 % agarose gel electrophoresis, 10 µl of the PCR product was 
transferred into 200 µl PCR tube and subjected to annealing program as follow: 95 °C 
10 mins, slow-gradient decrease from 95 °C to 85 °C at 2°C per second, rapid-gradient 
decrease from 85 °C to 25 °C at 0.1 °C per second and 4 °C as holding temperature. 
Then, 1 µl of Cel1 enzyme was added and mixed to the tube and incubated at 42 °C for 
30 minutes. After that, the tube was placed on ice to stop the reaction. Then, digested 
sample were prepared for native PAGE for visualisation and documentation as described 
in section 2.3.3.2. 
 
Reference 
Peters, A.H. et al., 1997. A drying-down technique for the spreading of mammalian 
meiocytes from the male and female germline. Chromosome research : an 
international journal on the molecular, supramolecular and evolutionary aspects 
of chromosome biology, 5(1), pp.66–8. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/9088645 [Accessed January 10, 2018]. 
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CHAPTER 3 
TALEN PLASMID DESIGN AND THE 
ESTABLISHMENT OF H2A.LAP1 KNOCKOUT 
(H2A.LAP1KO) MOUSE COLONY 
 
3.1 TALEN plasmid design and preliminary testing by Sangamo  
Transcription activator-like (TAL) effector nucleases (TALENs) are highly 
effective in inducing mutations at specific genomic loci and are a potential alternative 
to conventional gene targeting in mice. TAL proteins are transcriptional activators 
from Xanthomonas bacteria, that can bind to specific host DNA sequences and 
regulate plant genes during pathogenesis. Within the TAL structure, a central repeat 
domain mediates DNA recognition, with each repeat unit of 33–35 amino acids 
specifying one target base. DNA binding specificity is determined by the amino acids 
at positions 12 and 13 within each repeat, referred to as the repeat variant di-residue 
(RVD) (Figure 3-1). These motifs determine the base preference (Boch et al. 2009; 
Christian et al. 2010; Miller et al. 2011). 
The design of TALENs to target the H2A.Lap1 encoding gene was carried out 
by our collaborators from US-based company, Sangamo Ltd. At the time of TALEN 
design, in 2011, the Ensembl release 57 (March 2010) database listed four H2A.Lap1-
coding genes in mice: H2Afb3 (mH2A.Lap1a), Gm14920 (mH2A.Lap1b), H2Afb2 
(mH2A.Lap1c), and a pseudogene Gm14904, which was subsequently removed from 
all assemblies in later releases.  The H2A.Lap1 genes are over 92% identical in DNA 
sequence (with H2A.Lap1a and H2A.Lap1b being 98% identical), while the 
pseudogene is only 87% identical. All four genes are located on the X-chromosome 
(Figure 3-2, Table 3-1). The alignments of the four H2A.Lap1 genes are shown in 
Figure 3-3. 
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  Table 3-1: Genomic coordinates for H2A.Lap1 encoding 
genes. 
Gene 
Names 
Origin 
strand 
Chromosome 
Name 
Locus 
start 
Locus end % 
identical 
Length 
H2afb3 
ENSMUSG00000083616 
(H2A.Lap1a) 
- X 117426357 117426704 100 348 
Gm14920 
ENSMUSG00000067441 
(H2A.Lap1b) 
+ X 114128366 114128713 98.28 348 
H2afb2 
EG624153 
(H2A.Lap1c) 
+ X 113794787 113795134 92.55 349 
Gm14904 
ENSMUSG00000084053 
pseudo 
+ X 113311798 113312139 87.83 345 
 
 
 
 
Figure 3-1:  Schematic diagram of TALEN construct. 
Figure 3-2: H2A.Lap1 encoded genes on the X-chromosome 
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Figure 3-3: The alignment of H2A.Lap1 encoded genes. 
77 
 
Although the aim of this project was to target all H2A.Lap1 genes with one pair 
of TALEN constructs, two groups of H2A.Lap1-targeting TALENs were designed to 
test the specificity of TALENs given the high similarity between the three H2A.Lap1 
genes. One group targeted sequences present in all four H2A.Lap1 genes, while the 
second group targeted H2A.Lap1a gene only, subsequently shown to be the main gene 
expressed in the testes (see Table 3-2). The second group was designed to test how 
specific TALEN targeting can be in the case of highly homologous genes.  The 
alignment of these plasmids in the H2A.Lap1 genes is shown in Figure 3-4 (A). The 
nucleotide specificity of these plasmids lies in the 12th and 13th position of the repeat 
variable di-residue (RVD) in TAL effector repeats (shown in Figure 3-4 (B)). 
Zhang and colleague of Sangamo Bioscience, Inc, designed 19 plasmids (Table 
3-2) to target various regions of the genes on both DNA strands. The plasmids were 
paired to 22 pairs to find the pair that produces the highest activity, ensuring that a 
construct targeting a plus strand is paired with a construct targeting a minus strand, in 
its vicinity. In order to test the nuclear activity of FokI cleavage, each combination of 
two TALEN plasmids was transfected into mouse neuroblastoma 2a (Neuro 2a) cells 
using Lipofectamine 2000, as described in Chapter 2, section 2.7.2. The cells were 
harvested 24 h post-transfection for gDNA extraction, as described in Chapter 2, 
section 2.3.2.2. The H2A.Lap1 targeted sequence for each plasmid is shown in Figure 
3-4 (A). The ability of TALEN to cleave all H2A.Lap1 genes was tested by Sangamo, 
using two methods, Dual-Luciferase Single Strand Annealing Assay (DLSSA) and 
CelI cleavage assay in mammalian neuroblastoma 2a (Neuro 2a) cells.  
  
78 
 
 
 
      A  
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
Figure 3- 4: TALENs design are specific to target H2A.Lap1 genes. A) The 
alignment of TALEN’s targeting sequence to H2A.Lap1 genes. Blue coded is 
top strand, red coded is bottom strand. H2A.Lap1 gene targeted sequences that
are bound by TALEN RVDs were designed by Zhang et al (2011) as listed in
Table 3-2. Not all RVDs sequences were shown on H2A.Lap1 sequence. Only
RVDs sequence that produced the highest activity in DLSS assay were chosen
for transfection into Neuro 2a cells. B) Each TALEN consists of a DNA binding 
domain (obtained from TAL effector protein) fused to Fok1 endonuclease. The
nucleotide specificity lies in the 12th and 13th position (of total 30-34 amino 
acids) of the RVD in TAL effector repeats. This RVD recognition is one
nucleotide base.  
                                            101408 CGCCGCCACCGTCGCT  
                        101406 CAGGTCGCCGCCACCGTCG 
                                 101421 CCCGCACCTCCAGAG 
Lap1a ATGCCAAGGAACAGGGAAAACTGTCTTCGAGAGTCTTCAGGTCGCCGCCACCGTCGCTCCCGCACCTCCAGAGCT 
Lap1b --------------------------------------------------------------------------- 
Lap1c -------------C--------------A-AG-----------A------A-A--A-----------------G- 
Pseudo ----------G--CA------A-------T-G-G--------T--A------T-T------:------------C 
 
101409   TCGATTAGAAACGACAC 
Lap1a GAGCTAATCTTTGCTGTGAGCCTGGTGGAACAGCATCTGAGGGAGGTTAGCCGTGCCCGGAGGCTCAGTGATACG 
Lap1b -----G--------A------------------------------A-----------T---------------T- 
Lap1c -----G--------A----------------------------------------------------------T- 
Pseudo  -----G------A-A------------------AG---------CC------A----T---------------T- 
                     CACTCGGACCACCTTG 101422 
                TCGGACCACCTTGTCG 101423 
       
Lap1a GTGCCCATCTTCCTGGCAGCCATCCTGGAGTCCCTCACCCGCAGGTTGCTGGAGCTTGCCGGCAATGAGGCCCAA 
Lap1b -----------------------------------------------------------G--------------- 
Lap1c ------G---C-----T--------------T-------A-------------------G--------------- 
Pseudo  -----A—T-----------------------T-------TA----C-------------G---------A----G 
 
Lap1a CGCAGAGGTACCGAGAGGCGCATCAACTCCTGAACTGCTGGACTTGGCTGTCTACAGCAATATGGAGCTAAGTGA 
Lap1b --------------------------------------------------------------------------- 
Lap1c ------------C------T-----------C---C-----------AG----------G--------------- 
Pseudo  -AG---------C---T-A----------------------------AG-----T---------C---------- 
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Table 3-2: List of TALEN plasmids designed by Zhang et. al. 
Gene 
specificity 
Design # Name Binding site 
 
 
 
Specific to 
H2A.Lap1a 
101406 mH2A.Lap1--Tf1054a1 ttCAGGTCGCCGCCACCGTcg 
101407 mH2A.Lap1--Tf1058a1 gtCGCCGCCACCGTCGCTcc 
101408 mH2A.Lap1--Tf1059a1 gtCGCCGCCACCGTCGCTCcc 
101409 mH2A.Lap1--Tr1077a1 ctCACAGCAAAGATTAGCTca 
101410 mH2A.Lap1--Tr1078a1 ctCACAGCAAAGATTAGCtc 
101412  mH2a.Lap1--Tr1081a1 ctCACAGCAAAGATTag 
101413 mH2A.Lap1--Tf1090a1 ctGAGCTAATCTTTGCTgt 
101415 mH2A.Lap1--Tf1092b1 ctAATCTTTGCTGTga 
101416 mH2A.Lap--Tf1094a1 ctAATCTTTGCTGTGAgc 
101417 mH2A.Lap1--Tr1107a1 ctAACCTCCCTCAGATGCTgt 
101418 mH2A.Lap1--Tr1110a1 ctAACCTCCCTCAGATgc 
101419 mH2A.Lap1--Tr1119a1 ctCCGGGCACGGCTAACCTcc 
 
Conserved among 
H2A.Lap1a,b and 
c 
101421 mH2ALap1--Tf1073a1 ctCCCGCACCTCCAGAGct
101422 mH2ALap1--Tr1091a1 ctGTTCCACCAGGCTCACag 
101423 mH2A.Lap1--Tr1094a1 ctGCTGTTCCACCAGGCTca 
101424 mH2ALap1--Tf1113a1 ctGGTGGAACAGCATCTga 
101426 mH2ALap1--Tr1134a1 gtATCACTGAGCCTCCgg 
101427 mH2ALap1--Tf1207a1 gtTGCTGGAGCTTgc 
101429 mH2ALap1--Tr1224a1 gtACCTCTGCGTTcc 
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DLSSA is a novel system used to optimize and quantify ZFN or TALEN 
activities in transiently transfected cells. DLSSA is based on the Dual-Luciferase 
Reporter Assay System from Promega. Based on Gregory et al. (2014), the system 
allows for sequential measurement of two individual reporter enzymes, firefly 
(Photinus pyralis) and sea pansy (Renilla reniformis) luciferases, within a single tube. 
Both the firefly and the Renilla luciferase reporters have been re-engineered so that 
the firefly luciferase reporter construct contains two incomplete copies of the firefly 
coding regions, separated by DNA binding sites for either ZFNs or TALENs (Gregory 
et al. 2014). The 5' copy is derived from approximately two thirds of the N-terminal 
part of the firefly gene, and the 3' copy is derived from approximately two thirds of 
the C-terminal part of the firefly gene. The two incomplete copies contain 600-bp 
homology arms. The separated firefly fragments have no luciferase activity. ZFN and 
TALEN create a DNA double strand break which will trigger recombination that the 
flanking repeat, using the single strand annealing pathway, and subsequently restore 
the firefly luciferase function. The co-transfected promoterless Renilla luciferase 
plasmid provides an internal control. The luminescent activity of each reporter is read 
on a luminometer. Normalizing the activity of the experimental reporter (firefly) to 
the activity of the internal control (Renilla) minimizes experimental variability caused 
by differences in cell viability and/or transfection efficiency. The normalized value is 
used to determine the activity of a given ZFN or TALEN pair (Gregory et al. 2014). 
 
3.1.1 Pair 101421:101422 showed the highest activity in all four H2A.Lap1 genes 
The plasmid pair 101421:101422 was transfected into Neuro 2a cells and the 
Fok1 activity assessed using DLSSA assay, as shown in Figure 3-5. This assay was 
performed by Ranier Amora (2011) of Sangamo Biosciences Inc. 
The DLSSA were conducted on pairs that were intended to target the major form 
of H2A.Lap1, that is H2A.Lap1a gene, and also pairs that target all four H2A.Lap1 
encoded genes. Remarkably, all TALEN pairs that were designed to target 
H2A.Lap1a gene only, had a very high activity for H2A.Lap1a gene, with 10 out of 
14 pairs displaying preferential specificity to that gene. The pair that showed the 
highest specificity to the H2A.Lap1a gene only was 101418:101412. Meanwhile, the 
pair that showed the highest activity in all four genes was 101421:101422.  
Based on this observation, the CelI assay was used next to determine the TALEN-
induced gene modification activity in transiently transfected mouse Neuro 2a cells.
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Figure 3-5: TALEN plasmid pair 101421:101422 showed a high enzyme 
activity on all H2A.Lap1 genes. The graph showed DLSS assay on 22 pairs of 
TALEN plasmids. The histogram showed that TALEN pairs 101421:101422 and
101421:101423 have the highest activity of all four H2A.Lap1 genes compared to
other TALEN plasmid combinations, while 101418:101412 pair was the most 
specific against the main H2A.Lap1 gene, H2A.Lap1a. 
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3.1.2 Surveyor (CelI) assay showed pair 101421:101422 to have the highest 
activity 
The principle behind the CelI assay is that, once a double stranded break (DSB) 
is introduced by Fok1, the affected DNA will be naturally repaired by the error-prone 
non-homologous end joining (NHEJ) or by homologous recombination. The NHEJ 
process will create mismatch in some of the base pairs. When these strands are 
amplified via PCR, the mutated and wild type (wt) loci copy number is increased. The 
heterogenous PCR products are then subjected to a denaturation step, followed by a 
slow gradual re-annealing process. Because of the slow re-annealing process, some 
mutated strands will bind to wt complementary strands creating DNA heteroduplexes 
(Figure 3-6), producing a “bubble” in the mispaired region. 
CelI surveyor nuclease has a high specificity for mismatched DNA 
heteroduplexes, and when added to the reaction, it only cleaves heteroduplexes, 
producing shorter DNA fragments that can be visualised on agarose or 
polyacrylamide gel. The results of the CelI digestion are shown in Figure 3-7.  
Only TALEN pairs designed to target all four H2A.Lap1 genes were tested by 
CelI assay. The gel in Figure 3-7 showed that not all pairs of plasmids were able to 
produce an efficient digestion. Based on the percentage shown at the bottom of the 
gel, plasmid pair 101421:101422 showed the highest percentage of digestion in all 
three genes. The quantification of the bands is represented in the graph below (Figure 
3-8). 
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Figure 3-6: Schematic diagram of CelI assay principle. This assay 
involved heteroduplex formation by denaturing the amplicons at 95°C for 10
mins, followed by slow and gradual annealing, by decreasing the temperature
to 25 °C. During the slow temperature decrement, some wt strands bind to
mutated strands forming a “bubble” that results from mismatched DNA. The
CelI enzyme recognizes this mismatch and digests it. Hence, different sizes 
of DNA are visibly distinguishable via polyacrylamide gel electrophoresis.
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Figure 3-7: Three TALEN plasmid pairs showed a visible CelI digestion 
product on all H2ALap genes. The gel image showed CelI assay on all H2A.Lap1 
amplicons amplified from the gDNA of Neuro 2a cells transfected with TALEN
plasmids. The gel showed the digested amplicons of four H2A.Lap1 genes from
CelI assay using Neuro 2a cells. The wt uncleaved H2A.Lap1 band is indicated by 
the blue arrow and gave the most intense band on the gel. The cleaved amplicons
(heteroduplex strand) are indicated by the black arrow. The plasmid pairs
highlighted in red and blue were sent to us for confirmation of this observation. 
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Figure 3-8: TALEN plasmid pair 101421:101422 has the highest CelI enzyme
cleavage in H2A.Lap1 genes. This graph represents quantification of non-
homologous end joining, expressed as percentage produced by Cel1 assay 
depicted in Figure 3-7. The pair in green box are the plasmid pair which have the
highest cleavage percentage present in all four genes. 
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3.2 Validation of TALEN activity assay in cultured Neuro 2a cells 
3.2.1 Optimisation of Neuro 2a transient transfection using CMV-driven GFP 
plasmid 
To replicate observations by Sangamo, we cultured Neuro 2a cells in our 
laboratory and transfected them with two plasmid pairs, 101421:101422 and 
101414:101418. The transfection efficiency test was done prior to transfecting the 
cells with TALENs plasmids. To examine the efficiency of transfection conditions, 
we tested Neuro 2a cells using pEGFP-N1 because it contains the same CMV 
promoter as the TALEN plasmids. Briefly, in each well of a 24-well dish, the cells 
were transfected with 0.5 µg of plasmid DNA using 2.5 µl of Lipofectamine 2000 in 
a serum-antibiotic free medium for 24h. Figure 3-9 shows the three biological 
replicates of the transfected cells. Table 3-3 indicates the intensity of GFP and the 
percentage of cells transfected. The average number of cells that were successfully 
transfected by pEGFP-N1 is 67.9 % which was comparable to Neuro 2a transfection 
efficiency by Sangamo.  
The next step was to confirm the results obtained by colleagues from Sangamo 
and to choose the best TALEN pair for injection into mouse embryos, to create a 
H2A.Lap1 knock out (H2A.Lap1KO) mouse model. We cultured our Neuro 2a cells 
and transfected them with two TALEN plasmid pairs (101421:101422 and 
101414:101418) to obtain transient TALEN expression. Twenty-four hours post-
transfection, we harvested the cells and subjected them to genomic DNA (gDNA) 
extraction using Quick Extract Solution 2.0, as described in Chapter 2, section 2.3.2.2. 
The gDNA was then subjected to PCR amplification, as described in Chapter 2, 
section 2.3.3.1 
The list of primers used for amplification is shown in Table 3-4. To optimise the 
mutation detection method, we re-designed the primers for H2A.Lap1b gene to obtain 
a shorter amplicon (398 bp), for a better gel resolution. The amplicons were subjected 
to CelI assay as described in Chapter 2, section 2.7.3. The products of CelI enzyme 
digest were loaded onto 10% TBE gel and post stained with 0.5 µg/ml of EtBr. Figure 
3-10 shows a gel picture of all 4 H2A.Lap1 genes (in duplicate) isolated from Neuro 
2a cells, transiently transfected with TALEN plasmid pair 101421:101422 and 
101414:101418. CelI  assay shows that cells transfected with plasmid pair 
101421:101422 have cleaved bands present in all four genes and that they digest more 
efficiently than plasmid pair 101414:101418. This observation confirmed the findings 
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of Sangamo and gave us confidence to use this particular TALEN plasmid pair for 
microinjection into mouse embryos. 
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Table 3-3: The percentage of transfected Neuro 2a cells by pEGFP-N1.  
Replicate Total cells 
transfected 
(GFP/DAPI) 
(%) 
Percentage of transfection (Green channel 
only)
Total 
cells 
(DAPI 
only) Weak Medium High 
1 96 (70%) 44 30 22 137 
2 137 (75.3 %) 43 68 26 182 
3 116 (58.6 %) 38 41 37 198 
 
 
 
 
 
 
 
 
 
Figure 3-9: Optimised parameters with high transfection efficiency
was used in the transfection of TALEN pair 101421:101422 into Neuro
2a cells.  Images of Neuro 2a cells transfected with pEGFP-N1. The green 
florescent cells indicate cells that were transfected with the vector. Blue
florescence represents DAPI stained nuclei. 
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Table 3-4: List of standard PCR primers for H2A.Lap1 encoding genes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
H2A.Lap1 gene 
family 
Sequence  
(5’-3’)
Size of  
amplicon 
H2A.Lap1a 
(by Sangamo) 
Fwd- CAGCAGAAAGCAGCCAAGTGG  
Rev- GCAGGTCAGCCAAGAAGCA 
440 bp 
H2A.Lap1b 
(by Sangamo) 
Fwd- GTACGGTACAAAGGGAGATG 
Rev- GAGCAGGTCAGCCAAGCAGAG 
536 bp 
H2A.Lap1b Fwd- GTTGGGCATTGGACTTGGAC Rev-  CAGCCAAGTCCAGCAGTTC 
398 bp 
H2A.Lap1c 
(by Sangamo) 
Fwd- CAGGTCAGCAGAGAGCAATT 
Rev- CTCCATACTGCTGTAGACCT 374 bp 
H2A.Lap1Pseudo 
(by Sangamo) 
Fwd- GTCAGCAGAATGCAGCCAAATAT 
Rev- CAAGCCAGTAGCCAACATCAAG 459 bp 
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Figure 3-10:  TALEN 101421:101422 works efficiently in our mouse Neuro
2a cell culture. CelI assay on all H2A.Lap1 genes amplified from the gDNA of
Neuro 2a cells transfected with TALEN plasmids. A) CelI assay of H2A.Lap1 
amplicons (in duplicate for technical control) from Neuro 2a cells transfected
with plasmid pair 101421:101422 and B) CelI assay of H2A.Lap1 amplicons
from Neuro 2a cells transfected with plasmid pair 101414:101418.  
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3.2.2 T7 endonuclease I (T7EI) digests more efficiently than CelI surveyor 
nuclease in Neuro 2a cells 
Just like CelI, T7EI recognizes and cleaves imperfectly matched DNA. It also 
cleaves cruciform DNA structures, Holliday structures or junctions, heteroduplex 
DNA and more slowly, nicked double-stranded DNA. The cleavage site is at the first, 
second or third phosphodiester bond that is 5´ to the mismatch. In addition to being a 
cheaper alternative than the CelI surveyor nuclease, T7E1 has been shown to 
outperform CelI surveyor nuclease, in terms of sensitivity, with deletion in 
heteroduplex strands (Vouillot et al. 2015). 
Initially, we employed CelI assay to confirm TALEN activity in our Neuro 2a 
cells. However, we found that incubation with T7EI enzyme gave a better digestion 
efficiency (Figure 3-11).  
We tested the same Neuro 2a cells transfected with TALEN plasmid pair 
101421:101422, and amplified H2A.Lap1a, via the same PCR conditions. The 
cleaved band was quantified using ImageJ (Figure 3-11). We set up various digestion 
conditions, that include various enzyme concentrations (1 U-10 U) and duration of 
incubation (20 mins to 1 h). The results showed higher digestion efficiencies and more 
abundant cleaved bands in T7EI enzyme digestions in Neuro 2a cells. However, as 
we further employed T7EI enzyme to detect mismatch in our mice colony, we found 
that gDNA extracted from mouse ear punch showed better digestion efficiency with 
CelI enzyme. Therefore, we used the CelI enzyme for assaying our mice colony.  
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Figure 3-11: T7 endonuclease I digests more efficiently than CelI. The 
10% TBE gel showed digested H2A.Lap1a amplicons from Neuro 2a cells
(transfected with 101421:101422) under various conditions. As a positive
control, we used the digestion conditions suggested by Zhang et. al.  Black 
arrows show digested heteroduplex strands, whilst blue arrows indicate
homoduplex strands. Numbers in each lane represent the percentage of
cleavage/digestion. 
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3.2.3 H2A.Lap1 pseudogene Gm14904 is likely an assembly error   
As mentioned earlier, the design of H2A.Lap1-specific TALENs was done in 
2010, when Ensembl assembly (Ensembl Release 57, March2010) listed four 
H2A.Lap1 genes in mice genomes. The TALEN pair 101421:101422 successfully 
targeted three H2A.Lap1 genes but didn’t produce detectable alterations in the 
H2A.Lap1 pseudogene, Gm14904. Later mouse genome assemblies removed this 
gene altogether. Although Gm14904 is a pseudogene and, in theory, shouldn’t be 
expressed, many novel genes are often listed as pseudogenes until their expression is 
shown experimentally.  Our qPCR analysis showed that three H2A.Lap1 genes, 
H2afb3 (H2A.Lap1a), Gm14920 (H2a.Lap1b) and H2afb2 (H2A.Lap1c) were 
expressed in the testis of wt mice, while the expression of a pseudogene Gm14904 
was not detected (Figure 3-12). Hence, we concluded from our experimental analysis 
and Ensembl’s latest Assemblies that only three H2A.Lap1 genes are expressed, and 
TALEN 101421:101422 pair’s inactivity on the pseudogene, should not affect the 
knockout of H2A.Lap1. 
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Figure 3-12: The expression level of H2A.Lap1 mRNA in FVB/NJArc 
mouse. qPCR results using gene-specific primers. Expression relative to 
mouse -actin. 
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3.2.4 Screening potential founder mice for single nucleotide polymorphisms 
within three H2A.Lap1 genes 
One of the last steps we performed before attempting to produce a H2A.Lap1 KO 
in FVB/NJArc mice, was to investigate the presence of single nucleotide 
polymorphisms (SNPs) within all H2A.Lap1 genes, in this mouse strain.  Although 
most laboratories use inbred strains, one cannot rule out that mice are not completely 
inbred or, due to handling errors, may have been bred with a different strain, that is 
phenotypically similar, and thus may contain an appreciable number of SNPs. Since 
SNPs in the vicinity of H2A.Lap1 genes will create a signal in the surveyor nuclease 
assay, their presence would produce a false-positive result. Therefore, prior to 
microinjection of the TALEN plasmid, we performed the CelI assay on potential 
founder mice (Figure 3-13).  
FVB/NJArc are commonly used for production of transgenic mice because their 
fertilized eggs contain large and prominent pronuclei which facilitate the 
microinjection of DNA. This strain also produces a large number of pups (12-15 per 
litter), which is crucial for creating enough Po founders. (JAX® Mice Database). As 
shown in Figure 3-13, we have amplified three H2A.Lap1 genes from gDNA 
extracted from WT male and female FVB/NJArc mice ear notches. The amplicons 
were subjected to CelI assay and no detectable cleaved bands were identified. Hence, 
no SNPs were detected in the amplified regions, in this particular mouse strain. We 
therefore concluded that the FVB/NJArc mice from this particular facility can be 
safely used for production of H2A.Lap1 KO mice. 
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Figure 3-13: CelI assay on H2A.Lap1 genes from FVB/NJArc strain of 
female and male mouse gDNA. Symbol: ♂, male; ♀, female; +, added; -, 
without.  
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3.3 Production of H2A.Lap1KO founder pups by the delivery of TALENs to 
one-cell embryos   
TALENs can be delivered into single cell embryos either by pronuclear injection 
(PNI) of plasmid DNA or mRNA, or via intracytoplasmic injection (mRNA only). 
The experiments involving the delivery of ZFNs into rat embryos showed that 
injection of mRNA produces higher rates of mutants compared to plasmid DNA, with 
intracytoplasmic injection (ICI) of mRNA producing the highest rate of mutant 
founders (up to 75%) (Geurts et al. 2009). Thus, we chose to deliver the mRNA by 
ICI or PNI for the production of H2A.Lap1 KO founders.  
In vitro production of stable and ready-to translate TALEN mRNA involves 
several steps.  First, the capped RNA was produced by in vitro transcription using T7 
RNA polymerase. The incorporation of specially modified cap, anti-reverse cap 
analogue (ARCA), results in the synthesis of capped RNA that is more efficiently 
translated and is more stable in vivo than the standard cap. Immediately following ín 
vitro transcription, polyadenosine (polyA) tail was added to protect the mRNA 
molecule from enzymatic degradation in the cytoplasm and to enhance the efficiency 
of translation initiation in vivo. The summary of TALEN mice production is presented 
in Figure 3-14. 
Capped, polyadenylated and purified in vitro transcribed mRNA was adjusted to 
10 ng/µl for TALEN 101421 and 101422 and injected into fertilised one-cell 
embryos. We chose to use high concentrations of mRNA (10µg/µl), as it produced 
the highest percentage of mutant founder pups, although it resulted in the lowest birth 
rate (Geurts et al. 2009). The 1-2 µl injections were performed as either PNI or ICI, 
as indicated in Table 3-5. The single cell embryo was allowed to culture overnight to 
the 2-cell stage in a microdrop of embryo culture at 37 °C, in 5% CO2. All 
microinjection procedures were performed by Dr Jo Bowles and Ms Tara-Lynn 
Davidson (P. Koopman Laboratory, University of Queensland).  
The surviving two-cell embryos, displaying normal morphology, were implanted 
into pseudo pregnant female mice of the same strain. In cages where there was only 
one transfer mouse, another pseudo pregnant mouse was placed to act as a “nanny” 
(as indicated in Table 3-5). The “nanny” mouse helped to lessen stress on the transfer 
mother by acting as a partner in caring for the litter (as it would have had the same 
pregnancy schedule as the mother, eg: lactate/feed, natural instinct to care for the 
pups) and it also acted as a cage mate. After the pups were born and weaned, they 
were exported to us here at JCSMR, to be screened for mutation.    
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Figure 3-14: The summary of TALEN mice production 
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Table 3-5: List of microinjections performed by Koopman’s lab to produce viable founder. 
Injection 
Date 
Implant 
# 
Construct 
Name 
Background 
Strain 
F Plug 
Score 
Harvest Data Cell Division # Implanted Due 
Date 
DOB Total 
Pups/Alive #of F 
harvested 
# Oocytes 
Collected 
# Oocytes 
Injected 
2 
cell 
1 
cell 
mutated lysed 
7/11/2012 L68 TALENS 
(10 ng/µl)  
ICI 
FVB 10 of 
15 
15 106 101 44 0 0 57 22 Nov 
26/12
not  
pregnant
0 
22 Nov 
26/12
not preg 0 
14/11/2012 L69 TALENS 
(10 ng/µl)  
ICI 
FVB 14 of 
15 
15 107 99 23 0 0 76 23 Dec 
3/12
not  
pregnant
0 
n/a nanny n/a n/a 
28/11/2012 L74 TALENS 
(10 ng/µl) in  
ICI 
FVB 10 of 
15 
15 123 123 22 5 0 96 22 Dec 
17/12
Dec 18/12 5 
n/a nanny n/a 
6/12/2012 L79 TALENS 
(10 ng/µl) i 
PNI 
F2 3 of 10 10 60 41 26 2 0 13 26 Dec 
25/12
Dec 31/12 1 
n/a nanny n/a 
7/02/2013 L89 TALENS 
(10 ng/µl)  
ICI 
FVB 6 of 15 15 159 58 10 5 2 41 10 Feb 
26/13
Feb 27/13 3 
n/a nanny n/a 
11/02/2013 L90 TALENS 
(10 ng/µl)  
ICI 
FVB 7 of 15 15 114 110 28 1 1 80 28 Mar 
2/13
Mar 3/13 10 
n/a nanny n/a 
TOTAL       532 153    153   19 
*Symbols: ICI, intracytoplasmic injection; PNI, pronucleus injection. 
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As indicated in Table 3-5, a total of 532 oocytes were successfully injected and 
incubated for the next 24 h. Of those, 153 oocytes survived to 2-cell stage and were 
implanted into five pseudopregnant females FVB/NJArc. We also implanted the 
embryos into one F2 strain mice (PNI), which is a hybrid of B6D2/F1 strains, to see 
whether this strain can produce surviving litter. Table 3-5 also shows that the highest 
number of litters was produced by FVBN/JARc mice, when injections of mRNA into 
the cytoplasm (L90, 10 pups and L74, 5 pups) were used, suggesting that delivery of 
RNA via cytoplasm yields better results. From these six female mice, 19 healthy pups 
were born and when they were two weeks post weaning, they were transported to the 
JCSMR, to be genotyped. The efficiency of TALEN-mediated microinjections into 
mouse embryo is presented in Table 3-6. 
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Table 3-6: The efficiency of TALEN-mediated microinjections into mouse 
oocytes. 
TALEN 
mRNA 
concentration 
 
 
 
Mouse 
strain 
Total 
oocytes 
injected 
Total 
oocytes 
surviving 
to 2-cell 
stage/ 
total 
oocytes 
(%) 
Total 
oocytes 
implanted 
Pups 
born/implanted 
oocytes (%)  
 
Number 
of KO 
mice (%) 
(mutation 
rate) 
TALEN 
mRNA  
(10 ng) 
 
FVB 
(ICI) 491 
127 
 (25.8 %) 
127 
 
18/127 
(14.1 %) 
8/18 
(44 %) 
TALEN 
mRNA 
(10 ng) 
 
F2 
(PNI) 41 
26 
(63 %) 26 
 
1/26 
(3.8 %) 
1/1 
(100 %) 
TOTAL 532 
 
153 
(28.7%) 153 
 
19/153 
(12.4%) 
9/19 
(47.3 %) 
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3.3.1 A modification to CelI surveyor nuclease assay to detect homozygous 
mutant progeny in mice. 
In screening for mutations with Surveyor and T7 endonucleases, one relies on the 
heterogeneity of the sample pool, where WT sequences present alongside of mutated 
sequences. Thus, detection of mutations in Neuro 2a cells, where transient 
transfection efficiency is never 100%, is a perfect system for CelI and T7EI. However, 
when one attempts to produce a gene knock-out in a mouse where mutations are 
introduced into single cell embryos by injection with TALEN RNA, the outcome is 
anticipated to be i) wild-type (none of the alleles underwent NHEJ), ii) homozygous 
mutation (both alleles underwent NHEJ) or iii) heterozygous (only one allele was 
mutated via NHEJ). Surveyor and T7 endonuclease will only cleave mismatched 
DNA in the case of (iii), while (i) and (ii) will not produce short digestion products in 
the absence of heterogeneity. Moreover, all H2A.Lap1 genes are located on the X 
chromosome, of which male mice have only one copy. Hence, for male mice, they 
can either be hemizygous or wild type, neither of which can be distinguished by 
Surveyour nuclease. We therefore created the heterogeneity in male mice by adding 
equimolar concentrations of amplicons from wild type (or the background strain) into 
the amplicons of mutant mice, in a single tube prior to the T7EI or CelI enzyme 
digestion assay, as shown in Figure 3-15.  
Upon receiving the pups, we first genotyped them using CelI assay. In Figure 3-
16, an example of the CelI assay is shown in three of the founders. In male founder 
L74-5, amplicons for each gene were mixed with WT amplicons to detect hemizygous 
mutations.  
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Figure 3-15: CelI assay on H2A.Lap1 amplicons from male founder TALEN-
induced mouse requires improvisation, by adding wt amplicons to create
heterogeneity. The gel image showed H2A.Lap1a amplicons resolved in 2%
agarose gel. As a control, amplicons from Neuro 2a transfected cells were
included. The red box (*) indicates the reaction that contained equimolar
amplicons of wt and TALEN-induced mouse added in one tube for CelI assay, 
and produced digested bands showed by yellow arrows. Symbol: ♂, male; ♀, 
female; +, added; -, without; arrows, digested amplicons. 
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Figure 3-16: CelI assay on H2A.Lap1a, b and c genes showed a positive
digestion of gDNA from male founder L74-5 and female founders L90-3 
and L89-1. Blue arrows indicate the digested band from CelI cleavage activity.
Symbol: ♂, male; ♀, female; +, added; -, without; arrows, digested amplicons.
105 
 
The results showed that H2A.Lap1a, b and c genes were all mutated, which 
suggest the genotype of this male mouse is hemizygous mutant. Meanwhile, for 
female L90-3, we did not mix the sample with wt amplicons at first. This is because 
female mice have two copies of the gene, hence, heterogeneity is possible. However, 
the gel image for CelI assay on TALEN-only sample indicated that the H2A.Lap1a 
gene produced cleaved bands (suggesting the gene is a heterozygous mutant), while 
the other two genes did not. We then repeated the assay by mixing H2A.Lap1b and c 
gene with WT amplicons and the result showed that CelI did detect mismatches in 
these samples, suggesting H2A.Lap1b and c genes of female mouse L90-3 carry 
homozygous mutations on both alleles as well. The same approach was employed in 
determining the genotype of L89-1 female mouse. The gel image of CelI assay on 
L89-1 suggests that H2A.Lap1a and H2A.Lap1b are heterozygous mutants, whilst 
H2A.Lap1c is a homozygous mutant. As a result, CelI assay identified that 9 out of 
19 pups contained TALEN-induced mutations. 
3.3.2 Improvement in the screening method to characterise the mutation pattern 
method in TALEN-induced mice 
Next, in order to charcterize the exact mutation pattern in mice where TALENs 
induced them, the PCR products, obtained by amplification of all H2A.Lap1 genes, 
were cloned and 8-10 individual clones for each gene were sequenced by the Sanger 
method.  
Analysis of a single gene by cloning and sequencing individual clones is a 
laborious procedure. It becomes even more laborious and time consuming when a 
multiple-gene family needs to be screened in that manner. To characterise mutations 
introduced in all H2A.Lap1 genes, we had to amplify all three H2A.Lap1 encoding 
genes, ligate the amplification product, transform bacteria and subsequently purify 
and screen plasmids for inserts, before subjecting them to Sanger sequencing. For 
each gene, at least eight to ten clones had to be sequenced.  
To simplify the screening method, particularly the cloning and colony screening, 
I introduced several modifications to the work flow. First, I took advantage of a TA-
cloning technology, that allowed me to clone PCR products directly into a vector 
without restriction digests. Secondly, I set up a quick and robust colony PCR method 
using universal promoter T7 and SP6 primer, and introduced subsequent purification 
of the PCR products using magnetic beads Agencourt® AMpure® XP kit by Beckman 
Coulter. This approach provided a rapid screening of bacterial clones in 96 and 384-
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well format.  The Agencourt® AMPure® XP PCR Purification systems utilize 
Agencourt’s solid-phase paramagnetic bead technology for high-throughput 
purification of PCR amplicons. Agencourt® AMPure® XP utilizes an optimized buffer 
to selectively bind PCR amplicons, 100bp and larger, to paramagnetic beads. Excess 
primers, nucleotides, salts, and enzymes can be removed using a simple washing 
procedure with 70 % EtOH. The resulting purified PCR product is essentially free of 
contaminants. Hence, magnetic separation based purification gave us rapid, high 
throughput screening and good quality purified DNA. Furthermore, unlike column-
based purification, the magnetic separation method does not involve centrifugation 
and contains no salt carry-over that may interfere with the sequencing reaction. The 
workflow that we employed to genotype our mice is shown in Figure 3-17.  
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Figure 3-17: The workflow employed to characterise the genotype of 
TALEN mouse. 
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Table 3-7 shows the genotype and the exact mutations of all 19 founders. Our 
sequence analysis showed 57 % (4 of 7) of male founders and 41.6 % (5 of 12) of 
female founders were mutants. Most of the mutants carry nucleotide deletions in 
H2A.Lap1 genes, while L89-2 had a two nucleotides substitution in H2A.Lap1b gene 
and L74-5 contained a 286-bp insertion in the H2A.Lap1a gene, in addition to a 5-bp 
deletion. The longest deletion (160 bp) was found in H2A.Lap1a gene of L89-1 male 
mouse. Interestingly, in two founders, L90-4 and L90-8, at least one of the H2A.Lap1 
genes were not amplifiable, using gene specific primers. This observation often 
occurred in H2A.Lap1b and H2A.Lap1c genes. However, when we mixed primer 
pairs (eg: Lap1b FWD and Lap1c REV) we were able to detect a template, suggesting 
that TALEN activity induced the formation of a chimera between H2A.Lap1b and 
H2A.Lap1c genes, in these founder mice. We further sequenced these templates, and 
indeed, the sequences were hybrids of H2A.Lap1b and H2A.Lap1c genes. These 
particular chimeras were observed in five out of nine mutant founders (L79-1, L89-
2, L89-3, L90-6 and L90-8). The alignment of H2A.Lap1 genes from the founders to 
WT is shown in Figure 3-18 below.  
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Figure 3-18: Sequence alignment of H2A.Lap1 genes from mutant founders 
relative to H2A.Lap1 genes of wt FVB mice showed that successful mutations are 
created in coding region of H2A.Lap1 genes. In L79-1, H2A.Lap1c sequence is a 
hybrid of Lap1b and Lap1c genes. Symbols: -,  deletion; /, substitute by. Blue coded 
font, deleted nucleotide; red coded font, nucleotide substitution. 
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Table 3-7: Table showed the genotype and mutation pattern (by sequencing) of all 19 founder mice  
# Founders ID 
 
Genotype by sequencing/ Protein sequence implication 
H2A.Lap1a H2A.Lap1b H2A.Lap1c 
1 ♀L74-1 XX (wt) XX (wt) XX (wt) 
2 ♀L74-2 XX (wt) XX (wt) XX (wt) 
3 ♀L74-3 XX (wt) XX (wt) XX (wt)
4 ♂L74-4 XY (wt) XY (wt) XY (wt) 
5 ♂L74-5* X
∆5 +286Y (Hemizygous) 
Stop codon after 33 aa 
X∆15 Y (Hemizygous) 
Deletion of aa ELIFA 
X∆17 Y (Hemizygous) 
Stop codon after 35 aa 
6 ♀L79-1 
X∆10 X∆10   (Homozygous) 
Stop codon after 35 aa 
X∆12 X∆12(Homozygous) 
Chimera of b/∆/c 
Deletion of aa ELIF 
X∆15 X∆15 (Homozygous) 
Chimera of c/∆/b 
Deletion of aa ELIFA 
7 ♀L89-1* 
X∆22 X ∆160 (Homozygous) 
Stop codon after 19, 14 and 35 aa 
X∆5 X∆17 (Homozygous) 
 Chimera c/∆/b 
Stop codon after 39 and 35 aa 
X∆5 X∆5 (Homozygous) 
Stop codon after 39 aa 
8 ♂L89-2 X∆65 Y (Hemizygous) Stop codon after 18 aa 
XC/T,A/G Y (Hemizygous) 
Substitution of 1 aa 
X∆42 Y (Chimera b/∆/c) 
Deletion of 14 aa and absence of stop codon 
9 ♂L89-3 
X∆26 Y (Hemizygous) 
Chimera c/∆/a 
Stop codon after 32 aa
X∆10 Y (Hemizygous) 
Chimera b/∆/c 
Stop codon after 27 aa
X∆10 Y (Hemizygous) 
Chimera b/∆/c 
Stop codon after 27 aa
10 ♀L90-1 XX (wt) XX (wt) XX (wt) 
11 ♀L90-2 XX (wt) XX (wt) XX (wt)
12 ♀L90-3* 
X∆28 X∆5 (Homozygous) 
Deletion of aa ELIFA 
Stop codon after 28 and 39 aa 
X∆10 X∆10 (Homozygous) 
Stop codon after 27 aa 
X∆64 X∆64 (Homozygous) 
Stop codon after 34 aa 
13 ♀L90-4 
X∆15 X∆10 (Homozygous) 
Deletion of aa ELIFA 
Stop codon after 27 aa
No successful amplification. Locus had major 
genomic rearrangement 
No successful amplification. Locus had major 
genomic rearrangement. 
14 ♀L90-5 XX (wt) XX (wt) XX (wt) 
15 ♀L90-6 
X∆17 X∆17 (Homozygous) 
Chimera c/∆/a 
Deletion of aa ELIFA 
Stop codon after 35 aa
X∆5X∆5 (Homozygous) 
Chimera b/∆/c 
Stop codon after 39 aa 
X∆5X∆5 (Homozygous) 
Chimera c/b/∆/c 
Stop codon after 39 aa 
16 ♀L90-7 XX (wt) XX (wt) XX (wt) 
17 ♂L90-8 
X∆16 Y 
(Hemizygous) 
Stop codon after 27 aa
X∆17 Y 
(Hemizygous) 
Chimera c/∆/c/b 
No successful amplification. Locus had major 
genomic rearrangement. 
18 ♂L90-9 XY (wt) XY (wt) XY (wt) 
19 ♂L90-10 XY (wt) XY (wt) XY (wt)
Symbols: ♂, male; ♀, female; ∆, deletion; +, insertion; /, substitute by; wt, wild type; aa, amino acids; *, mouse that was chosen as parent breeder to produce H2A.Lap1KO colony. 
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3.3.3 In-frame mutation in founder L74-5 may be as detrimental as a 
frameshift mutation 
The male founder (L74-5) that we used for establishment of two strains of the 
H2A.Lap1 KO colony, carried an in-frame deletion mutation (∆15) in the H2A.Lap1b 
gene (Figure 3-19). This particular 15 bp deletion results in the removal of five amino 
acids (26ELIFA30) after the 25th amino acid in the protein sequence (Figure 3-20). In 
order to predict whether the deletion of these five amino acids may be deleterious to 
H2A.Lap1 function, we performed some in silico structural analysis. There are no 
existing high-resolution crystal structures of H2A.Lap1-containing nucleosome thus, 
we used an existing nucleosome structure containing canonical histone H2A protein 
as a proxy for H2A.Lap1 (Figure 3-20). 
 The amino acids in canonical H2A, equivalent to H2A.Lap1 residues 26-30, 
(ELIFA) correspond to a short loop between two helices towards the N-terminus of 
H2A (Figure 3-20). This loop interacts with other structural elements of H2A as well 
as histone H2B. Thus, removal of this loop is likely to cause significant structural 
disruption, removing key protein-protein contacts as well as potentially disrupting 
histone-DNA contacts that occur in close proximity to this region. This could lead to 
destabilisation of the nucleosome and consequently create a dominant negative 
phenotype. However, this conclusion is drawn from computer-based analysis and was 
not confirmed experimentally. That is why, most of our analyses of the H2A.Lap1 
KO phenotype were done on the progeny of L90-3 and L89-1 founders that contained 
premature stop codons in all three H2A.Lap1 genes. 
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Figure 3-19: TALEN induced mutations in all H2A.Lap1 genes of male 
founder L74-5. The image showed the sequence alignment of H2A.Lap1 genes 
from mutant male L74-5, relative to WT FVB mouse. Symbols: -,  deletion; +, 
insertion. Blue coded font, deleted nucleotide; red coded font, nucleotide 
substitution. 
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Figure 3-20: Structure of a canonical H2A-H2B dimer as observed in the 
context of a nucleosome (PDB ID: 1KX5). H2A is shown in purple and H2B
in yellow. The region equivalent to the deleted amino acids in H2A.Lap1b of
L74-5 (sequence alignment inset) is shown in dark blue. Amino acids in red 
form the ‘acidic patch’, a key interaction interface on the nucleosome surface.
114 
 
 
3.3.4 Choice of breeders to establish a H2A.Lap1 knockout colony  
To produce the next generation of mice, we chose founders i) that carried 
mutations in all H2A.Lap1 genes; ii) whose mutations produced a frame shift and a 
premature stop codon or an in-frame deletion that is deleterious to the function of 
H2A.Lap1; iii) in which chimera templates were not detected.  
Only two founders, male L74-5 and female L90-3, passed all three criteria. 
However, we also included a female founder L89-1, in the breeding program, that had 
a chimera between H2A.Lap1b and H2A.Lap1c on one of the alleles. We predicted 
that successive breeding would filter away that chimera in future generations, which 
has indeed happened by generation G3.  
Every founder was mated with a wt partner to produce hemizygous and 
heterozygous G1 offspring (Table 3-8). Mating with a wt partner is an important 
strategy to remove any nonspecific alterations that might have been introduced into 
the genome by TALENs. In each new generation, we filtered out 50 % of the original 
genome, to produce a specific H2A.Lap1KO mouse colony. Thus, progeny of 
heterozygous female L90-3 with her wt partner were designated NM1; progeny of 
homozygous female L89-1 and wt male, designated NM10; and progeny of 
hemizygous male L74-5 and his wt female partner were named NM5. We also mated 
hemizygous male L74-5 with the homozygous female L90-3 to generate hemizygous 
and homozygous mutant G1 offspring (strain NM4), in order to produce more mutant 
pups (refer to Table 3-8). For genotyping the pups that were born to the above couples, 
we eliminated the CelI assay step and ran the PCR products directly on 
polyacrylamide gel. This is because their predicted mutations, based on their parent’s 
mutations, were more than or equal to five nucleotide indels, able to be resolved on a 
polyacrylamide gel, provided the sample was run side by side with wt sample. 
Further, to confirm genotype, Sanger sequencing was undertaken. Genotyping results 
confirmed that most mutant pups inherited their parents’ mutations (see Table 3-8 and 
Figure 3-21). However, 28% of pups from all strains combined had unexpected 
aberrations that are described in the subsequent section. 
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 Table 3-8: Breeding strategy of TALEN founders in order to produce 
H2A.Lap1KO colony  
 
Genotype of 
parents  
 
Progeny 
G1 mouse 
ID 
Predicted progeny genotypes 
H2A.Lap1a H2A.Lap1b H2A.Lap1c 
♀L90-3 + ♂WT 
   L1a:  X∆28X∆5 
 L1b: X∆10 X∆10 
 L1c: X∆61X∆61 
NM1-G1 
♀/♂ 
X∆5X, X∆5Y 
X∆28X, X∆28Y 
X∆10X, X∆10Y 
 
X∆64X, X∆64Y 
 
(heterozygous female, hemizygous male) 
♀L89-1 + ♂WT  
 L1a: X∆160X∆22    
L1b: X∆17X∆17  
L1c: X∆5X∆5   
NM10-G1 
♀/♂ 
X∆160 X, X∆160Y 
X∆22 X, X∆22Y 
 
X∆17X, X∆17Y 
 
X∆5X, X∆5Y 
 
(heterozygous female, hemizygous male) 
♀L90-3 + ♂L74-5  
 Lap1a: X∆28X∆5  + 
X∆5,+286Y  
L1b: X∆10X∆10 + X∆15Y 
L1c: X∆64X∆64  +X∆17Y 
NM4-G1 
♀/♂ 
X∆5X∆5, +286, X∆5Y 
X∆28X∆5, +286, X∆28Y 
 
X∆10X∆15 
X∆10Y 
 
 
X∆64X∆17 
X∆64Y 
 
(homozygous female, hemizygous male) 
♂L74-5 + WT 
L1a: X∆5,+286Y 
L1b: X∆15Y 
L1c: X∆17Y 
*only produce all WT 
male and all 
heterozygous female. 
NM5-G1 
♀/♂ 
X∆5,+286 X X∆15 X X∆17 X 
(heterozygous female, hemizygous male) 
   Symbols: ♂, male; ♀, female; ∆, deletion; +, insertion; wt, wild type; G1, 1st 
generation. 
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Figure 3-21: Mutations are stably inherited by H2ALap1 TALEN 
progeny. The gel images indicate the amplicons of each H2A.Lap1 gene from 
the progeny of TALEN founders. A, pups from NM1 strain; B, pups from 
NM10 strain; C, pups from NM4 strain; and D, pups from NM5 strain. 
H2A.Lap1 genes from wt FVB mice were also amplified and loaded in each 
gel as a control. Symbols: ♂, male; ♀, female; ∆, deletion; +, insertion; wt, 
wild type; numbers, ID of pups. 
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3.3.5 TALENs induce stable and inheritable mutations in multi-copy genes but 
TALEN activity is retained for several embryonic divisions  
Two of the founders used to establish H2A.Lap1 KO colonies, L74-5 and L90-3 
(referred to as strains NM1, NM4 and NM5) did not present with any chimeric 
H2A.Lap1 genes or other detectable aberrations, except for the described mutations 
in the H2A.Lap1 genes. It was surprising to us to see that some of their G1 progeny 
suddenly presented with novel aberrations within H2A.Lap1 genes that were not 
detected in their parents.  Even the strain NM10, which was produced by crossing wt 
male with a female mouse L89-1 (harbouring a chimeric H2A.Lap1b/c gene in one of 
the alleles) produced G1 pups with a novel, previously undetected aberration in 
H2A.Lap1 genes. Figure 3-22 shows examples of NM10 G1 progeny, in which 
H2A.Lap1b and H2A.Lap1c genes were lost and a chimera H2A.Lap1b/c was formed 
instead. Altogether, in G1 generation of all four H2A.Lap1 strains, 22 (28.2%) out of 
78 pups contained novel, previously unobserved aberrations in the H2A.Lap1 genes 
(refer to Table 3-9). Further, the novel aberration spans 3.0 kb (or perhaps even more) 
in the chromosome (Figure 3-23). For this analysis, gene specific primers were 
designed to amplify over 2 kb chromosomal regions, including the region containing 
H2A.Lap1a, b and c genes. The primers were specific to each region. However, the 
same observation occurred with NM1, where H2A.Lap1b and c are lost and 
H2A.Lap1b/c chimera is detected instead.  
The detection of novel aberrations may be attributed to two possibilities: First, if 
TALENs induce mutations at multiple nonspecific loci, the genome may become 
unstable and undergo spontaneous mutations, possibly during mitosis and meiosis. 
Second, while TALEN activity is specific, it is retained after several early embryo 
divisions and novel mutations may arise from TALEN’s action in embryos of two, 
four or even eight cells, where extra mutations are introduced de novo in newly 
formed cells.  
To test both hypotheses, we continued breeding all four strains, following our 
breeding strategy in which a heterozygous female was mated with a wt male, so that 
in each consecutive generation, the original genome exposed to active TALENs was 
reduced by 50%. In that manner, we produced G2, G3 and G4 generations of pups. If 
the genome was altered to become unstable (hypothesis 1), we would expect that 
previously detected mutations may disappear, novel mutations may appear, and most 
importantly, the frequency of those mutations would not be reduced in each 
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consecutive generation. However, our analysis of those four generations by PCR and 
Sanger sequencing revealed that all previously detected mutations were maintained, 
no more novel aberrations were detected from generation G2 onwards and the 
frequency of the mutations decreased rapidly. Only 2.3% of G2 pups displayed 
aberrations seen in G1 and none of the pups of generations G3 and G4 had novel 
aberrations, but they did retain the original mutations in H2A.Lap1 genes (Table 3-
9).  
Therefore, we conclude that TALEN technology is capable of generating multi-
copy gene knockout mice, where several genes are modified simultaneously by only 
one pair of TALENs. TALEN mRNA is able to induce stable and inheritable 
mutations but the activity of the TALENs is retained even after several divisions (in 
our case two divisions, to a four-cell stage) creating a mosaic mouse.  The mosaicism 
may not be detectable in the founders and mice need to be bred until generation G3, 
to produce a pure non-mosaic colony. This phenomenon was also observed by others 
(Tesson et al. 2011) 
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Figure 3-22: The gel image of three H2A.Lap1 genes amplified from 
pups with recombination genotype.  The left panel indicates H2A.Lap1 
genes amplified using each gene specific primers. Right panel is the gel 
image indicating the presence of amplicons when amplified using 
combination of H2A.Lap1b and H2A.Lap1c primers. Symbol: ∆, deletion; 
numbers, ID of pups. 
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Figure 3-23: The TALEN pups have recombination genotype in H2A.Lap1b
and H2A.Lap1c gene. The gel image of H2A.Lap1b and c amplicons from gDNA
of pups with recombination genotype. The top panel shows the absence of
H2A.Lap1b and c genes in NM1 (#6 and &) and NM10 (#1, 2, and 3). Lower panel
indicates the formation of chimeric genes in NM1 which is likely a result of NHEJ 
between homologous genes, H2A.Lap1b and H2A.Lap1c. No specific band was
detected for NM10 using recombinant primers. Agarose gel image of
approximately ± 1.5kb region flanking H2A.Lap1b and H2A.Lap1c genes
amplified from the mice with recombination genotype. Symbols: Fwd, forward
primer; Rev, reverse primer; numbers, ID of pups.  
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Table 3-9: The percentage of offspring that inherited the TALEN founder 
mutation and offspring with recombination genotype 
Mice lineage Total mice 
produced 
% of mice that 
inherit parents’ 
mutation 
% of mice with 
novel aberration 
1st generation (G1) 78 37.0 28.2 (22/78) 
2nd generation (G2) 171 39.4 2.3 (4/171) 
3rd generation (G3) 198 49.0 0 
4th generation (G4) 241 48.0 0 
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3.3.6 H2A.Lap1 protein loss in KO mice is stably inherited by the progeny  
To confirm that any biochemical and phenotypic changes can be attributed to the 
depletion of H2A.Lap1 protein, we must first confirm the loss of H2A.Lap1 protein 
in the KO mice, as well as the absence of the wt form of H2A.Lap1 mRNA. We 
conducted qPCR experiments on the testes of wt and KO mice to check whether the 
wt form of H2A.Lap1 genes is still present. We designed primers (based on wt 
sequence) for all H2A.Lap1 genes of which either the forward and/or reverse were 
located within the known mutated (deleted) region. Figure 3-25 (A) shows that we 
could not detect the presence of wt H2A.Lap1 genes in any KO testes, suggesting that 
disruption of the H2A.Lap1 gene successfully produced truncated and non-functional 
mRNA for all H2A.Lap1 genes. 
We then proceeded to determine whether the full-length protein was lost in the 
KO mice, by conducting immunoprecipitation (IP) of H2A.Lap1 protein, from the 
testes of KO mice, followed by immunoblot with H2A.Lap1 antibody. We also 
performed immunofluorescent staining of hypotonic spreads of male germ cells from 
wt and KO mice using anti-H2A.Lap1 antibody. Indeed, as indicated in Figure 3-24 
(B), the immunoblot showed that H2A.Lap1 protein was lost in all samples from the 
testes of hemizygous founder mice (G0) and their progeny in the third generation 
(G3). Here the sperm samples were used as a negative control. In addition, 
immunofluorescent staining (Figure 3-24 (C)) showed undetectable signal with anti-
H2A.Lap1 antibody in the KO male germ cells. Hence, this confirmed that the protein 
of H2A.Lap1 is lost in the KO mice, and this loss is stably inherited by the progeny. 
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Figure 3-24: The loss of WT mRNA H2A.Lap1 genes and protein. A) the 
qPCR of three H2A.Lap1 genes showed that the mRNA of all three genes was
undetected, showing that the genes have been successfully disrupted by
TALEN. B) Western blot showed the immunoprecipitation (IP) of H2A.Lap1
protein from both testis and sperm cells. C) Immunofluorescence staining 
with H2A.Lap1 antibody on the hypotonic spread of male germ cells from
KO mice and their WT siblings.  
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3.3.7 No defect in sex ratio and genotype ratio distribution between KO mice and 
wt siblings 
Next, we examined the distribution of the sex and genotype ratio. The ratio of 
sexually producing species tends to be 1:1 (50 % male, 50% female). We 
hypothesised that in the absence of H2A.Lap1, the reproductivity of KO mice might 
be affected. To test this hypothesis, we conducted several strategies of breeding and 
examined the distribution of males and females amongst the offspring. We bred i) 
heterozygous female (H2A.Lap1 +/-) with wt male (H2A.Lap1+/+), ii) wt female with 
hemizygous male (H2A.Lap1-/Y) and iii) homozygous female (H2A.Lap1-/-) with 
hemizygous male (H2A.Lap1-/Y). As illustrated in Figure 3-25 (A), there was a 
skewness in the distribution of male and female pups born to the heterozygous female 
(H2A.Lap1 +/-) breed with wt male (H2A.Lap1+/+) (less male pups were born) (i). 
Curiously, although the difference was significant, the pattern of the sex distribution 
shows the same skewness when wt females are bred with wt males indicating that this 
is a strain specific effect. With regard to the genotype distribution, we observed no 
skewness in breeding pair (i) i.e. the ratio of wt versus H2A.Lap1 +/- females, and wt 
versus H2A.Lap1-/Y males both did not change (Figure 3.25 (B)).  Figure 3-25 (C) and 
(D) shows no significant difference in the distribution of male and female progeny 
from breeding pairs (ii) and (iii) as well. We could not compare the genotype 
distribution for breeding pairs (ii) and (iii) because breeding pair (ii) only produced 
all mutant females and all wt male, while breeding pair (iii) produced all mutant male 
and female offspring.  
 Hence, the disruption of H2A.Lap1 did not cause any abnormal effects in terms 
of the ratio of males to females for all types of KO mice. However, this was not the 
case when we crossed the hemizygous (H2A.Lap1-/Y) males with the wt females 
(H2A.Lap1+/+) as we observed less pups per litter being born when hemizygous males 
were bred with wt females, the result of which will be discussed in Chapter 5, section 
5.2.  
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i- Breeding pair: heterozygous female (H2A.Lap1+/-) + WT male (H2A.Lap1+/Y) 
 
A   
 
 
 
   
 
B   
 
 
 
 
 
  
    
 
 
 
 
 
 
    
 
128 
 
ii- Breeding pair: WT female (H2A.Lap1+/+) + hemizygous KO male (H2A.Lap1-/Y) 
 
C  
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iii-  Breeding pair: Homozygous KO female (H2A.Lap1 -/-) + hemizygous KO male  
(H2A.Lap1 -/Y) 
  
 D  
 
 
 
 
 
  
Figure 3-25- The sex ratio and genotype distribution of the KO mice progeny
showed no difference compared to the wt mice progeny. (A) Graph indicates 
skewness in terms of sex ratio distribution in breeding pair (i), although significant,
the pattern is the same between WT and KO mice. (B) Graph indicates that there
is no significant difference in terms of genotype distribution between both male 
and female pups produced by breeding pair (i). (C) Graph indicates that there is no
significant difference in the sex ratio distribution of offspring produced by breeding
pair (ii). (D) Graph indicates that there is no signifcant difference in terms of sex 
ratio distribution in breeding pair (iii). 
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3.4 Discussion 
In this collaborative study, we have successfully applied TALEN technology to 
generate the first H2A.Lap1 knockout mouse. This kind of simultaneous knock-out 
in mice, where several genes were disrupted with only one pair of TALENs, has not 
been done before to our knowledge. 
We tested engineered TALEN pairs for activity in two in vitro assays, Dual 
Luciferase Single Strand Annealing Assay and CelI/T7 endonuclease assay, using 
cultured mouse Neuro 2a cells. We have found T7EI to be more affordable and more 
efficient than the CelI enzyme, in cultured cells. Perhaps a more notable improvement 
in screening for TALEN-induced mutations was the development of a simplified 
workflow and the introduction of a robust high throughput DNA purification step, 
using magnetic beads. 
Having established that TALEN pair 101421:101422 was the most active against 
all H2A.Lap1 genes, we used it for microinjections into 532 oocytes, of which 153 
(28.8 %) survived to two-cell stage and were implanted into pseudopregnant females. 
Nineteen pups (12.4 % of initial embryos implanted) were born, of which nine had all 
three H2A.Lap1 genes disrupted (47.3%). By breeding founder mice, we have shown 
that TALEN technology induces stable and heritable genomic alterations at multiple 
specified locations of the genome, thus allowing simultaneous disruption of several 
multicopy genes with only one pair of TALENs. We have also observed that TALEN 
mRNA can stay active through several early embryonic divisions, a phenomenon also 
observed by others (Tesson et al. 2011; Li et al. 2014) and similarly in the CRISPR-
Cas9 system (Sung et al. 2014). We have discovered that disruption of highly 
homologous genes can lead to the formation of gene chimeras and genomic 
rearrangements which is a concern for TALEN-mediated gene editing and other 
related technologies, like CRISPR. However, this unwanted side-effect can be 
eliminated simply by breeding-out unwanted alterations. In our case, all genomic 
rearrangements were eliminated by generation three.  
We have made several important observations about TALEN technology during 
the establishment of the H2A.Lap1 KO. Firstly, by targeting only one of the 
H2A.Lap1 genes, H2A.Lap1a of a multicopy gene family, we had a chance to test the 
specificity and selectivity of TALEN technology. The high specificity was 
demonstrated when we used the Dual Luciferase Single Strand Annealing assay, on 
cultured cells (Figure 3-5). TALEN pairs designed against the H2A.Lap1a gene only, 
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showed no or minimal activity on the other two H2A.Lap1 genes (H2A.Lap1b and 
H2A.Lap1c, that are 98% and 92% identical to H2A.Lap1a). This is a remarkable 
result, given the high degree of homology between the genes, and given that the 
targeted sequences differed by only 2 (in most cases) to 3 nucleotides in the 15 
nucleotide target sequences. On the other hand, 13 TALEN pairs were designed to 
target all three H2A.Lap1 genes, and 10 of these pairs were successful, although with 
varying activity, so the best pair was selected for an in vivo disruption in mouse 
embryos.    
Secondly, we have confirmed the findings of other researchers (Tesson et al. 
2011) that TALEN mRNA retains its activity through several embryonic divisions, 
so that several unique modifications of each H2A.Lap1 gene were detected in some 
founder mice and their progeny, creating a mosaic genotype. This finding calls for 
fine-tuning of the stability of in vitro produced mRNA, possibly by incorporation of 
less stable 5’-cap structures.  
Thirdly, we observed a novel phenomenon that seems to be specific to 
simultaneous knock-outs of highly homologous genes – formation of chimeras 
between H2A.Lap1 genes. Every chimera contained a small deletion of one of the 
genes, suggesting that the NHEJ mechanism was acting. It is also possible that a 
subtype of the NHEJ mechanism, called terminal microhomology (Lieber 2010), was 
employed here, in which distal DNA ends that display at least four nucleotide 
homology can be joined together, even in the absence of all NHEJ components, at the 
sites of DSBs. As H2A.Lap1b and H2A.Lap1c genes are 92% identical, such a 
mechanism is highly plausible. The reason that H2A.Lap1a gene was not a frequent 
part of a chimera (except in 2 out of 5 chimera cases, L89-3 and L90-6) is that it is 
positioned on the opposite strand from H2A.Lap1b and c and is 3.631-3.298 Mb 
away, while H2A.Lap1b and H2A.Lap1c are clustered together (refer to Table 3-1).  
This important observation suggests that TALEN knockout technology may 
cause chromosomal translocations and genomic rearrangements when genes 
belonging to a multi-copy family are disrupted simultaneously. It is important to point 
out that other technologies that rely on NHEJ for inducing mutations, like 
CRISPR/Cas9 technology, are also likely to have a similar effect on homologous 
genes. However, several rounds of backcrossing of heterozygous mutants to WT mice 
can successfully eliminate these undesired genomic modifications. In our case, the 
third generation of pups was free of rearrangement and mosaic mutations.  
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Finally, TALEN technology showed an interesting trend: it seems that TALEN 
produced all or nothing activity in our 19 founders. Either all three genes (six alleles 
in females) were disrupted (nine founders were mutants for all H2A.Lap1 genes) or 
no disruption occurred at all (ten founders were wt). The TALEN technology is 
comparable to the widely used alternatives, CRISPR-Cas9, Cpf1, a putative class 2 
CRISPR effector (Zetsche et al. 2015) in terms of producing genetically altered 
offspring. 
 Injections of Cas9 mRNA and sgRNA at the same concentration as we used (10 
ng each) via intracytoplasmic into FVB/N mouse single cell embryo resulted in 87 % 
of embryos being implanted. Following implantation, 54 % of the transferred embryos 
produced viable pups, of which 65 % were mutant (Sung et al. 2014). Another study 
showed a cytoplasmic injection of hCas9 mRNA and sgRNA at 10 ng produced 29.4 
% viable pups and of that 45 % were mutants (Mashiko et al. 2013). Meanwhile, 
injections of “low” concentrations (10 ng) of AsCpf1 RNA, via the pronucleus, 
yielded only 3 % surviving pups, of which 3.4 % were mutant (Watkins-Chow et al. 
2017). In our case, we experienced a rather lower survival rate of embryos, but we 
believe that it might have been due to adjusting and fine-tuning the injection technique 
and embryo handling at the beginning of the experiment. The first two rounds of 
injections resulted in no pups born, while the last round of injections resulted in the 
highest number of healthy pups born (n=10). Nevertheless, in spite of unsuccessful 
first rounds, our overall statistics are well within the range of CRISPR and TALEN 
experiments performed by others, with the mutation rate of 47.3%. The mutation rate 
observed by Qiu et al. (2013)in their TALEN-modified mice was between 13-67 %. 
which suggests that the mutation rate occurring in our hands was reasonably high.  
Although we did not see a significant difference in terms of distribution of the 
sexes, this does not rule out that the disruption of H2A.Lap1 might have an effect on 
a different aspect of reproduction, including testis morphology and a number of pups 
produced by hemizygous male mice, as mentioned in the earlier part of section 3.3.7, 
and this will be discussed in Chapter 5. However, first, it was important to show that 
our TALEN approach did not produce any off-target mutations. 
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CHAPTER 4 
EXOME SEQUENCING TO DETERMINE WHETHER 
TALENS GENERATE OFF-TARGET MUTATION(S) 
 
4.1 Introduction 
In the previous chapter, we described the generation of H2A.Lap1KO mice using 
TALEN technology. The mutations generated in all three H2A.Lap1 genes in the KO 
mice were shown to be stably inherited by the progeny up to the current G7 
generation. We have shown that TALENs, designed against only one of the 
H2A.Lap1 genes, have a very high activity for the desired gene and low activity 
against the other two H2A.Lap1 genes, which provides strong evidence in support of 
the high specificity and selectivity of TALEN technology. However, we wanted to 
investigate the effect of TALEN activity on the rest of the genome and to understand 
whether TALENs, designed against H2A.Lap1, generated any off-target genomic 
alterations. This kind of validation was important for two reasons: firstly, we wanted 
to ensure that any physical and biochemical manifestations in the KO mice were a 
direct consequence of H2A.Lap1 depletion. Secondly, we wished to see whether 
TALENs were prone to generations of multiple off-target genomic alterations, as has 
been predicted by several research groups but never validated experimentally (Boel 
et al. 2016; Tsai et al. 2015; Cho et al. 2014). This is obviously important if genome 
editing tools are going to be broadly used in research, medicine and agriculture. 
However, the detection of off-target mutations is more challenging than on-target 
mutations due to the number of potential genome-wide locations (Kanchiswamy et al. 
2016) 
There are several methods used to identify off-target sites, caused by site specific 
nucleases (SSN) including TALEN (Zischewski et al., 2016). The methods include 
amplification and sequencing of pre-selected off-target sites, exome sequencing, 
whole genome sequencing (WGS), BLESS (direct in situ breaks labelling, enrichment 
on streptavidin, and next generation sequencing), GUIDE-seq (genome-wide, 
unbiased identification of DSBs enabled by sequencing), LAM-HTGTS (linear 
amplification-mediated high-throughput genome-wide translocation sequencing) and 
Digenome-seq (in vitro Cas9-digested whole genome sequencing). Of all these 
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methods, the targeted sequencing of exons allows the identification of relevant 
variants in the exomes, but costs only a fraction of whole genome sequencing. 
Therefore, I decided to identify any potential TALEN- induced off-target sites and 
use the exome sequencing approach to validate any observed phenotypic changes in 
the KO mice as resulting from an H2A.Lap1 depletion. 
The strategy for identification of off-target mutations in H2A.Lap1KO mice was 
based on the sequencing of exomes from three mice of the same strain, in three 
consecutive generations. The breeding scheme was set up in such a way that every 
new generation would contain only 50% of the TALEN modified genome of the 
H2A.Lap1 altered parent. The logic was that if there were off-target mutations, the 
number of genomic alterations detected in KO mice would be reduced by 50% in each 
subsequent generation of progeny, due to our breeding strategy of heterozygous 
female (H2A.Lap1+/-) mated with wt male (H2A.Lap1+/Y). Thus, if for example, the 
number of off-target alterations in G1 mice was 100, then in G2 that number would 
reduce to 50, and by G3 the number would be 25. If we see this trend, it would indicate 
the presence of initial off-target events, and would allow us to evaluate the 
effectiveness of the TALEN approach. 
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4.2 Results 
4.2.1 Preparation of samples for exome sequencing 
Successful next generation sequencing (NGS) depends on the high quality of 
gDNA input. We extracted gDNA (using a method described in Chapter 2 section 
2.3.2.1) from three hemizygous KO (H2A.Lap1-/Y) male mice (NM4 strain) 
originating from three consecutive generations (NM4-G1-#28, NM4-G2-#18 and 
NM4-G3-#32). One hemizygous male mouse from the NM1 strain, NM1-G2-#23, 
was also used to determine if any off-target events were common between different 
TALEN injection rounds (Figure 4-1). Our DNA quantification indicated that the 
concentration of DNA was between 200 and 320 ng/µl (except for NM1-G2-#23, 
which was 95.5 ng/µl): the 260/280 ratio was between 1.8-1.9 and 260/230 ratio was 
between 2.0-2.2, which met the requirement for NGS.  
The mice that we chose were genotyped prior to sequencing. The genotype of 
H2A.Lap1 genes determined for NM4-G1, G2, and G3; and NM1-G2 are H2A.Lap1a 
(X∆5Y), H2A.Lap1b (X∆10Y) and H2A.Lap1c (X∆64Y). The purified gDNA (Figure 4-
1) was sent to the Australian Phenomics Facility (APF) for exome enrichment using 
the Agilent SureSelect XT2 All Exon Kit, and each exome sample sequenced using 
paired-end reads at the Biomolecular Research Facility (BRF), on the Illumina HiSeq 
2000 sequencer. As discussed above, the strategy of sequencing the genome of mice 
from three consecutive generations, originating from the same strain, was crucial for 
identifying and tracking the dilution pattern. 
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Figure 4-1: Purified gDNA from KO mice strain NM1 and NM4 that was used for
exome enrichment and sequencing. Symbols: numbers, ID of pups. 
139 
 
4.2.2 Reference sequence used in bioinformatics analysis is of FVB/NJ, not 
FVB/NJArc 
It is important, for reasons outlined below, to describe the background strain of 
mice that we used in generating the H2A.Lap1KO colony. We used FVB/NJArc mice 
to generate our KO strain. The FVB mouse line originated from an outbred colony of 
Swiss mice, established at the National Institute of Health (NIH) in the 1930s for 
general purposes (N:GP colony). From the N:GP colony, a second colony (N:NIH) 
was established in the 1940s and selected based on their sensitivity to histamine 
diphosphate (HSFS/N=sensitive and HSFR/N=resistance) (Taketo et al. 1991; Wong 
et al. 2012). The HSFS/N colony was found to carry the Fv-lb gene which is 
susceptible to the B strain of Friend leukaemia virus (Taketo et al. 1991). The mice 
were then inbred to homozygosity and designated FVB/N (for Friend Virus B-type 
susceptibility), where N refers to NIH, the origin of the mice (Taketo et al. 1991). The 
strain was exported to the Jackson laboratory (JAX) in 1988 at F38 and designated 
FVB/NJ. The mice were then bred by the Animal Resources Centre (Arc), Western 
Australia in 2003 and designated as FVB/NJArc. To date, the genome of FVB/NJArc 
has not been sequenced. The only genome that was sequenced is of FVB/NJ strain, 
but the genome has not been assembled (Wong et al. 2012). Therefore, despite being 
the same strain, there may exist genetic variation between FVB/NJ and FVB/NJArc. 
As described below, the first step in looking for TALEN’s off target effect was to use 
the fully assembled and annotated mm10 genome which is primarily based on the 
wild type C57BL/6 mouse strain. 
4.2.3 TALENs do not recognise off-target locations that have close sequence 
homology to targeted H2A.Lap1 gene regions 
We collaborated with bioinformaticians from the Department of Immunology, 
JCSMR, Dr Field and Dr Andrews who have developed a workflow to use massively 
parallel sequencing reads as a sole data source to identify exonic mutations from 
ENU-mutated C57/BL6J strain of mice (Andrews et al. 2012). To detect the off-target 
sites or variants from TALEN-induced mice, they used the mouse exome analysis 
pipeline, shown in Figure 4-2.  
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Figure 4-2: Workflow and filtering strategy used to identify off-target sites
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Since no reference genome specific to FVB/NJArc strain was available, the 
published mm10 genome was used as reference sequence in the first step of our 
analysis. Our analysis of the TALEN DNA sequences (labelled 101421 and 101422, 
see Chapter 3 Figure 3.4) designed to target H2A.Lap1 genes started firstly with a 
BLAST (allowing 3-5 mismatches in the sequence) search of either TALEN sequence 
101421 or 101422 (which is a target sequence for all H2A.Lap1 genes) against the 
mm10 reference genome. The search revealed 583 possible mutations, of which 54 
overlapped with exons or splice sites; however, no match was detected when the 54 
hits were aligned with the exome sequencing data from our KO mice. Secondly, when 
the TALEN sequences, 101421 and 101422, were analysed in BLAST as a pair, no 
hits were found. Therefore, based on these two observations, we concluded that the 
design of the TALEN pair is highly specific to H2A.Lap1 genes and since the double 
strand break on the targeted sequence will only take place in the presence of a TALEN 
pair, it is highly unlikely that the off-target mutation will be introduced even if one 
TALEN plasmid still persists. 
 
4.2.4 Higher coverage was obtained with our sample and a higher number of 
variants detected relative to mm10 mouse reference genome 
The exome of our KO mice was sequenced using 100-bp paired end reads 
generated by the Illumina HiSeq 2000. The exomes of three mice (NM4-G1-28, 
NM4-G2-18, and NM4-G3-32) were sequenced to a depth of approximately 350 to 
over 600x coverage (Table 4-1), providing more data for high confidence variant and 
indel (insertion-or-deletion) calling. The resultant reads were aligned to the C57BL/6 
mouse reference genome (mm10). The lower number of reads resulting from the 
NM1-G2-23 sample are probably due to degradation of the sample, as seen in Figure 
4-1. The exome capture efficiency was uniformly high with approximately 45-50 % 
of all DNA sequenced being exonic.  
Raw sequence reads can be transformed into meaningful information by 
employing various software applications to detect variants in the genome. In our 
analysis, the software SAMtools, Pindel and Janda were used to detect raw and 
structural variants in the KO mice. The initial filtering was done by detecting raw 
variants using the Sequence Alignment/Map (SAM) format and tools. This software 
allows the analysis and manipulation of alignments (such as sort, merge and remove 
duplicates) in SAM/BAM format (Li et al. 2009). It can also be used to detect single 
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nucleotide polymorphisms (SNPs) and short indels (up to 60 bp), and to present it in 
the alignment of text-based viewer (Li et al. 2009).  
Differences in the number of raw variants, (comprising single nucleotide 
variations, SNVs), indels and structural variants (SVs), were detected by comparing 
our exon sequencing data and the mm10 reference sequence (Table 4-2). The numbers 
resulted from variants with a score ≥ 40 anywhere in the genome. The typical SNVs 
observed in C57BL/6J at exome covered 30x depth is 7000 SNVs, 1950 deletions, 
and 1880 insertions. Our colony has shown SNVs at least 22 times higher, small 
deletions at least 3.3 times higher, and small insertions at least 3.8 times higher than 
the typical observations (Table 4-3). However, knowing that we align our sequences 
with a non-related C57BL/6J strain used for mm10 reference genome, we predicted 
that those differences due to the strain variability. Indeed, the number of SNVs and 
indels was dramatically reduced when our data was compared to FVB/NJ genome 
(see below) Furthermore, a much larger size of the sequencing library at 600x depth 
may also contribute to the increment number of variants.  
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Table 4-1: The total reads sequenced and number of reads aligned to exonic target 
regions per sample. The read length is based on Illumina HiSeq 2000 and the 
approximate size of mouse exome was obtained from Andrews et al. (2012). 
Samples Total 
reads 
Read 
length (bp) 
Total sequence 
bases 
(read count x read 
length) 
(A) 
Approximate 
size of mouse 
genome (Mb) 
(B) 
Approximate 
coverage 
(A/B) 
NM4-G1-28 226905460 100 22.69x109 37 613
NM4-G2-18 228920578 100 22.89x109 37 619
NM4-G3-32 129857884 100 12.98x109 37 351
*Symbols: G1, 1st generation, G2, 2nd generation, G3, 3rd generation. 
 
Table 4-2: The raw variants detected from KO mice sequencing data 
Samples SNVs Small deletions Small insertions 
NM4-G1-28 1745670 82379 90762 
NM4-G2-18 1768957 81956 90005 
NM4-G3-32 693686 33823 38321 
*Symbols: G1, 1st generation, G2, 2nd generation, G3, 3rd generation. 
 
Table 4-3: Variants output after strain FVB/NJ filter was applied 
Samples SNVs Small deletions Small insertions 
NM4-G1-28 21256 3889 4378 
NM4-G2-18 26646 4064 4445 
NM4-G3-32 13417 1589 2032 
*Symbols: G1, 1st generation, G2, 2nd generation, G3, 3rd generation. 
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Given the differences in mouse strains, we applied a variant call format (VCF) 
filter specific to the FVB/NJ strain to remove the strain variant differences from the 
list. VCF is a text file that stores sequence data about the position of variants in the 
genome, based on the reference sequence. In addition, VCF also contains genotype 
information which allows the user to estimate allele frequencies (Danecek et al. 
2011). Indeed, application of the FVB/NJ filter drastically reduced number of SNVs 
and indels (Table 4-3) but the numbers were still high and required further 
investigation 
Importantly, however, after the variant filter was applied to our exome 
sequencing data, there was no dilution effect observed from one generation to the 
next, rather, the variant numbers correlated with the original number of reads. This 
provides strong evidence that the discrepancies between the reference genome, 
filtered with FVB/NJ filter, and our exome data are not due to off-target activity of 
TALENs. 
 
4.2.5 Structural variant (SV) and indel analysis detected expected mutation in 
all three samples 
Further analysis was done to detect SVs because any off-target effects would 
cause deletions or insertions (indels). Structural variants are genomic rearrangements 
of 50 bp or more; they comprise balanced as well as unbalanced events. Deletions, 
insertions, and duplications alter the copy number of the genome and are thus known 
as unbalanced SVs. Inversions and translocations do not change the copy number and 
are known as balanced SVs (Tattini et al. 2015; Guan & Sung 2016). Detecting 
structural variants is a challenging task, hence multiple tools were used to ensure all 
SVs in the sample were detected. Our samples were analysed using two separate SV 
algorithms; Janda (unpublished) and Pindel.  
Janda is used to detect and identify SVs (deletions, duplications, translocations 
and inversions) from aberrant mapped pair reads and for realigning the junction from 
large SVs in whole genome sequencing data. Meanwhile Pindel uses pattern growth 
algorithm to identify the breakpoints of large deletions (1 bp -10 kb) and medium 
sized insertions (1-20 bp) (Ye et al. 2009). While Janda did not detect any structural 
variants in the region of interest, Pindel detected only three expected deletions in 
H2A.Lap1 genes: H2A.Lap1a (5 bp) (Figure 4-3 (A)), H2A.Lap1b (10 bp) (Figure 4-
3 (B)), as well as a large deletion of 64 bp in H2A.Lap1c (Figure 4-3 (C)). The 
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coverage for H2A.Lap1b and H2A.Lap1c was low (0-12 and 0-7 times, respectively); 
nonetheless, the deletion was still detectable. These variants represent the TALEN-
specific generated mutations and support our genotype characterization, as described 
earlier in section 4.2.1. Based on Figure 4-3, we have summarized the indels detected 
in all three genes, as listed in Table 4-4. Our structural variant analysis did not detect 
any evidence of unexpected insertion or genomic rearrangement. 
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A) The alignment of exome sequencing data to H2A.Lap1a          
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B) The alignment of exome sequencing data to H2A.Lap1b          
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C) The alignment of exome sequencing data to H2A.Lap1c 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-3: Exome sequencing allows to detect all 3 expected mutations in H2A.Lap1 genes. The images showed the output from 
SV calls by Pindel in all H2A.Lap1 genes. The highlighted region (yellow box) indicates the deleted region detected in all samples by
SAMtools. The black arrows pointing at the white box indicate mapping quality of 0; occurs with ambiguously mapped reads. Blue
arrows pointed at red box indicate unmapped mate. A) The alignment of H2A.Lap1a gene with mm10 reference genome. The yellow
box highlighted 5 bp gap; B) The alignment of H2A.Lap1b gene with mm10 reference genome. The yellow box highlighted 10 bp gap; 
C) The alignment of H2A.Lap1c with mm10 reference genome. The yellow box highlighted 64 bp gap. Symbols: ∆, deletion 
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Table 4-4: Expected mutations detected from sequencing data 
Gene Deletion Insertion 
H2A.Lap1c chrX:116681178-
116681525 
3 samples show 64 bp deletion 
(116681247-116681312) 
 
0 
H2A.Lap1b chrX:117014757-
117015104 
4 samples show 10 bp deletion 
(~1171014833-117101842) 
 
0 
H2A.Lap1a chrX:120312748-
120313095 
4 samples show 5 bp deletion 
(120313011-120313015)
 
0 
 
 
Table 4-5: Variants with heterozygous and homozygous deletions detected from 
sequencing data of KO mice 
Samples No Call 
Genotype (deletions, Q>100, whole genome, FVB/N strain 
variants removed) Total Homozygous  Heterozygous 
0/0 1/1 2/2 0/1 0/2 1/2 
NM4-G1 111 131 732 2  388 2 27 1393 
NM4-G2 116 127 727 3  392 3 25 1393 
NM4-G3 314 219 527 8  306 4 15 1393 
*Symbols: G1, 1st generation, G2, 2nd generation, G3, 3rd generation. 
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4.2.6 Further analysis to detect heterozygous and homozygous deletions 
Further analysis of the VCF output was conducted to find heterozygous and 
homozygous deletions within the exome (in collaboration with Dr Sebastian 
Kurscheid, JCSMR). Indels common to the wild-type FVB/NJ were filtered by 
applying a cut off quality score of >100. Table 4-5 indicates the detection of all 
variants with deletions. For a diploid organism, the genotype indicated by two alleles 
carried by the sample, encoded by a 0 for reference allele, 1 for the first alternative 
allele and 2 for the second alternative allele. Whenever we found a 0/0, 1/1, and 2/2 
it is a homozygous call. The 0/0 means the sample is homozygous with regard to the 
reference, 1/1 is homozygous with alternative allele 1, and 2/2 is homozygous with 
alternative allele 2. The heterozygous calls 0/1, 0/2 and 1/2 indicate the 
heterozygous variants with one reference allele and one alternative allele (0/1, 0/2) 
and even heterozygous variants with 2 alternative alleles (1/2) (Van der Auwera et 
al. 2013). In other words, homozygous indels are the ones where both homologous 
chromosomes of the FVB/NJ genome have the same allele but different from the 
reference mm10 genome and therefore these are strain specific. On the other hand, 
if TALENS did produce off-targets, this would produce heterozygous indels.  
As shown in Table 4-5, after filtering against the FVB/NJ genome, 417 NM4-
G1, 420 NM4-G2 and 325 NM4-G3 heterozygous (0/1+0/2+1/2) indels remained. 
These numbers again did not display a 50% dilution pattern from G1-G3. To provide 
further evidence that these remaining indels are due to strain differences between 
FVB/NJArc and FVB/NJ mice, we interrogated the 19 indels common to all three 
NM4 G1-G3 mice (Figure 4-4, the location of these putative indels are shown in 
Table 4.6).  
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Table 4-6: Common variants with deletions detected in all three KO mice that 
were sequenced 
# Chromosome Locus start Locus end Deletion size (bp) Gene ID 
1 1 171573961 171573965 4 ENSMUSG00000004709 
2 1 173270636 173270648 12 ENSMUSG00000049605 
3 1 173760152 173760189 38 ENSMUSG00000073489 
4 12 115158545 115158549 5 ENSMUSG00000093894 
5 12 115335195 115335199 5 ENSMUSG00000095197 
6 12 115808522 115808526 21 ENSMUSG00000091087 
7 12 115833994 115834007 14 ENSMUSG00000096020 
8 17 23882468 23882474 7 ENSMUSG00000096445 
9 17 35266213 35266218 6 ENSMUSG00000073411 
10 17 36189406 36189415 10 ENSMUSG00000054128 
11 17 48145527 48145531 5 ENSMUSG00000073386 
12 2 119618224 119618250 27 ENSMUSG00000072980 
13 3 7604075 7604079 5 ENSMUSG00000040329 
14 4 41195246 41195333 88 ENSMUSG00000028433 
15 4 42871823 42871856 34 ENSMUSG00000050141 
16 5 113819659 113819689 31 ENSMUSG00000048163 
17 7 8245023 8245027 5 ENSMUSG00000053720 
18 7 47981089 47981093 5 ENSMUSG00000067173 
19 X 95940663 95940678 16 ENSMUSG00000057421 
  
Figure 4-4: Computational analysis predicted 19 putative heterozygous deletions.
The number of heterozygous deletion detected in all three generations. The 19 deletions
(overlapped) are commonly detected in all 3 mice. 
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4.2.7 Validation of 19 indels from sequencing data using PCR amplification to 
determine whether they are true indels or strain specific variations 
In order to prove that the 19 indels are indeed strain specific and not off-target 
effects, I amplified ~300-450 bp regions spanning all 19 indels and compared them 
to the wt FVB/NJArc mice. To do this, I designed a primer pair for each indel and 
conducted PCR amplification from gDNA from our hemizygous KO mice (NM4-
G3) and the WT FVB/NJArc, as a positive control. The primers are listed in Table 
4-7. The amplicons from both hemizygous KO and WT mice were visualised by 
PAGE. In Figure 4-5 D, we incorporated the amplicon from the first generation of 
knockout mice (G1) to show that the genotypes of the indels were heritable. Table 
4-7 shows that the deletion size of indels varied from 5 to 88 bp. These are the indels 
with heterozygous deletions, based on the analysis in the previous section. If the 
indels are specific to our strain, when compared to the WT, they should show the 
same amplicon size as our hemizygous KO mice sample. As we demonstrated in 
Chapter 3, a 5 bp deletion in the genotype of our hemizygous KO mice progeny can 
be detected, therefore a heterozygous sample should be visible on PAGE. We did 
not detect any differences in the size of the amplicons between hemizygous KO and 
WT mice (Figure 4-5), nor did we detect any deletion (heterozygosity) in the 
samples. Furthermore, we sequenced 5 of these putative indels, which confirmed 
that the hemizygous KO and wt mice are identical in the nucleotide sequence where 
the indels were predicted to be (Figure 4-5 C). 
Not all of the actual lengths of the indels determined experimentally 
corresponded to the predicted size of the indels (Figure 4-5 D), but the results 
unequivocally show that these 19 indels are specific to our inbred strain of mouse 
and not a consequence of TALEN activity. The discrepancy between the 
bioinformatics analysis and the PCR validation experiments (Table 4-8), might be 
due to an assembly error in the database, used in the variant calling. 
In conclusion, based on exome sequencing, we could not detect off-target sites 
in the exonic region of our KO mice, which confirms the specificity of TALEN 
targeting to their recognition sequences. Further, the mutations generated by 
TALEN are stably inherited by the KO mice progeny. 
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Table 4-7: List of primers used to amplify 19 indels from TALEN mutant mice 
Indel 
# Gene ID Sequence (5’-3’) 
Expected 
product 
length 
(bp)
1 ENSMUSG00000004709 (∆4) F- AAGAAGACAGAACAGGGCTCAC 
R- TAGCTCACATTGTCATCCTTGG 
419 
2 ENSMUSG00000049605 (∆12) F- GACAGTGTACACATTGGTCATT 
R- TGGAGATGATGAGAATGTAAGA 
458 
3 ENSMUSG00000073489(∆38) F- TTAATGCCACATGATCAGTTAT 
R- CCTAGACCATCTATTTTGGTTT 
426 
4 ENSMUSG00000093894 (∆5) F-AAGTCTACAAGCAAACCTTCTC 
R-CATATACATGGGTGACAATGAC 
452 
5 ENSMUSG00000095197 (∆5) F-GCTGTATCTGAGCAAGTCTACA 
R-ATACACTTGGGTGACAATGAC 
464 
6 ENSMUSG00000091087 (∆21) F-TAGATGGACATTTACAAAGCTG 
R-TATCCTCACCTGTTCCAAAC 
412 
7 ENSMUSG00000096020 (∆14) F-TAGATGGACATTTACAAAGCTG 
R-GCTACACCTTCACAAGCTACTA 
402 
8 ENSMUSG00000096445 (∆6) F-GTTGTGATGTCTTCTGTGCTC 
R-GTACTCAGAACTGCCCACATA 
405 
9 ENSMUSG00000073411 (∆5) F-GGAAGGAGCAGAATTACACAT 
R-GTTCAAGGAAGATCTTGACACT 
468 
10 ENSMUSG00000054128 (∆10) F-GTGCACTCCTGTGTCTTTTT 
R-GCTGGACTACTACAACCTGAGT 
451 
11 ENSMUSG00000073386 (∆5) F-TTCTTGAGTCCTCTTCAACTCT 
R-CTCTCTGACAGGAAGCATTTAT 
413 
12 ENSMUSG00000072980 (∆27) F-ACTCGGGAAAACAAAACAAAC 
R-AAAGAAATATGGCGACTCTCT 
418 
13 ENSMUSG00000040329 (∆5) F-CAATGAAAGGGGTATAGTTCAT 
R-AATTGTGAGAAGTTTCATTGTG 
445 
14 ENSMUSG00000028433 (∆88) F-CAGGGTCTAGTTTGTCCAGTAT 
R-TTGCCATCTTTATCCTACAGAC 
401 
15 ENSMUSG00000050141 (∆34) F-AGGAGCTGACAGAGTCAATTT 
R-GACGACTCCTGTGCTCAGAT 
401 
16 ENSMUSG00000048163 (∆31) F-CAGACGTTGTAAACAGAGTTTT 
R-ACACAGTGGAGTCTAACCTCAG 
409 
17 ENSMUSG00000053720 (∆5) F-CAGACACTGAAGAACACTAGCA 
R-TCACATTTGGAATTGTATTCAC 
409 
18 ENSMUSG00000067173 (∆5) F-CAGGTAGAGGCTCTTCATCA 
R-ACCCGATGTTTTTGTTTATAGT 
418 
19 ENSMUSG00000057421 (∆16) F-TCTACATCATCACTTTCCTCAA 
R-GCGAGTCTGTTCCATTTATACT 
411 
Symbols: ∆, deletion 
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Figure 4-5: Interrogation of predicted off-target heterozygous deletions in KO 
mice. A: 300-400bp regions surrounding 19 common predicted heterozygous
deletions were amplified from gDNA of KO and FVB/NJArc in-house wt mice. 
PCR products size of a wt and KO was compared by resolving on 10 % 
polyacrylamide gel, side by side. The predicted deletion is indicated with △, 
followed by a number of nucleotides. The image represents the template amplified 
from G3 KO mouse (NM4:G3-32) and our inbred wt FVB/NJArc. The templates 
showed the putative indels constantly detected in SNVs analysis. B) Positive 
controls showing that a deletion as small as 5-10 nt can be resolved on 10 % 
polyacrylamide gel. Lane 1, a heterozygous △5nt, lanes 2, 3, 4 wt.; lane 5, 
homozygous △10nt C) 5 out of the 19 PCR products were sequenced by Sanger 
sequencing to show that FVB/NJArc and KO mice have identical sequences but
they are different from the mm10 reference genome. D) Table showing that the 
prediction tools are often inaccurate at predicting the presence or the size of a 
putative deletion. Symbols: ∆, deletion; #, indel’s number as indicated in table 4-6; 
G1, 1st generation, G2, 2nd generation, G3, 3rd generation.). 
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Figure 4-6: FokI will only cleave when TALENs bind to both sense and antisense
strand. Image showed a schematic representation of a TALEN pair (adapted and
modified from Kim & Kim (2014)). Each TALEN is composed of transcription
activator-like effectors (TALEs) at the 5' terminus and the Fok1 nuclease domain at
the 3' terminus. Each TALE (~34 amino acids) repeat independently recognizes its
corresponding nucleotide base with 2 repeat variable di-residue (RVD) located at 12th
and 13th position.  
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4.3 Discussion 
In this chapter, we have described how we employed bioinformatic filtering 
following exome sequencing, as a strategy to determine the location of possible 
indels to detect off-target sites as well as to validate on-target mutation. This strategy 
was important in determining the specificity of the TALEN genome editing tool. 
The key element in genome editing is the specific recognition of the targeted DNA 
sequence, within a large genome. In TALEN, the specificity of sequence recognition 
comes from protein-DNA interactions. TALENs are artificial endonucleases in 
which a DNA binding domain (obtained from TAL effector (TALE) protein) is 
fused to the cleavage domain of Fok1 endonuclease which is dimeric in nature. The 
nucleotide specificity is determined by amino acids 12 and 13 of the 30 to 34 amino 
acids in the repeat domains of TAL (Figure 4-6).  
TALEN was shown to have specific cleaving activity for all three functional 
H2A.Lap1 genes (Chapter 3). This is also supported by our BLAST search on the 
nucleotide sequence designed to target H2A.Lap1 genes from the 101421 and 
101422 TALEN plasmids. We used mm10 as a reference genome with either one of 
the 15 nt sequences, corresponding to H2A.Lap1 genes, that were targeted by 
TALENs, and our BLAST search resulted in 54 possible sites on the exonic region. 
However, none of the indels matched to the indel list generated from exome 
sequencing data of FVB/NJARc KO mice. The same was the case even with 3-4 
mismatched nucleotide allowed. Thus, this validates the specificity of Sangamo’s 
design of TALEN’s for all functional variants of H2A.Lap1. 
Next, the analysis of detected SNVs and indels was performed. In order to do that 
our approach was to monitor whether there is any dilution in the variant output from 
each generation of mouse (G1-G3). We applied several variant callers to filter our 
sequencing data, and for every variant caller (GATK. Pindel, Janda) applied, we did 
not see any pattern of dilution that could suggest the presence of unexpected indels 
in our mice. Although we still observed a high number of variants in the output, the 
number did not correspond to the dilution pattern but to the sequencing depth. 
Importantly, TALEN activity usually does not generate single nucleotide variants 
(SNVs), so the presence of a high number of SNVs was also indicative of the 
differences between strains rather than the being a product of TALEN activity. In 
addition, we detected the expected mutations in the sequencing data for all 
H2A.Lap1 genes, in all three mice. Hence, this validates our genotype analysis 
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presented in Chapter 3. Further, not only have we proved that there is no dilution 
pattern from one generation to the next, we have also shown that the high number 
of variants detected was specific to our inbred FVB/NJArc mouse strain. 
Since we detected a high number of variants that are not present in the reference 
mouse genome database (primarily based on C57BL/6 mouse), we conducted 
further variant filtering by calling the genotype of the indels to see whether there 
was any dilution pattern. Again, we did not observe a dilution pattern in 
heterozygous indels. Interestingly, we did detect 19 heterozygous indels that were 
shared between G1 to G3 mice. Our careful experimental validation that included 
amplification of each genomic region and analysis of its sequence, revealed that 
those putative indels are a feature of in-house FVB/NJArc strain and have not 
resulted from TALEN activity.  
According to the published literature, most studies conduct initial computational 
filtering to predict off-target sites, prior to establishing their KO model. Following 
this, various sequencing methods are utilized to further identify any potential off-
target sites. However, not many have taken the sequencing output and tested it 
experimentally (Boel et al. 2016; Liu et al. 2015; Cho et al. 2014). We have extended 
the analysis in order to prove, experimentally, that the 19 heterozygous indels are 
true variants specific to our inbred strain. Our validation of the 19 indels via PCR 
reaction, and 5 by Sanger sequencing, showed that there is no difference between 
the indels in the WT and KO mice, proving that these 19 heterozygous indels are 
indeed variation specific to our inbred FVB/NJArc strain. We also propose that this 
experimental validation step should become standard practice when determining the 
specificity of indels from NGS output. This is especially important when the KO 
model established, does not originate from the same background strain as the 
reference genome used in filtering variants bioinformatically.  
Our analysis has proven that TALENs display high specificity in gene targeting. 
However, during the course of this study, the CRISPR/Cas9 system has overtaken 
TALENs as the tool of choice for genome editing. These two editing tools are often 
compared for their ease of customization. The Cas9 nuclease can be easily retargeted 
to new DNA sequences by simply purchasing a pair of oligos encoding the 20-nt 
guide sequence. In contrast, retargeting of TALENs to a new DNA sequence 
requires the construction of two new TALEN genes. Although a variety of protocols 
exist for TALEN construction, it takes substantially more time to construct a new 
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pair of TALENs. However, it appears that TALEN specificity is higher than 
CRISPR. Studies have shown that mutagenesis of sequences with a high similarity 
to the on-target site is 77 % for CRISPR and only 1 % for TALENs (Veres et al. 
2014). In addition, it has been shown that RNA guided nuclease (RGN) can 
introduce unintended indels at off-target sites with as many as five mismatches (Tsai 
et al. 2015). Although the efficiency of CRISPR RNA guide nucleases (RGNs) in 
targeting has improved in recent years (Lee et al. 2016), the report on off-target sites, 
until now, has been unavailable (Nakajima et al. 2016). Further, despite the 
development of various computational programs to predict off-target sites, they still 
miss a fair number of undetected off-target regions. For instance, the MIT CRISPR 
Design Tool (http://crispr.mit.edu) and the E-CRISP (http://www.e-crisp.org/E-
CRISP), which were used to predict off-target cleavage generated by CRISPR, have 
been utilized widely by researchers (Singh et al. 2015; Puente et al. 2015; Sánchez-
Rivera et al. 2014; Heigwer et al. 2014; Doench et al. 2014; Long et al. 2014)to 
predict their off-target sites based on their degree of similarity to the intended 
targeted site. However, they are still unable to pick up a number of off-target sites 
because these two programs simply do not consider off-target sites bearing more 
than 3 or 4 mismatches (Tsai et al. 2015). One concern of the off-target effect is that 
they might introduce alterations to a tumour suppressor gene, such as a 
chromosomal translocation, which could lead to unfavourable clinical outcomes 
(Tsai et al. 2015). Many steps have been taken with CRISPR to reduce the problem 
of off-target. One such approach is the double-nicking strategy (Tsai et al. 2015) 
which has added more complexity to the design for the CRISPR/Cas9 system. Even 
with the improved double nicking strategy, CRISPR still has off-target sites, as 
demonstrated in (Tsai et al. 2015). 
 In an approach similar to that of CRISPR, we generated several sequences to 
target the intended sites, however, we tested them in the luciferase assay and 
measured their activity efficiency in cell lines (as described in Chapter 3 section 
3.1). This approach of combining the screening methods in order to ensure TALEN 
cleaves specifically is similar to that suggested by Ran et al. (2013) to be conducted 
on CRISPR-Cas9 system. TALEN, on the other hand, cleaves specifically with a 
higher degree of flexibility in design. Researchers can virtually target any sequence 
simply by manipulating the four-main repeat variable di-residues (RVDs) in the 
DNA binding domain of the TAL construct. This simple one to one recognition of 
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TALEN, together with the requirement of flanking 5' thymine, not only have given 
TALEN the advantage over ZFN, but also over CRISPR.  
The main objective of this chapter was to determine whether TALENs could 
cause any off-target cleavage and we have successfully shown, to the best of our 
ability, that TALEN did not induce any off-target effects in the exonic region of our 
KO mice. Although we did not conduct whole genome sequencing, our sequencing 
result from the exome region clearly indicates that no disease-causing genes were 
affected by TALEN, which is a significant concern when using gene targeting in 
biomedical and clinical applications. Therefore, this technology is suitable for 
generating a specific KO model, with low probability of unwanted cleavage 
occurring in the genome. Another very important conclusion from our investigation 
presented here, is that computer generated predictions need to be tailored carefully 
to the experimental set up, and even then, predicted aberrations must be checked in 
the wet lab in order to make sound conclusions about specificity of a method used 
for targeting. Once the specificity of the mutation is confirmed, the phenotypic and 
biochemical changes that we observed in our KO mice can only be attributed to the 
loss of H2A.Lap1. Our assessment is confined to the biological function of 
H2A.Lap1 expression, predominantly in the testes, at low but detectable levels in 
the brain and in white blood cells, and will be presented in the following chapter. 
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CHAPTER 5 
CHARACTERISATION OF H2A.LAP1KO MICE 
 
5.1 Introduction 
In chapter 4, it was shown that TALEN approach was successful at editing a 
multi-copy gene family of H2A.Lap1 by a single pair of TALENs. It was also shown 
that this approach offers a high level of specificity, as the exome sequencing analysis 
and wet lab validation did not detect any off-target sites of TALEN activity. Chapter 
5 is dedicated to the investigation on the effect of the loss of H2A.Lap1 in 
spermatogenesis of H2A.Lap1-/Y males. Firstly, the fertility of H2A.Lap1-/Y males 
was assessed. Secondly, the epigenetic landscape of round spermatids, the main germ 
cell subpopulation that expresses H2A.Lap1, was examined. As H2A.Lap1 is 
enriched in euchromatin of autosomal chromosomes, as well as within the inactive X 
chromosome (at genes that escape X chromosome inactivation), we examined these 
two nuclear locations separately. Thirdly, the overall anatomy of seminiferous tubules 
of wild type versus H2A.Lap1-/Y mice was compared.  
 
5.2 Results and discussion 
5.3 The litter size produced by hemizygous H2A.Lap1-Y males is significantly 
reduced in comparison to their wild type litter mates. 
In order to test the fertility of hemizygous H2A.Lap1-/Y males, 5 hemizygous 
male mice were paired with 10 wt females aged 3-6 months. As a control, 5 age-
matched wt male siblings were also mated at the same time with the wt females aged 
between 3 and 6 months. Each male was paired continuously with two females for a 
period of 2-3 months until the statistically sound number of pups for each trio could 
be obtained. Each litter size was recorded on the morning after the birth. In most 
cases, each litter was assigned to a particular mother, as most females birthed on 
different days. Altogether, 39 litters and 259 pups were produced by 5 hemizygous 
males and 23 litters and 209 pups were produced by the wt male siblings. All males 
tested were from generation 3 (G3) thus were free from mosaicism/recombination 
genotype. Our analysis showed that the hemizygous H2A.Lap1-/Y males produced a 
significantly low number of pups per litter compared to their wt siblings, with 
hemizygous H2A.Lap1-Y males producing an average litter size of 6.48 pups/litter 
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and their wt siblings producing 8.46 pups/litter on average (figure 5-1). This reduced 
litter size indicates a subfertility phenotype for H2A.Lap1-Y males and implied that 
H2A.Lap1 is required for fertility.  
In order to uncover the reasons for H2A.Lap1-/Y subfertility, the epigenetic 
landscape of haploid round spermatids (RS), the subpopulation of germ cells that 
displays the highest expression of H2A.Lap1 in wt mice, was examined using 
immunofluorescent microscopy analysis and the drying-down meiotic spread 
technique (Peters et al. 1997).  
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Figure 5-1: The litter size produced by hemizygous H2A.Lap1-Y males is 
significantly reduced in comparison to wild type litter mates. The scatter plot 
showed the size of litter produced by breeding pairs of wt female (H2A.Lap1 +/+) 
with wt male (H2A.Lap1 +/Y) and wt female (H2A.Lap1 +/+) with hemizygous KO 
male (H2A.Lap1 -/Y). The analysis was conducted on 10 age matched females (3-6 
mo) which were bred with age matched wt (n=5) and hemizygous KO (n=5) males. 
Statistical test, ANOVA, showed that there is a significant reduction in the number 
of litter produced from the hemizygous KO pair. ***p value=0.0006547 (p ≤ 0.001).
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5.4 The nuclei of round spermatids in H2A.Lap1 KO mice are significantly 
smaller in hypotonic conditions.  
Historically, spermatocyte and spermatid spreading techniques were used to 
study chromatin state of those cells. The cells are incubated in hypotonic solution 
containing sucrose, followed by a solution containing detergent and formalin, as a 
fixative, at pH 9.2. These conditions allow cells to swell up and burst their membrane 
but also result in enlarged nuclei and overall slight decondensation of chromatin, 
improving its accessibility for immunolabeling.  
In our experiments, when H2A.Lap1-/Y germ cells were spread on the glass slides 
for immunofluorescence staining, we consistently noticed that the size of the round 
spermatid nuclei in the absence of H2A.Lap1 was smaller than the size of wt RS. In 
order to rule out any discrepancies in the preparation of spreads, wt and H2A.Lap1 -
/Y germ cells were spread at the same time, using the same type slides, reagents and 
incubation conditions. The prepared spreads were stained with DAPI and the nuclei 
size of round spermatids was measured and compared between wt and KO mice. The 
analysis of 77 wt RS and 81 KO RS showed that KO RS nuclei display a significant 
reduction in size (Figure 5-2). Thus, the average size of nuclei in wt mice in hypotonic 
conditions was 16.01 µm whilst in KO mice it was only 9.5 µm. Microscopy analysis 
also showed a more uniform shape of nucleus in KO mice, suggesting that the 
hypotonic conditions did not induce decondensation of chromatin of H2A.Lap1 KO 
RS to the same extend as in wt mice.  
As H2A.Lap1 is known to be associated with decompacted, transcriptionally 
active euchromatin (EU) and is absent from the highly compacted heterochromatic 
chromocenter (CC) of RS (which stains strongly with DAP1)  (Soboleva et al. 2012), 
the CC would not be affected by the absence of H2A.Lap1 but the surrounding 
euchromatin would. Therefore, we measured the fluorescence intensity of the DAPI 
signal in chromocenter and in the surrounding euchromatin and calculated their ratio 
(CC-B)/(EU-B), where B is a background (or autofluorescence). We hypothesised 
that the ratio would decrease in H2A.Lap1 KO RS versus wt mice due to a more 
compacted nature of euchromatin in the absence of H2A.Lap1 (because the DAP1 
staining of euchromatin would be stronger). We also scored early round spermatids 
(ERS) separately from late round spermatids (LRS), to reflect the observation that 
H2A.Lap1 has a higher expression in LRS and it also acquires an additional function 
of re-activating X-chromosome-coded genes in LRS (Soboleva et al. 2012). To 
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distinguish early and late RS, we used lectin-PNA staining that visualised the growing 
acrosome in RS.  
Indeed, we observed that the average (CC-B)/(EU-B) ratio in wt ERS and LRS 
was 3.77 and 3.97, respectively, while in the H2A.Lap1-/Y the ratios were significantly 
smaller, 2.98 and 2.68, for ERS and LRS, respectively (Figure 5-2, C). This represents 
a 1.4-fold difference indicating that the euchromatin of H2A.Lap1 KO RS is 1.4 times 
more condensed in hypotonic conditions compared to wt. (Table 5.1). These in vivo 
findings confirm our previous in vitro results, that showed that H2A.Lap1 
decondenses the chromatin fibre upon its incorporation (Soboleva et al. 2012). In 
conclusion, we show here, for the first time, that the lack of H2A.Lap1 causes 
chromatin condensation in vivo.  
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Figure 5-2: The nuclei of round spermatids in H2A.Lap1 KO mice are significantly
smaller in hypotonic conditions A) Immunofluorescence images of Round spermatid 
nuclei stained with 4’,6-diamidino-2-phenylindole (DAPI) in wt and hemizygous KO 
mice. The diameter shown is a direct measurement by LAS-AF software, size is in µm. 
B) Detailed analysis of RS in wt (n=77) and hemizygous KO (n=81) showed a 
significant difference in the diameter of nucleus between wt and hemizygous KO mice 
in hypotonic conditions (observation is consistent in 4 independent experiments, wt n=3 
and KO n=4, aged between 3 mo and 10 mo). C) The ratio of DAPI fluorescence 
between the chromocentre and euchromatin. This quantification acts as internal control
for the subsequent immunofluorescence quantification and controls for the fact that
euchromatin in H2A.Lap1 -/Y round spermatids is more condensed. ***, p ≤ 0.001, 
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5.5 The active promoter mark, H3K4me3, accumulates in euchromatin of 
H2A.Lap1 KO round spermatids.  
Although we have shown that euchromatin of RSs that lacks H2A.Lap1 does not 
decompact in hypotonic conditions to the same level as in wt RS, and that the 
H2A.Lap1-/Y males are subfertile and produce smaller litters, the spermiogenesis and 
haploid spermatid differentiation still appears to proceed in the absence of H2A.Lap1, 
which implies that there may be a compensatory mechanism(s) in place. 
Spermatogenesis is a vital process that ensures the propagation of a specie and thus 
has evolved to be extremely robust and error-proofed. In addition, the epigenetic 
machinery is known to be highly dynamic and adaptable to changing conditions. One 
of the most striking examples of this adaptability is when the histone TH2B variant is 
knocked-out in mice. In spite of a complete lack of TH2B, the mice were fertile and 
displayed no deficiencies in spermatogenesis. It appeared that a compensational 
mechanism evolved in mice lacking TH2B, where nucleosomes containing somatic 
H2B were decorated with H3K122 and H4K77 crotonylation rendering those 
nucleosomes unstable mirroring TH2B-containing chromatin (Montellier et al. 2013). 
Thus, we wondered whether a similar epigenetic compensatory mechanism may 
take place in H2A.Lap1 KO mice. In order to address this hypothesis, we stained wt 
and H2A.Lap1 KO round spermatids with H3K4me3, an epigenetic mark that is 
associated with active gene promoters similar to H2A.Lap1 and thus may be a good 
candidate for such a compensatory mechanism. 
The staining results were quite striking, showing that in the absence of 
H2A.Lap1, H3K4me3 accumulates in the euchromatin of RS to a much higher level 
than in the wt RS, and that this accumulation phenomenon is not an artefact of the 
lack of decondensation in hypotonic conditions of H2A.Lap1-less euchromatin but a 
true enrichment. The accumulation of H3K4me3 in euchromatin was compared to the 
chromocenter staining intensity, and the ratio of (CC-B)/(EU-B), where B is a 
fluorescence background, was calculated as described in Figure 5-2. The (CC-
B)/(EU-B) ratio in ERS was 9.18 and 2.62 in wt and H2A.Lap1KO respectively; and 
for LRS, 11.69 and 3.24 in wt and H2A.Lap1 KO respectively. Even after taking in 
account the 1.4-fold more condensed euchromatin in KO round spermatids, this result 
shows that there was an ~2.6 fold more H3K4me3 in the euchromatin of H2A.Lap1 
KO RS than in wt RS. This indicates that the H3K4me3 mark accumulates in the 
euchromatin in the absence of H2A.Lap1 and may be one of the ways of 
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compensating for the lack of H2A.Lap1 at the TSS of active genes (Figure 5-3, Table 
5-1). Unexpectedly, unlike H2ALap1, H3K4me3 is also found at the heterochromatic 
chromocentre. We have set up cross reactivity controls and found that H3K4me3 
antibodies were also cross-reacting with H3K9me3. However, staining with 
H3K9me3 did not show any difference between KO and wt round spermatids (data 
not shown). We concluded that euchromatin staining produced by anti-H3K4me3 
antibodies reflected true H3K4me3 status in euchromatin.   
Since H3K4me3 is preceded by H3K4me2, we also assessed the (CC-B)/(EU-B) 
ratio in order to investigate if the H3K4me2 mark also accumulates in the euchromatin 
regions of RS in a similar fashion. We found that in ERS, H3K4me2 accumulation is 
higher in KO spermatids than in wt but this accumulation is less pronounced, which 
can be attributed simply to the lesser level of decondensation of KO RS in hypotonic 
preparations (Figure 5-4). Interestingly, this small difference disappears in LRS, 
probably due to the fact that wt LRS also acquire more H3K4me2 in euchromatin 
(Figure 5-4). Therefore, we can conclude that H3K4me3 but not H3K4me2 may be 
involved in a compensatory mechanism to replace H2A.Lap1.  
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Table 5-1: H3K4me3 enrichment in chromocenter (CC) and euchromatin (EU) in the 
differentiating round spermatids (RS) of KO mice. Numbers indicate ration intensity 
CC/EU 
Genotype WT KO 
Stages of RS 
Early round 
spermatids 
(ERS) 
(Stage 1-4)
Late round 
spermatids 
(LRS) 
(Stage 5-7)
Early round 
spermatids 
(ERS) 
(Stage 1-4) 
Late round 
spermatids 
(LRS) 
(Stage 5-7)
DAPI  3.77 3.97 2.98 2.68
H3K4me3 9.18 11.69 2.62 3.24
 
Figure 5-3: The active promoter mark, H3K4me3, accumulates in euchromatin of
H2A.Lap1 KO round spermatids. A) The quantification strategy used to examine the 
enrichment of H3K4me3 in euchromatin. In order to compare different slides with each
other, fluorescent ratio of (CC-B)/(EU-B) was measured to assess enrichment of 
H3K4me3 in the euchromatin. B) Images of early round spermatids (ERS) and late round
spermatids (LRS) from the hypotonic spread of male germ cells. The sample was
indirectly stained with active promoter mark, H3K4me3 (red) and Lectin PNA
(conjugated with Alexa Fluor 488, green), a marker for acrosome to determine the stages 
of RS cells. DNA was co-stained with DAPI (blue). Scale bar is 10 µm. C) The 
quantification of H3K4me3 signal based on the ratio of (CC-B)/(EU-B). *** p≤0.001, 
ANOVA test. Number of mice used in this analysis wt n=1, KO n=1. 
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Figure 5-4: H3K4me2 does not accumulate in euchromatin of round 
spermatids in KO mice.  A) The quantification strategy used in examining the 
enrichment of H3K4me2 in euchromatin. B) Images of early round spermatids 
(ERS) and late round spermatids (LRS) from the hypotonic spread of male germ
cells. The sample was indirectly stained with active promoter mark, H3K4me2
(red) and Lectin PNA (conjugated with Alexa Fluor 488, green), a marker for
acrosome to determine the stages of RS cells. DNA was co-stained with DAPI 
(blue). Scale bar is 10 µm.  C) The quantification of H3K4me2 intensity in 
chromocenter and euchromatin determined as described in previous figures. 
ANOVA test ***p<0.001. Number of mice used in this analysis wt n=1, KO n=1.
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5.6 H2A.L.2 histone variant displays an unusual behaviour in round and 
condensing spermatids in the absence of H2A.Lap1.  
Another interesting possibility is that histone variants, that belong to the same 
family as H2A.Lap1, may be involved in the compensation mechanism when 
H2A.Lap1 is absent. As have been reported previously and described in detail in the 
introduction chapter, H2A.Lap1 belongs to the family of testis-specific histone variants 
that comprise of H2A.L.1, H2A.L.2, H2A.L.3 and H2A.Lap1 (Govin et al. 2007; 
Soboleva et al. 2012). All these histone variants contain a short acidic patch and upon 
incorporation into the chromatin, relax chromatin fibre and destabilise the nucleosomes 
in vitro (Soboleva et al 2012). Extensive work has been done on deciphering the 
function of H2A.L.2 variant by the Khochbin laboratory (Barral et al. 2017; Govin et 
al. 2007) in which it was shown that H2A.L.2 histone variant is expressed by 
condensing spermatids (at the time when H2A.Lap1 has already ceased from the 
nucleus) and is associated with pericentric heterochromatin. H2A.L.2 is actively 
involved in histone-protamine exchange by destabilising the nucleosomes allowing for 
transitional proteins to associate with the DNA (Barral et al. 2017).  
We entertained a possibility, that in the absence of H2A.Lap1, H2A.L.2 may 
change its expression timing and be expressed earlier, in order to compensate for the 
lack of H2A.Lap1. Our immunofluorescent staining with anti-H2A.L.2 serum (a gift 
from S. Khochbin) have shown that in the wt round spermatids, the signal is very weak 
and the laser power and the gain needs to be raised in order to detect any signal (Laser 
at 30% (normally 20%), gain at 880nm (normally 400-600nm). However, in the KO 
round spermatids, when the identical settings were used, the signal seemed to be 
stronger (Figure 5-5 A). Although the signal was quite weak in both cases, it was 
definitely more obvious and looked more specific in KO RS. In addition, we found a 
very interesting change in H2A.L.2 localisation in the condensing spermatid nuclei in 
the absence of H2A.Lap1. Thus, the wt condensing spermatid staining was identical to 
the previously reported, where H2A.L.2 was enriched in pericentric heterochromatin 
(Govin et al. 2007), while in the KO condensing spermatids, we could not see H2A.L.2 
enrichment in the pericentric heterochromatin in the majority of condensing 
spermatids. Instead, the H2A.L.2 signal was uniform and weak throughout the 
condensing spermatid nuclei (Figure 5-5 B). This finding implied that in the absence 
of H2A.Lap1, H2A.L.2 is mislocalised and that the histone-protamine exchange may 
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not be as efficient in the H2A.Lap1–deficient mice, which may contribute to the 
subfertility phenotype observed in the H2A.Lap1-/Y male mice.   
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Figure 5-5: H2A.L.2 localisation in the nuclei of round and condensing 
spermatid in H2A.Lap1-/Y mice is different from the wild type. A) Images of 
the round spermatid cells from the hypotonic spread of germ cells were indirectly
immunostained with serum raised against H2A.L.2. Under the same laser/gain
settings, H2A.L.2 signal is stronger in the hemizygous KO sample than in wt. B) 
HA.L.2 localisation in condensing spermatid cells. White arrows indicate 
pericentric heterochromatin. C) The histogram depicting the number of cells with 
H2A.L.2 enriched in pericentric heterochromatin region and the number of cells
with diffused signal of H2A.L.2. D) qPCR on other testis- specific histone variant 
on 18 do, 24 do and 30 do testes in wt and KO mice. Number of mice used in this 
analysis wt n=1, KO n=1. 
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5.7 Localisation of RNA polymerase II within splicing speckles is affected in 
H2A.Lap1-/Y round spermatids.  
Previously, it was shown in our laboratory, that H2A.Lap1 directly interacts with 
active form of RNA Polymerase II (both initiating and elongating forms of RNA Pol II 
with CTD S2P and S5P) and that RNA Pol II and H2A.Lap1 reside within splicing 
speckles, the transcriptional and splicing hubs of round spermatid nuclei (Soboleva et 
al 2017). We have performed immunofluorescent staining of round spermatids from wt 
and H2A.Lap1 KO mice using RNA Pol II S5P antibodies. As it was expected, the 
staining in the wt round spermatids produced a signal in the euchromatin with very 
bright foci corresponding to the splicing speckles that surround the chromocenter 
(Figure 5-6, wt panel). Surprisingly, RNA Pol II S5P distribution in more than 70% of 
KO round spermatids was quite different: the pattern was a lot more diffused and the 
signal in the splicing speckles was no longer shaped into well-defined foci (Figure 5-
6, KO panel).  
Intrigued by this observation, we investigated whether the splicing speckle 
morphology is affected by the absence of H2A.Lap1, so we used splicing speckle 
marker, Y12, to identify splicing speckles in the KO and wt rounds spermatids. The 
staining, shown in Figure 5-7, did not reveal any morphological changes in the splicing 
speckles appearance. The Y12 signal in KO and wt round spermatids was observed as 
bright well-defined foci and was perfectly colocalised with the DAPI depleted regions 
of the nuclei, as expected (white arrows, Figure 5-7). This finding implied that 
H2A.Lap1 plays an important part in the anchoring of the RNA Pol II at the splicing 
speckle region and in the absence of H2A.Lap1, even in the presence of upregulated 
H3K4me3, RNA Pol II is not efficiently recruited or retained at these important 
transcriptional and splicing hubs of the round spermatids. In other words, this finding 
uncovers a novel function for H2A.Lap1 in the splicing speckles of round spermatids: 
it seems that direct interaction between H2A.Lap1 and active form of Pol II may serve 
as an anchor for Pol II, or a detailed postal address, as without H2ALap1, RNA Pol II 
can only find the approximate region within and around the splicing speckles but not 
the exact location. 
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Figure 5-6: Localisation of the active form of RNA polymerase II within splicing 
speckles is affected in H2A.Lap1-/Y round spermatids. A) Immunofluorescent 
staining of hypotonic spreads of male germ cells from wt and hemizygous KO mice
testis showing round spermatids.  Cells were indirectly labelled with anti- Pol II S2P 
antibodies and co-stained with DAPI to visualise DNA. Scale bar is 10 µm.  White 
arrows show accumulation of Pol II S2P signal in splicing speckles of WT round
spermatid cells. The signal is diffused in hemizygous KO sample. B) The histogram 
plot showing that majority of RS cells in hemizygous KO mice have diffused Pol II S2
localisation in the euchromatin compartment of round spermatids. Number of mice 
used in this analysis wt n=1, KO n=1. 
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Figure 5-7: Splicing speckle morphology is not affected by the absence of
H2A.Lap1. The hypotonic spreads of germ cells from wt and hemizygous KO adult
mice testis are shown. Cells were indirectly immunostained with the antibody against
splicing speckles marker, Y12 and counterstained with DNA-binding dye, DAPI. 
Scale bar is 10 µm. White arrows show accumulation of Y12 signal in DAPI depleted 
regions. The staining showed no difference in Y12 localisation in hemizygous 
H2A.Lap1 -/Y samples. Number of mice used in this analysis wt n=1, KO n=1. 
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5.8 H3K36me3 enrichment in autosomal euchromatin of round spermatids is 
affected by the absence of H2A.Lap1.  
Actively transcribed genes have well-defined epigenetic landscape that decorates 
the different regions of the gene. Thus, promoter regions and TSSs are decorated by 
H3K4me3 (and H2A.Lap1), while the body of the active gene is decorated with 
H3K36me3. We assessed early and late round spermatids for the H3K36me3 to see if 
we can uncover any differences in KO vs wt RS. Interestingly, we found that 
H3K36me3 is significantly depleted in the euchromatin of ERS of KO mice (Figure 5-
8). This trend disappears in the LRS, as both wt and KO mice display less H3K36me3 
in the euchromatin, probably reflecting the overall lower transcriptional activity of LRS 
in comparison to ERS. However, the fact that H3K36me3 intensity is lower in KO ERS 
may indicate that the overall transcription efficiency may be lower in KO round 
spermatid and represents an important finding that requires further investigation.  
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Figure 5-8: H3K36me3 accumulation in euchromatin of hemizygous KO mice
reduced in early round spermatid. A) The quantification strategy used in examining 
the enrichment of H3K36me3 in euchromatin. B) Images of early round spermatids 
(ERS) and late round spermatids (LRS) from the hypotonic spread of male germ cells.
The sample was indirectly stained with active promoter mark, H3K36me3 (red) and
Lectin PNA (conjugated with Alexa Fluor 488, green), a marker for acrosome to
determine the stages of RS cells. DNA was co-stained with DAPI (blue). Scale bar is 10 
µm.  C) The quantification of H3K36me3 intensity in chromocenter and euchromatin 
was determined as a ratio of (CC-B)/(EU-B). ANOVA test, ** p<0.01, ***p<0.001. 
Number of mice used in this analysis wt n=1, KO n=1. 
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5.9 Effect of H2A.Lap1 absence on overall gene transcription and splicing 
efficiency.  
Inability of active form of RNA Pol II to anchor within slicing speckles and the 
observation that H3K36me3 mark may be depleted within euchromatin of H2A.Lap1 
KO round spermatids raised a possibility that the transcription of highly expressed 
genes, that usually contain H2A.Lap1 within their TSS, may be affected in the absence 
of H2A.Lap1. To test that, 17 genes, whose expression is restricted to RS stage and 
whose TSS contains H2A.Lap1-associated nucleosome were chosen for qPCR. The 
level of expression of those genes was compared between wt and H2A.Lap1 of 30-day 
old testis. The 30-day old testis were chosen because we have shown previously 
(Soboleva et al. 2012). So, that at this stage of seminiferous tubule development, round 
spermatids represent the majority of cell population (up to 80% of tubules contain 
round spermatids, stage 1-8), with no elongating-condensing spermatids. The results 
showed that the expression of 17 genes was significantly affected in the KO sample 
(Figure 5-9). 
We also subjected 30-day old testis from a different group of 3 wt and 3 
H2A.Lap1-/Y mice to Next generation RNA-sequencing experiment to assess whether 
overall gene expression is affected by the lack of H2A.Lap1. Unfortunately, we didn’t 
see any difference between the wt and KO mice (apart from down-regulation of 
H2A.Lap1 coding genes and one other gene, Abr), partly due to the fact that we did not 
use spike-in control, which is necessary to compare global changes in gene expression, 
partly due to the possibility that in this particular KO trio, all samples may have had a 
very high degree of compensation, so that RNA-seq experiment needs to be repeated 
using spike-in control and larger number of biological replicates per group.  
However, the same RNA-seq data was used to analyse whether RNA splicing 
was affected in the H2A.Lap1 KO testis. It was shown previously (Soboleva et al. 
2017), that H2A. Lap1-containing nucleosomes are present at the intron/exon 
boundaries where H2A.Lap1 directly interacts with the spliceosome subunits and with 
the transcribed RNA, implying a function for H2A.Lap1 in regulation of preRNA 
splicing. Thus, we analysed the level of intron retention (IR) in the wt and KO samples. 
The program IRFinder was used (Middleton et al. 2017) with default settings to search 
for retained introns in each individual samples. The results were pooled for each group 
(wt n=3, KO n=3) and differential IR was analysed as described by the authors, using 
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scripts provided with IRFinder. After the initial analysis, a total of 1289 IR events were 
found, which included many events of low significance (p-value > 0.1), low or non-
uninform coverage of introns (A/B-IntronDepth, A/B-IntronCover), or events which 
were associated with annotated/known minor isoforms of transcripts. These events of 
IR were systematically excluded, thus resulting in a list of 131 retained introns. 
We observed that differential IR upon KO of H2A.Lap1 is characterised by an 
even split between increased and decreased IR levels (66 increased/65 decreased). 
However, we also observed that there is a shift in the levels of intron-retention ratios 
to such an extent that mean IR ratios of introns with increased retention in the KO mice 
(IR ratio 0.13) are higher than the mean IR ratios with increased retention in WT mice 
(IR ratio 0.9) (Figure 5-10). The results support the conclusion that there is higher IR 
in the KO mice. Interestingly, the data also shows that there is less variability of IR in 
the absence of H2A.Lap1 but further experiments are required to confirm the observed 
trend. 
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Figure 5-9: Expression level of autosomal round spermatid-specific genes (17 
genes) that normally contain H2A.Lap1 nucleosome in their TSS in wt and 
H2A.Lap1 KO mice testis. The expression level was determined using qPCR,
first normalised to -actin and then to one of the WT mice to obtain the expression 
fold difference. WT (n=3) and H2A.Lap1 KO (n=3), ANOVA test, **p<0.01. 
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Figure 5-10: H2A.Lap1 KO mice showed higher intron retention. The IR
ratio was determined by using IRfinder program (Middleton et al. 2017). The
average IR ratio for each mouse is from an average ratio from 131 retained
introns.  
189 
 
5.10 H2A.Lap1 depletion affects the epigenetic landscape of post meiotic sex 
chromatin (PMSC) and expression of X-chromosome coded genes that escape 
inactivation. 
One of the interesting features of H2A.Lap1 was its incorporation into the 
chromatin of inactivated sex chromosomes in the late round spermatids (stages 5-8), 
and its involvement in reactivation of post-meiotically silent sex-chromatin (PMSC) 
associated genes (Soboleva et al. 2012). Therefore, it was very interesting to assess 
epigenetic landscape of the PMSC in round spermatids that lack H2A.Lap1 and the 
level of expression of the X-chromosome-coded genes that normally contain 
H2A.Lap1 nucleosomes at their TSS.  
There is a number of epigenetic marks that are known to be associated with the 
PMSC and appear to be enriched at that site, when microscopic immunofluorescent 
analysis is used. It has been shown by our laboratory and others that, apart from 
H2A.Lap1, histone variant H2A.Z, as well as multiple post-translational histone 
modifications, such as H3K9me2, H4K8ac, H4K12ac, H3K4me2 and 3 and Lysine 
crotonylation (Kcr) decorate silenced sex chromosomes (Greaves et al. 2006; 
Namekawa et al. 2006; van der Heijden et al. 2007; Montellier et al. 2012).  
As in immunofluorescent staining above, enrichment at PMSC was compared to 
round spermatid chromocenter (CC) and expressed as a ratio of PMCS/CC. Also, early 
and late round spermatids were examined separately to reveal a possible dynamic of 
those marks during rounds spermatid differentiation, which was not done by previously 
published works.  
Thus, staining with anti-Lysine crotonylation antibody (Kcr) revealed that in the 
early round spermatids, Kcr of PMSC is significantly depleted in the absence of 
H2A.Lap1. Interestingly, it was also observed that the PMSC decoration by Kcr 
becomes generally depleted in LRS in both, wt and KO round spermatids. That trend 
has not been observed before (Figure 5-11). This finding indicates that Krc is not 
upregulated at the PMSC to compensate for H2A.Lap1 absence, even though it was 
shown to be present at the TSS of X-chromosome coded genes that escape inactivation 
during PMSC silencing (Montellier et al. 2012). Moreover, it seems to be affected by 
the absence of H2A.Lap1 in early round spermatids (at the time when H2A.Lap1 is not 
present on PMSC) for reasons that are unclear.  
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Figure 5-11: Kcr intensity is reduced in PMSC of hemizygous KO round 
spermatids. A) Images of hypotonic spreads of early round spermatids (ERS) and late 
round spermatids (LRS). The sample was indirectly stained with pan anti-Kcr antibody 
and Lectin PNA (conjugated with Alexa Fluor 488), to determine the stages of RS cells.
DAPI was used to counterstain nuclei. White lines in merged images indicate the path 
used to determine fluorescence intensity across the PMSC and chromocenter. Scale bar
is 10 µm. B) The quantification of KCr intensity as a ratio of PMSC to chromocenter 
fluorescence. ANOVA test, * p≤0.05, ** p≤0.01, ***p≤0.001. Number of mice used
in this analysis wt n=1, KO n=1. 
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Another interesting finding was that a chromatin mark, H3K4me2, was depleted 
at the PMSC in the LRS in the absence of H2A.Lap1 (Figure 5-12) suggesting that it is 
also not involved in the compensation for the loss of H2A.Lap1 at the TSS of X-
chromosome coded genes that become reactivated in late round spermatids.  
Other active mark, H4K8ac, and a repressive mark, H3K9me2 were also 
assessed. H3K9me2 was of interest because it was hypothesised that in the absence of 
decondensing function of H2A.Lap1, PMSC may display a more condensed behaviour. 
However, no difference between wt and KO round spermatids were observed for both 
marks (Figures 5-13 and 5-14).   
The lack of compensation in PMSC, at least at the level of 4 marks examined, 
prompted us to check transcription levels of the X-chromosome coded genes that are 
known to become re-activated at the time, when H2A.Lap1-nucleosome is loaded at 
their TSS in the late RS (Soboleva et al. 2012). Six genes were accessed in 30 do testis 
by quantitative real time PCR and their relative expression was compared between the 
wt and H2ALap1 KO. Interestingly, all 6 genes were downregulated with 5 out of 6 
genes showing consistent downregulation by approximately 20% in all H2A.Lap1 -/Y 
mice that were examined (Figure 5-15). This important finding implies that H2A.Lap1 
is important factor that ensures high level of expression of X-linked genes and that in 
the absence of H2A.Lap1, expression of these genes becomes less efficient.  
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Figure 5-12: H3K4me2 was depleted at the PMSC in the late RS in the absence of 
H2A.Lap1 A) Hypotonic spreads of early round spermatids (ERS) and late round 
spermatids (LRS) from wt and H2A.Lap1 KO testis. The sample was indirectly stained 
with anti-H3K4me2 (red signal), Lectin PNA (conjugated with Alexa Fluor 488) and 
DAPI (blue), to visualise nuclei.  White lines in merged image indicate the path used to 
determine fluorescence intensity across the post meiotic sex chromatin and 
chromocenter. Scale bar is 10 µm. B) The quantification of H3K4me2 intensity in post 
meiotic sex chromatin shown as a ratio of PMSC to CC. ANOVA test, **, p<0.01, ***
p<0.001. Number of mice used in this analysis wt n=1, KO n=1. 
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Figure 5-13: H4K8Ac displays no difference between wt and KO round spermatids
but is reduced in PMSC of late round spermatids in both wt and hemizygous KO mice.
A) Images of early round spermatids (ERS) and late round spermatids (LRS) of hypotonic 
spreads of male germ cells. The samples were indirectly stained with anti- H4K8Ac 
antibody (red ), and Lectin PNA (conjugated with Alexa Fluor 488), a marker for acrosome 
to determine the stages of RS cells. Nuclei were counterstained with DAPI. White lines in 
merged image indicate the path used to determine fluorescence intensity across the post 
meiotic sex chromatin and chromocenter. Scale bar is 10 µm. B) The quantification of 
H4K8Ac intensity in post meiotic sex chromatin. ANOVA test, ** p≤0.01, ***p≤0.001. 
Number of mice used in this analysis wt n=1, KO n=1. 
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Figure 5-14:  The intensity of repressive mark, H3K9me2 displays no 
difference between wt and KO round spermatids but is significantly 
increased in PMSC of late round spermatids (LRS) in both wt and
hemizygous KO mice. A) Images of early round spermatids (ERS) and late round
spermatids (LRS) from the hypotonic spread of male germ cells. The sample was 
indirectly stained with anti- H3K9me2 antibody (red), Lectin PNA (conjugated
with Alexa Fluor 488), a marker for acrosome to determine the stages of RS cells
and counterstained with DAPI to visualise nuclei. White lines in merged image 
indicate the path used to determine fluorescence intensity across the post meiotic
sex chromatin and chromocenter. Scale bar is 10 µm. B) The quantification of 
H3K9me2 intensity in post meiotic sex chromatin shown as a ratio of PMSC/CC. 
ANOVA test, *** p<0.001. Number of mice used in this analysis wt n=1, KO 
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Figure 5-15: Round spermatid-specific X-linked genes that contain H2A.Lap1 in 
their TSS, showing reduced level of expression in H2A.Lap1 KO mice. The 
expression level was determined using qPCR, first normalised to β-actin and then to 
one of the WT sample to obtain the expression fold difference. WT (n=3) and 
H2A.Lap1 KO (n=3), ANOVA test, *** p<0.001.   
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5.11 H2A.Lap1 KO testis contain more clogged seminiferous tubules 
Finally, the overall testis morphology was assessed of formalin fixed, paraffin 
embedded testis sections, stained with Hematoxylin and Eosin (H&E). Hematoxylin 
binds to DNA and RNA, thus stains nuclei blue/violet, while eosin binds to cytoplasmic 
proteins, rich in Arginines and Lysines, and stains cytoplasm pink/red (Baker 1962). 
The testis size and seminiferous tubule cellular make up appeared similar in wt and 
hemizygous KO testis (data not shown). All cell types were represented and cellular 
layers corresponded to what was expected for each seminiferous tubule stage. As 
hypotonic conditions were not used for this preparation, round spermatid size of 
hemizygous KO spermatids did not differ from the wt cells. However, it was noticed 
that in some H2A.Lap1-/Y mice, seminiferous tubules were more often clogged so that 
the lumen was blocked by cytoplasmic residues (also known as residual bodies, RB), 
as indicated by pink staining of lumen in H&E-stained sections. In order to access this 
phenomena in more detail, sections from 20 mice (9 wt and 11 hemizygous KO 
siblings) were analysed and it was found that significant percentage of tubules were 
clogged in the H2A.Lap1 KO tubules (Figure 5-16).   
The presence of clogged lumen in H2A.Lap1 KO testis indicates that the 
clearance of residual bodies by somatic Sertoli cells is inadequate in the absence of 
H2A.Lap1. Residual bodies are formed by the shedding cytoplasm of maturing 
elongating spermatids, as during maturation, spermatids must acquire motility which 
is achieved via an almost complete loss of cytoplasm, as well as nucleus shrinkage and 
a development of a flagellum. The residual bodies are cleared via phagocytosis by 
Sertoli cells in a stage-dependent manner (Garza et al. 1991). 
 Interestingly, H2A.Lap1 was shown by us previously to be a constituent of RBs 
(Soboleva et al. 2012), (Figure 5-17, D, E).  Staining of paraffin-embedded 
seminiferous tubule sections with anti-H2A.Lap1 antibody also showed H2A.Lap1 
signal in a form of multiple small foci in the lumen of tubules during stages III-VI, that 
co-insides with the formation of the residual bodies (Figure 5-17, A-C). Most 
surprisingly, we detected a signal within the nuclei of the Sertoli cells at the stages of 
active phagocytosis of RB by Sertoli cells. Intrigued by this novel observation, that 
H2A.Lap1 signal is detected not in the cytoplasm, which would be expected from the 
phagocytosis of H2A.Lap1-containing RBs, but in the nucleus of Sertoli cells, the 
mRNA expression of H2A.Lap1 in Sertoli cell line, TM4, was measured and compared 
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to H2A.Lap1 expression in total testis as well as in brain regions that are known to 
express small but detectable level of H2A.Lap1 mRNA. To our surprise, mRNA 
expression of H2A.Lap1 was undetectable in Sertoli cells (Figure 5-17, F). This finding 
prompted us to hypothesise that H2A.Lap1 is not expressed by SC but instead becomes 
a part of the nuclear makeup of the Sertoli cells in a protein form, through being 
engulfed by Sertoli cells. Further, upon incorporation into Sertoli cell chromatin, 
H2A.Lap1 may be involved in activation of a particular gene expression program, so 
that in the absence of H2A.Lap1, genes that may control function of Sertoli cells in 
clearing Residual bodies are not efficiently expressed, resulting in inefficient 
mechanism and clogged tubules. Alternatively, it is plausible that H2A.Lap1 may also 
bring important factors to the Sertoli cells that are required for a proper function of SC. 
Although these suggestions are highly speculative and require further investigation, if 
proven to be correct, this finding will represent a novel mechanism, where epigenetic 
information may be transferred extra-cellular, from germ cells to somatic Sertoli cells.  
  
198 
 
A  
 
 
 
B  
Figure 5-16: Hemizygous KO mice has more clogged tubules. A) image of 
hematoxylin and eosin (H&E) stained seminiferous tubule from wt and hemizygous 
KO mice. B) Histogram plot of the percentage of seminiferous tubule with clogged 
lumen in hemizygous KO mice (n=9) and their wt siblings (n=11). ANOVA test, 
**p=0.006547 (≤0.01) 
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Figure 5-17: H2A.Lap1 is a component of residual bodies and Sertoli cell nuclei.
A-C) adult mouse testis paraffin embedded sections were stained with anti-H2A.Lap1
antibodies and co-stained with DAPI to visualize nuclei. A: stage III-IV tubule shows
that H2A.Lap1 appears in RB but not yet enriched in Sertoli cells. B: in stage V-VI
tubules H2A.Lap1 is enriched in RB and SC nuclei; C: during stage XI RB disappear
but H2A.Lap1 is still present in SC nuclei. Yellow arrows indicate SCs. D: Purified
RBs stained with Pyronin Y, bar 20µm. E: Western blot. Lane T: 130µg of whole testis
extract; lane L:110µg of whole liver extract; lane RB: 13 µg of RB extract. F: Sertoli
cells do not express H2A.Lap1 mRNA. Level of expression of H2A.Lap1, measured
by qPCR in Sertoli cell line, TM4, cerebellum, cortex, hippocampus and testis of adult
mice. N=3, Error bars represent standard deviations.  
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CHAPTER 6 
GENERAL DISCUSSION 
 
 
 Previous studies by Soboleva et al. (2012, 2017) identified H2A.Lap1 as a 
component of the TSS and the intron-exon boundary of active genes expressed in the 
testis and the brain. In the testis, H2A.Lap1 is expressed meiotically and post-
meiotically, from late pachytene to the late round spermatid stage coincident with the 
highest levels of expression that occurs during spermatogenesis. These observations 
suggested a role in transcription and splicing but all the experiments to date where 
correlative in nature. The availability of a H2A.Lap1 knockout would be an invaluable 
tool for investigating the importance of this histone variant. However, as the H2A.Lap1 
protein is expressed from three different genes, this was a technically challenging feat. 
Our aim was to devise the most efficient and specific strategy to inhibit the function of 
all three genes. In this thesis, we report a simplified TALEN approach that achieved this 
goal whereby we used one pair of TALENs to specifically and simultaneously disrupt 
three gene copies of H2A.Lap1. To our knowledge this has not been done before (the 
TALEN methodology for producing the H2A.Lap1 KO mouse was recently submitted 
as a preprint; https://www.biorxiv.org/content/ early/2017/12/13/233379.article). 
 The major findings of this study are that H2A.Lap1 KO mice: 1) are subfertile, 
2) have nuclei in round spermatids that are more condensed in hypotonic salt conditions, 
3) display an apparent epigenetic compensatory mechanism with an increase in 
H3K4me3 and possibly H2A.L.2, 4) show a disruption of the hubs of transcription that 
are enriched with RNA Pol II, 4) have altered patterns of intron retention and reduced 
expression of genes, especially on the X chromosome, 5) an altered PMSC epigenetic 
landscape and most interestingly 6) exhibit a clogged seminiferous tubule phenotype. 
 
6.1 TALENs versus CRISPR. 
A major ongoing question is whether a RNA (e.g. CRISPR)- or protein (e.g. 
TALEN)-based mechanism will ultimately prove to be more specific for genome editing 
and this will be critical for future medical therapies. In this study, we have successfully 
applied the TALEN technology, whereby we used one pair of TALENs to specifically 
and simultaneously disrupt three gene copies of H2A.Lap1. Many human diseases are 
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caused by gene copy number variations (de Smith et al. 2008) and therefore the use of a 
limited number of genome editing enzymes might help in the future treatment of such 
diseases. The use of only one pair of TALENs, rather than multiple pairs, reduces the 
complexity of the TALEN approach (and hence the cost) and would reduce the 
likelihood of mosaicism and most importantly, reduce the possibility of off-target 
mutations. Indeed, our rigorous exome analyses did not reveal any TALEN-induced off-
target mutations. We also found that the computational tools used to predict putative 
SNVs and indels have limitations, and therefore wet-lab validation is required before 
any conclusions can be made about off-target mutations. 
The TALEN approach did expose several interesting phenomena. Firstly, the 
simultaneous knockout of highly homologous H2A.Lap1 genes leads to the formation 
of chimeras between these genes. This can be explained by the fact that TALEN activity 
can be retained for several cell divisions following their injection into the 2-cell stage, 
thus producing a mosaic genotype, as previously observed (Tesson et al. 2011; Li et al. 
2014). As every chimera contained a small deletion, it is likely that terminal 
microhomology, a mechanism of NHEJ, was involved (Lieber 2010). It is important to 
point out that other technologies that rely on NHEJ for inducing mutations, like 
CRISPR/Cas9 technology, will also likely produce chimeras between highly 
homologous genes. Several rounds of backcrossing can successfully eliminate such 
small-scale genomic rearrangements. Secondly, we observed an all-or-nothing effect 
whereby the TALENs either modified all 3 H2A.Lap1 genes (6 and 3 alleles from female 
and male pups received its own unique mutation, respectively) or modified none, which 
reduced the need for a more complex breeding and screening strategy to establish a 
H2A.Lap1 KO colony.  
 
6.2 H2A.Lap1 KO mice are viable but subfertile suggesting a compensatory 
mechanism may exist. 
One of the main findings of this work was that the loss of H2A.Lap1 caused mild 
subfertility that manifested itself in smaller litter sizes when hemizygous (H2A.Lap1-/Y) 
males were mated with wt females.  This suggests that while H2A.Lap1 is important for 
fertility, it is not essential. However, there are a number other factors and/or 
compensatory mechanisms that could explain why only a mild subfertile phenotype is 
observed.  
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The fertility issues of hemizygous KO males may be somewhat obscured by the fact 
that the FVB/NJ strain of mouse is known to be exceptionally fertile characterised by 
>90% of successful mating’s enabling the production of very large litters (9.5 pups per 
litter on average). In comparison, another widely used inbred strain, Balb/c, is 
characterised by less than 50% of successful mating’s and only 5.2 pups per litter on 
average (Silver, Lee 1995). In the future, it would be important to re-analyse the fertility 
of hemizygous KO on a less fertile mouse genetic background i.e. backcross our 
hemizygous KO males with Balb/c mice.  
An alternative view to one that H2A.Lap1 may not be essential for fertility is that it 
does play crucial role and hence compensatory epigenetic mechanisms come into play. 
Several active promoter-associated histone PTMs as well as a related histone variant, 
H2A.L.2, were examined by immunofluorescence. A major finding was that H3K4me3 
became more enriched in the euchromatin of autosomal genes in the absence of 
H2A.Lap1, implying that this PTM may indeed play a compensatory role. Similarly, it 
was also observed that H2A.L.2 changed its expression timing, being expressed earlier 
in round spermatids, suggesting that H2A.L.2 may also play a compensatory role. In the 
future, ChIP-Seq experiments need to be performed to show that H3K4me3 and/or 
H2A.L.2 replaces H2A.Lap1 on promoters in H2A.Lap1 KO mice that were previously 
occupied by H2A.Lap1.  
Ultimately, to prove that H2A.Lap1 is crucial for spermatogenesis, a conditional 
transgenic mouse needs to be produced whereby H2A.Lap1 is specifically knocked out 
only in the adult testis. 
 
6.3 H2A.Lap1 deficient mice display major changes to nuclear compaction and 
to the organisation of transcriptional hubs  
Perhaps the most remarkable discovery in this thesis is that in the absence of 
H2A.Lap1, the nuclei of round spermatids become significantly more compacted and 
therefore if compensatory mechanisms do exist, they are unable to decompact chromatin 
to the same extent as H2A.Lap1. Previously, we demonstrated that H2A.Lap1 could 
inhibit the folding of a chromatin fibre in vitro (Soboleva et al. 2012). The hypotonic 
spread technique employed here allowed us to show for the first time that H2A.Lap1 
regulates compaction of the chromatin fibre in vivo. In the future, it will be of great 
interest to investigate how this H2A.Lap1 induced loss of compaction alters high-order 
genome organisation e.g. by performing Hi-C experiments on isolated round spermatids. 
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Another exciting finding is that in the absence of H2A.Lap1, RNA Pol II no longer 
occupies microscopically distinct transcription hubs or factories. Previously (Soboleva 
et al. 2017), this laboratory demonstrated that H2A.Lap1 co-localises with splicing 
speckles, which were also sites of active transcription because both the initiation and 
elongation form of RNA Pol II were enriched at these distinct nuclear bodies. We show 
here that in the absence of H2A.Lap1, RNA Pol II no longer occupies the same territory 
as splicing speckles becoming more diffuse within round spermatid nuclei. This suggests 
that H2A.Lap1, perhaps given its location at the TSS of active genes, has an important 
role in the recruitment and/or anchoring of RNA Pol II to active territories of 
transcription and splicing. This is consistent with previous mass spec data (Soboleva et 
al. 2012) where it was shown that H2A.Lap1 directly interacts with RNA Pol II. 
Alternatively, perhaps the loss of nuclear organisation caused by the increased 
compaction of H2A.Lap1 deficient nuclei may indirectly cause the mis-localisation of 
RNA Pol II.  
 
6.4 RNA-Seq analysis of 30-day mouse testes reveals no changes in gene 
expression but alterations to intron retention. 
Given the major changes in nuclear condensation, RNA Pol II nuclear localisation 
and the fact that H2A.Lap1 KO male mice are subfertile, it was a surprise to find that 
our RNA-Seq experiments revealed no genes whose expression were altered 
significantly in the absence of H2A.Lap1 (data not shown). One interpretation of this 
observation is that H2A.Lap1 may have no role in transcription initiation but only in 
splicing. However, we do not believe that this is the case (especially given that 
H2A.Lap1 is uniquely located at the TSS of highly expressed genes). There are several 
non-mutually exclusive reasons why no apparent change in global gene expression was 
observed.  
 First, as discussed in section 5-9, each individual wt and KO mouse testicle (three 
mice per each condition) displayed large individual gene transcriptome variability, and 
current RNA-Seq analysis pipelines cannot take into account such expression variability. 
In other words, such variability would mask any significant changes in gene expression. 
Indeed, we have come to the realisation that different ways of analysing RNA-Seq data 
needs to be developed that actually examines this expression variability/noise because it 
is possible that such patterns of variability may in fact be the distinct expression 
signature for a particular phenotype (normal or impaired). Second, as discussed above, 
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the replacement of H2A.Lap1 with H3K4me3 or H2A.L.2, or any other mark not yet 
investigated e.g. H2A.Z may result in restored levels of gene expression. However, our 
qPCR results produced using a different set of mice and a small number of autosomal 
genes showed an overall small but significant reduction of gene expression in the 
absence on H2A.Lap1, supporting our hypothesis that H2A.Lap1 is a crucial factor 
involved in control of high level of gene expression.  
 A third possibility is that H2A.Lap1 may have a more important role in inducing 
gene activation in response to intrinsic or external signals rather than maintaining steady 
state levels of gene expression. There is experimental support for this notion.  
Preliminary experiments (performed by Tanya Soboleva) revealed that when mice testes 
were subjected to physiological stress (by elevating testicular temperature to 42ºC for 
30 minutes), this had a devastating effect on the seminiferous tubules of H2A.Lap1 KO 
mice compared to wt mice (Figure 6-1). In KO mice, the seminiferous tubules contain 
almost no meiotic and post-meiotic cells plus a large number of typical apoptotic cells 
are also visible. On the other hand, wt tubules appear largely normal. This example 
illustrates that under physiological stress, H2A.Lap1 becomes essential.  
Recently, we established a collaboration with Timothy Bredy (The Brain 
Institute, University of Queensland) who has established the mouse model to investigate 
the memory of fear (Lin et al. 2011). In this paradigm, a conditioned stimulus (CS, in 
this case, a sound) is presented with an unconditioned stimulus (US, such as a foot 
shock). After several CS and US pairings, the CS alone induces the state of fear, 
evidenced by ‘freezing’ and an increased heart rate, among other reactions, which are 
monitored. The regions of the brain critical for this conditioned fear response are the 
hippocampus and the medial prefrontal cortex (mPFC) (regions where H2A.Lap1 is 
expressed). Most excitingly, their laboratory performed fear-conditioning experiments 
comparing hemizygous KO versus wt mice and found that H2A.Lap1 KO mice exhibited 
a slower rate of fear acquisition and impaired long-term memory of this fear (Figure 6-
2). Significantly, RNA-Seq experiments (by T. Soboleva) revealed that before fear 
training, ~ 50 genes had an altered expression when wt mPFC was compared with KO 
mPFC. However, following fear training, the expression of > 300 fear-related genes 
were impaired (data not shown). In other words, the major impact of the loss of 
H2A.Lap1 was the induction of fear gene expression but not the steady state expression 
of constitutive genes in the mPFC.  
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Finally, while our RNA-Seq testis data did not reveal any changes in gene 
expression when wt versus H2A.Lap1 KO mice were compared, the loss of H2A.Lap1 
increased the extent of intron retention providing support for our proposal that 
H2A.Lap1 has a role in the regulation of pre-mRNA splicing. This is the first 
demonstration that H2A.Lap1 has a role in splicing in its proper physiological context, 
the testes.  
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Figure 6-1: Heat treatment of mice testis. Panels A and C – wt FVB/NJArc, B and 
D- H2A.Lap1 KO. A and B – non-treated controls, C and D – mice testes were 
submerged into 42°C water bath for 30 minutes three times on three consecutive days 
and sacrificed on day 4. Note that control H2A.Lap1 KO mouse (panel B) has clogged 
seminiferous tubules, marked with #. Upon heat treatment, H2A.Lap1 KO mouse 
(panel D) lost majority of spermatocytes and round spermatids and contains 
numerous apoptotic cells marked by *, while the wt FVB/NJArc tubules (panel C) 
display almost normal phenotype with all cell types present and with a small number 
of apoptotic cells in the tubules (*). Scale bar is 250µm.
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Figure 6-2: H2A.Lap1 depletion associated with impaired long-term memory. A i) 
Hemizygous KO mice exhibit a slower rate of acquisition of fear compared with wild
type mice following 1 day of behavioural training (*p<0.05, t test, t=2.068 df=30).
Although this difference goes away after a second day of training, there remains a trend,
suggesting that the hemizygous KO mice have impaired or less stable fear memory. A 
ii) A retention test for short-term memory (Day 5) and long-term memory (Day 30, A 
(iii)), revealed a reduction in freezing at day 30. These initial observations strongly
suggest that the hemizygous KO mice have less robust fear memory compared with wild
type mice. This effect on fear memory is not due to any group differences in locomotor
activity (A (iv)) or generalized anxiety (A (v)), suggesting a fundamental role of 
H2A.Lap1 in the formation and stability of long-term memory. B i) showed that both 
hemizygous KO and wt mice have memory compare with chance, and hemizygous KO
mice show less preference to the novel object, because their memory about the familiar
object is not as good as wt mice. Figure B ii) and iii) are all control data: B ii) shows that 
wt and hemi spent same amount of time to explore objects during learning period
(sample control); B iii) shows they spent similar amount of time during test (choice
phase). 
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6.5 Loss of H2A.Lap1 alters the post-meiotic sex chromatin epigenetic landscape 
During meiosis the sex chromosomes become highly condensed and silenced in 
order to avoid illegitimate recombination between the X and Y chromosome. This 
inactivation continues post-meiotically and this inactivation in round spermatids is 
referred to as post-meiotic sex chromatin (PMSC). Despite this silencing however, ~20 
% of X-chromosome coded genes become activated in order to produce proteins that are 
vital for later stages of spermiogenesis. Others and we have shown that PMSC are 
decorated by a number of specific histone variants (H2A.Lap1 and H2A.Z) and PTMs 
necessary to ensure either gene silencing or activation of the required genes (Greaves et 
al. 2007; Moretti et al. 2016; Montellier et al. 2013). H2A.Lap1 is targeted to the inactive 
X chromosome in late round spermatids and this is coincident with X-linked gene 
activation. In addition to H2A.Lap1, histone crotonylation (Kcr) also decorates the TSS 
of reactivated X chromosome genes (Montellier et al. 2013). Other active marks, 
including H3K4me2 and H4K8Ac are also associated with PMSC (Khalil et al. 2004).  
Our results have shown that neither Kcr, H3K4me2 nor H4K8ac increased at 
PMSC to compensate for the loss of H2A.Lap1. In fact, Kcr became depleted at PMSC 
in early round spermatids (ERS) when H2A.Lap1 was absent. On the other hand, 
H3K4me2 was depleted in late round spermatids (LRS) of H2A.Lap1 KO mice for 
reasons that are unclear. Given that there was no apparent epigenetic compensation at 
PMSC (at least for the active marks investigated), it was perhaps not surprising that the 
overall expression efficiency of X-linked genes was reduced by ~ 20% in H2A.Lap1 KO 
mice. However, to confirm that no epigenetic compensation process occurs on the X 
chromosome (unlike autosomes), it will be necessary to perform ChIP-Seq experiments 
examining these as well as other active marks. 
 
6.6 Dynamic epigenetic changes between early and late round spermatids  
This thesis has yielded other interesting observations concerning the changing 
epigenetic landscape between ERS and LRS that has not been observed before. In spite 
of lack of difference between wt and KO round spermatids, we have observed that the 
repressive mark H3K9me2 becomes more enriched in LRS on PMSC which coincides 
with a depletion in the active marks H4K8Ac and Kcr. At euchromatin, we also observed 
other active marks (H3K36me3 and H3K4me3) become depleted in LRS in wt mice. 
These reductions in active marks at the latter stages of round spermatid differentiation 
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might be in preparation for the global shut down of transcription that occurs when the 
round spermatids begin to elongate and condense.  
Another intriguing observation is that in the absence of H2A.Lap1, H2A.L.2 
loses its heterochromatin enrichment in elongating-condensing spermatids. This could 
be because it begins to be expressed earlier in KO round spermatids being incorporated 
into euchromatin and therefore by the time the condensing spermatid stage is reached, 
there are limiting amounts of H2A.L.2 protein to be incorporated into heterochromatin. 
Alternatively, in ways that are not understood, the proper expression H2A.Lap1 is 
subsequently required for the proper expression and incorporation of H2A.L.2 into 
heterochromatin in condensing spermatids e.g. if H2A.Lap1 regulates the expression of 
a H2A.L.2 chaperone. It is worth noting that H2A.L.2 KO mice are infertile (Barral et 
al. 2017) and therefore mis-incorporation of H2A.L.2 could provide one possible 
explanation as to why H2A.Lap1 KO mice are subfertile. Clearly, future experiments 
are required to test these speculative ideas. 
 
6.7 A possible role for H2A.Lap1 in somatic Sertoli cell function. 
A final intriguing and unexpected finding of this thesis was that H2A.Lap1 was 
detected in the nucleus of Sertoli cells even though, based on a Sertoli cell line, is not 
expressed in these cells. Sertoli cells are crucial for the proper differentiation of male 
germ cells. They send intracellular signals to control differentiation of spermatogonial 
stem cells, they clear multiple apoptotic events by phagocytosis (up to 50% of germ cells 
undergo apoptosis (Nakanishi & Shiratsuchi 2004), they are solely responsible for 
clearing out residual bodies from the lumen, and they create a blood-testis barrier that 
allows germ cells to proliferate and differentiate in an immuno-privileged environment 
(reviewed in Sharpe et al. (2003).  
Previously, this laboratory demonstrated that H2A.Lap1 is a constituent of 
residual bodies (RB) (Soboleva et al. 2012). Here, we observed that RB are not cleared 
efficiently by Sertoli cells in H2A.Lap1 KO testes thus producing tubules that are 
clogged.  Given that Sertoli cells phagocytose RB, it would not be surprising to find 
H2A.Lap1 in the cytoplasm. However, what is fascinating is that H2A.Lap1 is found in 
the nucleus indicating that H2A.Lap1 is imported into the nucleus presumably to 
perform an important function i.e to regulate gene expression and/or splicing. 
Alternatively, given that H2A.Lap1 is a RNA binding protein, and that RB is enriched 
with RNA, H2A.Lap1 may transport regulatory RNA molecules into the nuclei of Sertoli 
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cells. Future experiments would include purifying Sertoli cells (Anway et al. 2003) and 
performing H2A.Lap1 ChIP-Seq experiments to confirm its incorporation into 
chromatin and determining its genomic locations. In addition, it would be necessary to 
purify RB and perform mass spec as well as iCLIP experiments to determine the protein 
and RNA partners of H2A.Lap1.  If proven to be true, this would represent a novel 
mechanism of epigenetic regulation whereby an epigenetic regulator (H2A.Lap1) 
produced by one cell type can be transferred to a different cell type to regulate the 
expression and function of its genome.  
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Supplementary Table S1: List of high confidence differential Intron Retention events as estimated by IRFinder in H2A.Lap1KO and wt mice 
         WT KO 
 Chr Start End 
Intron-GeneName/ 
GeneID Direction 
Excluded 
Bases 
p- 
diff 
p- 
increased 
p-
decreased 
IR 
ratio 
Intron 
Cover 
Intron 
Depth 
Splices 
Max 
Splices 
Exact 
IR 
ratio 
Intron 
Cover 
Intron 
Depth 
Splices 
Max 
Splices 
Exact 
1 17 24594595 24594671 
Pkd1/ 
ENSMUSG00000032855 + 10 0.00086152 0.999138 0.00086152 0.156426 1 32.8214 174 174 0.061088 1 14.9643 229 229 
2 15 58430098 58430178 
D15Ertd621e/ 
ENSMUSG00000037119 + 10 0.00162941 0.00162941 0.998371 0 0 0 306 306 0.027825 1 8.21429 286 286 
3 11 58042642 58042743 
Larp1/ 
ENSMUSG00000037331 + 10 0.0042067 0.0042067 0.995793 0.024978 1 33.8919 1206 1206 0.043358 1 61.5946 1259 1259 
4 2 30030370 30030451 
Sptan1/ 
ENSMUSG00000057738 + 10 0.00455201 0.995448 0.00455201 0.011764 1 21.6897 1822 1821 0.004246 1 8.65517 2029 2029 
5 5 108655364 108655439 
Dgkq/ 
ENSMUSG00000004815 - 10 0.00534799 0.994652 0.00534799 0.205882 1 4.66667 18 18 0 0 0 32 32 
6 8 3636421 3636493 
Stxbp2/ 
ENSMUSG00000004626 + 10 0.00673497 0.00673497 0.993265 0.015367 1 11.3462 727 726 0.035253 1 27.0769 741 735 
7 4 155587784 155587860 
Nadk/ 
ENSMUSG00000029063 + 10 0.00727491 0.00727491 0.992725 0.034411 1 16.5357 464 445 0.072941 1 31 394 379 
8 8 84003002 84003115 
1700067K01Rik/ 
ENSMUSG00000046408 + 10 0.00872941 0.991271 0.00872941 0.029904 1 13.1628 427 427 0.008197 1 4 484 484 
9 9 108814351 108814429 
Nckipsd/ 
ENSMUSG00000032598 + 10 0.0107419 0.989258 0.0107419 0.187713 1 3.92857 17 17 0.014032 0.441 0.357143 31 31 
10 11 120562545 120562654 
P4hb/ 
ENSMUSG00000025130 - 10 0.0123026 0.987697 0.0123026 0.013173 1 11.8537 888 888 0.003845 1 3.36585 872 872 
11 5 145043556 145044096 
1700018F24Rik/ 
ENSMUSG00000029620 + 10 0.0126676 0.0126676 0.987332 0.05673 1 132.132 2197 2132 0.073283 1 168.594 2132 2070 
12 7 122220739 122220849 
Chp2/ 
ENSMUSG00000030865 + 10 0.0128993 0.0128993 0.987101 0.010649 0.98 1.55 144 144 0.065476 1 11 157 157 
13 15 76596698 76596776 
Cpsf1/ 
ENSMUSG00000034022 - 10 0.0130521 0.986948 0.0130521 0.038286 1 19.7857 497 497 0.015302 1 8.5 546 546 
14 7 25303497 25303581 
Prr19/ 
ENSMUSG00000058741 + 10 0.013681 0.013681 0.986319 0.026437 1 25.9333 955 947 0.045531 1 48.4667 1016 1012 
15 10 127720020 127720152 
Myo1a/ 
ENSMUSG00000025401 + 10 0.0157843 0.984216 0.0157843 0.038462 1 12.08 301 301 0.011028 1 3.78 339 339 
16 15 89282004 89282090 
Ppp6r2/ 
ENSMUSG00000036561 + 10 0.0166393 0.983361 0.0166393 0.03639 1 12.5 329 329 0.01369 1 5.34375 383 383 
17 8 56532514 56532775 
Cep44/ 
ENSMUSG00000038215 - 10 0.0168562 0.0168562 0.983144 0.097925 1 33.2178 280 280 0.157553 1 47.1287 234 234 
18 17 24678052 24678595 
Zfp598/ 
ENSMUSG00000041130 + 10 0.0170308 0.0170308 0.982969 0.10352 1 47.3442 405 405 0.154513 1 65.2419 351 351 
19 17 34027522 34027622 
H2-Ke6/ 
ENSMUSG00000073422 - 10 0.0171102 0.0171102 0.98289 0.075614 1 14.8056 181 181 0.148354 1 28.9167 166 166 
20 7 44500438 44500967 
Fam71e1/ 
ENSMUSG00000051113/ 
known-exon + 68 0.0189671 0.0189671 0.981033 0.04649 1 168.211 3082 3057 0.057507 1 208.795 3054 3018 
21 14 55719142 55719239 
Rabggta/ 
ENSMUSG00000040472 - 10 0.0193371 0.0193371 0.980663 0.066407 1 20.4857 288 288 0.116162 1 34.1714 260 260 
22 5 110342404 110342499 
P2rx2/ 
ENSMUSG00000029503 - 10 0.0208594 0.979141 0.0208594 0.110528 1 39.1429 315 315 0.06645 1 24.4857 344 344 
216 
 
23 15 76248900 76248977 
Grina/ 
ENSMUSG00000022564 + 10 0.0218147 0.978185 0.0218147 0.013051 1 55.963 4224 4224 0.00855 1 40.5556 4688 4688 
24 9 21833173 21833363 
Dock6/ 
ENSMUSG00000032198 - 10 0.0225117 0.977488 0.0225117 0.033329 1 3.93056 114 113 0.000332 0.0444444 0 133 133 
25 15 89185464 89185537 
Dennd6b/ 
ENSMUSG00000015377/ 
known-exon - 10 0.0233786 0.976621 0.0233786 0.143243 1 106 634 620 0.107609 1 83.4444 692 681 
26 2 24926194 24926271 
Arrdc1/ 
ENSMUSG00000026972/ 
known-exon - 10 0.0234023 0.976598 0.0234023 0.446062 1 24.963 26 26 0.23057 1 13.1852 38 38 
27 14 54468781 54469035 
Lrp10/ 
ENSMUSG00000022175 + 10 0.0241515 0.0241515 0.975848 0.023757 1 7.39796 304 304 0.053316 1 14.6429 260 260 
28 17 25235111 25235181 
Gnptg/ 
ENSMUSG00000035521 - 10 0.0244091 0.0244091 0.975591 0.06821 1 18.6667 246 246 0.12535 1 26.0833 180 179 
29 18 84947939 84948022 
Timm21/ 
ENSMUSG00000024645 - 10 0.0263483 0.0263483 0.973652 0.111015 1 32.9677 264 248 0.173333 1 47.3871 226 214 
30 17 25829163 25829239 
Jmjd8/ 
ENSMUSG00000025736 + 10 0.0267616 0.973238 0.0267616 0.030678 1 3.89286 120 120 0.003021 0.409091 0.285714 132 131 
31 7 44860911 44860988 
Pnkp/ 
ENSMUSG00000002963 + 10 0.0267624 0.0267624 0.973238 0.008621 0.925373 2 227 227 0.036394 1 11.4815 301 301 
32 7 25704278 25704783 
Tgfb1/ 
ENSMUSG00000002603 + 10 0.0290665 0.970933 0.0290665 0.024472 0.785859 3.13568 125 125 0.002105 0.383838 0.211055 182 182 
33 1 171222153 171222374 
Tomm40l/ 
ENSMUSG00000005674 - 41 0.0295543 0.0295543 0.970446 0.089864 1 5.43056 51 50 0.219411 1 11.8056 36 35 
34 3 145578358 145578444 
Znhit6/ 
ENSMUSG00000074182 + 10 0.0306191 0.969381 0.0306191 0.010899 1 4 363 362 0 0 0 370 369 
35 7 126862720 126862817 
Hirip3/ 
ENSMUSG00000042606 + 10 0.0307826 0.969217 0.0307826 0.106735 1 73.4857 615 604 0.077013 1 63.9143 766 749 
36 X 74276556 74276645 
Dnase1l1/ 
ENSMUSG00000019088 - 10 0.03125 0.03125 0.96875 0.000602 0.0126582 0 19 19 0.183406 1 3.81818 17 17 
37 2 25616312 25616531 
Ccdc183/ 
ENSMUSG00000026940/ 
known-exon - 10 0.0320405 0.0320405 0.967959 0.138908 1 191.482 1182 1182 0.166628 1 212.941 1064 1063 
38 1 36520227 36520518 
Cnnm3/ 
ENSMUSG00000001138 + 10 0.033357 0.966643 0.033357 0.38109 1 11.6991 19 18 0.170681 1 8.02655 39 36 
39 Y 821360 821449 
Uba1y/ 
ENSMUSG00000069053 + 10 0.0336092 0.0336092 0.966391 0 0 0 168 168 0.023121 1 4 169 169 
40 1 182442297 182442632 
Trp53bp2/ 
ENSMUSG00000026510 + 10 0.0337359 0.966264 0.0337359 0.056584 1 2.51908 42 42 0 0 0 60 60 
41 17 25149101 25149210 
Clcn7/ 
ENSMUSG00000036636 + 10 0.0340887 0.965911 0.0340887 0.115744 1 11.7805 90 90 0.049459 1 5.46341 105 105 
42 13 24831929 24832009 
Tdp2/ 
ENSMUSG00000035958 + 10 0.0342681 0.0342681 0.965732 0.01 1 3 297 294 0.031064 1 9.71429 303 299 
43 10 81261715 81261794 
Matk/ 
ENSMUSG00000004933/ 
known-exon + 10 0.034556 0.034556 0.965444 0.152308 1 3.41379 19 19 0.423547 1 9.55172 13 13 
44 17 34590260 34590460 
Gpsm3/ 
ENSMUSG00000034786 + 10 0.0364772 0.0364772 0.963523 0.088235 1 3 31 28 0.294664 1 8.35526 20 19 
45 3 94430651 94430817 
Tdrkh/ 
ENSMUSG00000041912/ 
known-exon + 10 0.0371743 0.0371743 0.962826 0.47262 1 126.359 141 141 0.583856 1 155.734 106 106 
217 
 
46 18 35800029 35800109 
Ube2d2a/ 
ENSMUSG00000091896 + 10 0.0377401 0.96226 0.0377401 0.01332 1 48.0714 3561 3557 0.00881 1 33.5 3769 3767 
47 8 70783809 70784142 
Mast3/ 
ENSMUSG00000031833 - 10 0.0394907 0.960509 0.0394907 0.035466 1 2.61069 70 70 0.000874 0.0804954 0 92 92 
48 5 114870265 114870718 
4930519G04Rik/ 
ENSMUSG00000029564 + 10 0.0401014 0.0401014 0.959899 0.155203 1 160.017 871 871 0.187688 1 175.832 761 761 
49 5 31075853 31075954 
Cad/ 
ENSMUSG00000013629 + 10 0.0417683 0.958232 0.0417683 0.020905 1 4.27027 200 200 0.001516 0.274725 0 181 181 
50 17 49449161 49449434 
Mocs1/ 
ENSMUSG00000064120 + 10 0.0422586 0.0422586 0.957741 0 0 0 58 58 0.061971 1 1.91589 29 29 
51 X 73779526 73779613 
Idh3g/ 
ENSMUSG00000002010 - 10 0.0424464 0.0424464 0.957554 0.002801 0.844156 1 356 356 0.016129 1 5 305 305 
52 4 129551870 129551947 
Lck/ 
ENSMUSG00000000409 - 10 0.0426883 0.0426883 0.957312 0 0 0 28 28 0.12 1 3 22 22 
53 X 73779171 73779465 
Idh3g/ 
ENSMUSG00000002010 - 10 0.0433323 0.0433323 0.956668 0.001415 0.369718 0.175439 260 260 0.013778 1 3.01754 216 216 
54 17 26125391 26125477 
Mrpl28/ 
ENSMUSG00000024181 + 10 0.0435337 0.0435337 0.956466 0.001437 0.631579 0.8125 439 435 0.012058 1 5.6875 466 459 
55 2 20859796 20859880 
Arhgap21/ 
ENSMUSG00000036591 - 10 0.0442231 0.0442231 0.955777 0.02381 0.945946 1 41 40 0.131222 1 4.83333 32 32 
56 15 97749741 97750005 
Rapgef3/ 
ENSMUSG00000022469 - 10 0.0445239 0.955476 0.0445239 0.054546 0.858268 1.5 26 26 0.00568 0.291339 0 51 51 
57 4 21759529 21759622 
Tstd3/ 
ENSMUSG00000028251 - 10 0.0451364 0.954864 0.0451364 0.013348 1 3.57143 263 263 5.24E-05 0.0120482 0 226 226 
58 17 56318150 56318246 
Uhrf1/ 
ENSMUSG00000001228 + 10 0.0461142 0.953886 0.0461142 0.054154 1 45.8611 801 801 0.036967 1 35.5833 927 926 
59 17 24590937 24591014 
Pkd1/ 
ENSMUSG00000032855 + 10 0.0474164 0.952584 0.0474164 0.128535 1 16.6667 105 103 0.069431 1 10.2963 131 128 
60 5 33730059 33730143 
Fgfr3/ 
ENSMUSG00000054252 + 10 0.0490416 0.950958 0.0490416 0.089005 1 2.83333 29 29 0.002247 0.0810811 0 36 36 
61 19 6315096 6315171 
Cdc42bpg/ 
ENSMUSG00000024769 + 10 0.0495059 0.0495059 0.950494 0 0 0 84 84 0.04 0.938462 3 72 72 
62 8 123268549 123268744 
Fanca/ 
ENSMUSG00000032815 - 10 0.051309 0.948691 0.051309 0.036882 0.956757 3.29333 86 86 0.001542 0.151351 0 98 98 
63 3 103064157 103064233 
Nras/ 
ENSMUSG00000027852 + 10 0.0521193 0.947881 0.0521193 0.012228 1 13.0357 1017 1016 0.005505 1 6 1042 1042 
64 1 36825346 36825428 
Tmem131/ 
ENSMUSG00000026116 - 10 0.052319 0.947681 0.052319 0.015152 1 3 195 195 0.001284 0.277778 0 216 216 
65 8 119615507 119615610 
Adad2/ 
ENSMUSG00000024266 + 10 0.0531216 0.946878 0.0531216 0.086279 1 59.2051 620 620 0.062333 1 44.8718 674 673 
66 9 21832945 21833034 
Dock6/ 
ENSMUSG00000032198 - 10 0.0546569 0.0546569 0.945343 0.002552 0.240506 0 94 94 0.030083 1 2.63636 85 85 
67 15 86130190 86130256 
Gramd4/ 
ENSMUSG00000035900 + 10 0.0552617 0.0552617 0.944738 0.005225 0.0892857 0 17 16 0.1875 1 3 13 13 
68 Y 927891 927969 
Kdm5d/ 
ENSMUSG00000056673 + 10 0.0566219 0.0566219 0.943378 0.004184 0.0882353 0 21 21 0.143885 1 2.85714 17 17 
69 9 35272627 35272701 
Rpusd4/ 
ENSMUSG00000032044 + 10 0.0572766 0.0572766 0.942723 0.034163 1 3.96154 112 112 0.085121 1 9.76923 105 105 
70 10 81595245 81595322 
Tle6/ 
ENSMUSG00000034758 - 10 0.0585013 0.0585013 0.941499 0.00622 0.38806 0.222222 62 62 0.05 1 3 57 57 
71 12 111671347 111671424 
Ckb/ 
ENSMUSG00000001270 - 10 0.0592346 0.940765 0.0592346 0.089783 1 9.66667 98 98 0.033058 1 3.55556 104 103 
218 
 
72 6 113466154 113466252 
Il17re/ 
ENSMUSG00000043088 + 10 0.0597225 0.940277 0.0597225 0.146919 1 7.75 45 44 0.063291 1 5 74 74 
73 17 47690261 47690573 
Prickle4/ 
ENSMUSG00000096549 - 10 0.0604604 0.93954 0.0604604 0.200524 0.966887 2.5082 10 10 0.047889 0.910596 1.10656 22 22 
74 5 110656641 110656815 
Ddx51/ 
ENSMUSG00000029504 + 10 0.0606755 0.939325 0.0606755 0.029664 1 13.8485 453 446 0.014894 1 7.10606 470 470 
75 8 71472117 71472194 
Dda1/ 
ENSMUSG00000074247 + 10 0.0614111 0.938589 0.0614111 0.01532 1 24.037 1545 1525 0.009349 1 15.2222 1613 1581 
76 19 10054121 10054226 
Fads3/ 
ENSMUSG00000024664 + 10 0.0615068 0.0615068 0.938493 0.006818 0.315789 0.0512821 46 46 0.081581 1 2.48718 26 26 
77 10 81260182 81260907 
Matk/ 
ENSMUSG00000004933 + 10 0.0625 0.0625 0.9375 0.013198 0.427972 0.320557 30 30 0.09296 0.854545 2.97213 29 29 
78 9 99324240 99324896 
Esyt3/ 
ENSMUSG00000037681 - 10 0.0626425 0.0626425 0.937358 0.054951 1 8.37308 144 143 0.104674 1 15.3154 131 130 
79 8 4135020 4135131 
Cd209g/ 
ENSMUSG00000079168 + 10 0.062814 0.062814 0.937186 0.189723 1 4.68293 20 20 0.465991 1 7.85366 9 8 
80 X 7708021 7708110 
Gpkow/ 
ENSMUSG00000031148 + 10 0.0642543 0.0642543 0.935746 0.002825 0.405063 0.30303 143 143 0.02069 1 3 142 142 
81 4 59071752 59072284 
AI481877/ 
ENSMUSG00000038598 - 10 0.0649458 0.935054 0.0649458 0.042665 0.831418 1.7381 38 38 0.00363 0.222222 0 61 61 
82 8 105894480 105894622 
Nrn1l/ 
ENSMUSG00000044287 + 27 0.0649679 0.935032 0.0649679 0.214286 1 3 11 11 0.025065 0.591304 0.723404 23 23 
83 9 108814747 108814927 
Nckipsd/ 
ENSMUSG00000032598 + 10 0.0649928 0.935007 0.0649928 0.268275 1 10.6324 29 29 0.121951 1 5 36 36 
84 7 109525349 109525538 
St5/ 
ENSMUSG00000031024 - 10 0.0662378 0.933762 0.0662378 0.040992 1 20.6027 482 482 0.024953 1 13.2055 516 516 
85 19 6232400 6232527 
Ppp2r5b/ 
ENSMUSG00000024777 - 10 0.0694062 0.930594 0.0694062 0.052767 0.786325 3.06383 55 55 0 0 0 55 55 
86 8 109667185 109667526 
Pkd1l3/ 
ENSMUSG00000048827 + 10 0.0701059 0.0701059 0.929894 0.00193 0.386707 0.218045 200 200 0.013381 0.963746 2.83459 207 207 
87 19 32016566 32016683 
Asah2/ 
ENSMUSG00000024887 - 10 0.0705808 0.929419 0.0705808 0.132161 1 4.72093 26 26 0.002796 0.0560748 0 16 16 
88 7 128203033 128203157 
Itgad/ 
ENSMUSG00000070369 + 10 0.0719873 0.0719873 0.928013 0.211203 1 16.0652 54 54 0.336425 1 28.3913 50 50 
89 11 74837472 74837611 
Mnt/ 
ENSMUSG00000000282 + 10 0.0723232 0.927677 0.0723232 0.057143 1 4 63 63 0.007692 0.643411 0.849057 75 75 
90 14 70647549 70647636 
Npm2/ 
ENSMUSG00000047911 - 10 0.0727771 0.0727771 0.927223 0 0 0 62 62 0.049215 1 4.45161 85 85 
91 11 62283707 62284130 
Ttc19/ 
ENSMUSG00000042298 + 10 0.0730313 0.0730313 0.926969 0.006374 0.622276 0.958084 97 92 0.053205 1 4.38323 78 77 
92 13 55542657 55542783 
Fam193b/ 
ENSMUSG00000021495 - 10 0.0733485 0.926651 0.0733485 0.226463 1 44.5 151 151 0.163443 1 32.0417 163 163 
93 4 129556005 129556287 
Lck/ 
ENSMUSG00000000409 - 10 0.0759715 0.924028 0.0759715 0.043478 0.720588 1.54545 34 32 0.008333 0.411765 0.281818 49 48 
94 7 81169062 81169166 
Slc28a1/ 
ENSMUSG00000025726 + 10 0.07776 0.07776 0.92224 0 0 0 23 23 0.120752 1 4.39474 31 31 
95 3 115888277 115888439 
Dph5/ 
ENSMUSG00000033554/ 
known-exon + 10 0.0778693 0.922131 0.0778693 0.02132 0.743421 1.67742 66 66 0 0 0 91 91 
96 19 6315787 6315863 
Cdc42bpg/ 
ENSMUSG00000024769 + 10 0.0781546 0.921845 0.0781546 0.069552 1 3.21429 42 42 0 0 0 40 40 
219 
 
97 9 26766072 26767076 
Glb1l2/ 
ENSMUSG00000036395 - 10 0.0787172 0.0787172 0.921283 0.005277 0.466801 0.439698 88 88 0.026449 0.779678 1.73869 63 63 
98 10 78182722 78182945 
Pwp2/ 
ENSMUSG00000032834 - 10 0.0788994 0.921101 0.0788994 0.185647 1 5.47126 24 24 0.043956 0.591549 1.6092 35 35 
99 7 127933114 127933370 
Prss36/ 
ENSMUSG00000070371 - 10 0.0793608 0.920639 0.0793608 0.092794 1 3.58 35 34 0.03169 0.97561 1.44 44 44 
100 3 67355626 67356220 
Rsrc1/ 
ENSMUSG00000034544 + 10 0.0794349 0.0794349 0.920565 0.043336 1 30.1239 642 642 0.061195 1 41.4573 617 617 
101 14 55719345 55719429 
Rabggta/ 
ENSMUSG00000040472 - 10 0.0798407 0.0798407 0.920159 0.021828 1 8.03333 360 360 0.03986 1 15.9 383 383 
102 3 94484402 94484491 
Celf3/ 
ENSMUSG00000028137 + 10 0.0799223 0.0799223 0.920078 0.436606 1 105.394 133 131 0.522864 1 134.788 122 120 
103 5 147356373 147356843 
Flt3/ 
ENSMUSG00000042817 - 10 0.0805198 0.0805198 0.91948 0.017094 0.434783 0.336957 25 23 0.101666 0.836957 1.92391 17 17 
104 17 78655659 78655748 
Strn/ 
ENSMUSG00000024077 - 10 0.0807355 0.919265 0.0807355 0.022512 1 2.30303 100 100 0 0 0 134 134 
105 8 117453220 117453822 
Cmip/ 
ENSMUSG00000034390 + 10 0.0830894 0.916911 0.0830894 0.012996 0.858108 1.86975 142 142 0.001288 0.239865 0 186 186 
106 19 47127109 47127250 
Pdcd11/ 
ENSMUSG00000025047 + 10 0.0833279 0.916672 0.0833279 0.041629 1 6.03774 139 139 0.013423 1 2 147 147 
107 4 156016273 156016361 
Tnfrsf4/ 
ENSMUSG00000029075 + 10 0.0843714 0.0843714 0.915629 0.000801 0.025641 0 32 32 0.084577 1 2.125 23 21 
108 19 3898638 3898717 
Tcirg1/ 
ENSMUSG00000001750 - 10 0.0849191 0.0849191 0.915081 0.008566 0.449275 0.37931 52 52 0.04918 1 3 58 58 
109 14 54638191 54638326 
Cdh24/ 
ENSMUSG00000059674 - 10 0.0860852 0.0860852 0.913915 0.041812 0.48 0.45098 11 11 0.204368 0.984 2.56863 10 10 
110 19 45050725 45050875 
Sfxn3/ 
ENSMUSG00000025212 + 10 0.0868991 0.913101 0.0868991 0.061114 1 10.0893 155 155 0.030064 1 5.98214 193 193 
111 10 127185172 127185286 
Arhgef25/ 
ENSMUSG00000019467 - 10 0.0876231 0.0876231 0.912377 0.217311 1 33.5952 121 121 0.297581 1 51.2619 121 121 
112 2 25288552 25288764 
Tmem210/ 
ENSMUSG00000026963 + 10 0.0886251 0.0886251 0.911375 0.029981 1 58.4146 1732 1732 0.0376 1 70.5976 1673 1673 
113 4 12054832 12055030 
Tmem67/ 
ENSMUSG00000049488 - 10 0.0890738 0.910926 0.0890738 0.010997 1 3.94737 355 351 0.002538 0.81383 1 393 388 
114 8 105330009 105330094 
Fhod1/ 
ENSMUSG00000014778 - 10 0.089207 0.910793 0.089207 0.098144 1 18.9355 161 161 0.059941 1 13.6452 196 196 
115 5 124114645 124114714 
Ogfod2/ 
ENSMUSG00000023707 + 10 0.0903724 0.0903724 0.909628 0.038603 1 20.96 522 518 0.056573 1 34.24 571 562 
116 5 137642013 137642095 
Sap25/ 
ENSMUSG00000079165 + 10 0.0907339 0.909266 0.0907339 0.259477 1 29.4333 84 84 0.174392 1 20.0667 95 95 
117 8 83316461 83316800 
Elmod2/ 
ENSMUSG00000035151 - 10 0.092368 0.092368 0.907632 0.027322 0.917933 1.48872 53 53 0.079169 1 3.95489 46 46 
118 10 79866585 79866667 
Plppr3/ 
ENSMUSG00000035835 - 10 0.0926591 0.0926591 0.907341 0 0 0 13 13 0.185804 1 2.96667 13 12 
119 7 126373836 126373921 
Spns1/ 
ENSMUSG00000030741 - 10 0.0934002 0.9066 0.0934002 0.28497 1 24.7097 62 59 0.185938 1 14.1613 62 59 
120 7 4551135 4552627 
Ptprh/ 
ENSMUSG00000035429 - 140 0.0945848 0.0945848 0.905415 0.140981 0.987426 6.89299 42 38 0.29037 1 7.36531 18 17 
121 11 120284555 120284719 
Bahcc1/ 
ENSMUSG00000039741 + 10 0.0948123 0.905188 0.0948123 0.12 1 3 21 21 0.016064 0.571429 0.677419 35 35 
122 7 27212383 27212959 
Itpkc/ 
ENSMUSG00000003752 - 10 0.0957519 0.904248 0.0957519 0.038009 0.980565 4.70175 118 118 0.015485 0.90636 2.2807 145 145 
220 
 
123 11 78190390 78190477 
Rab34/ 
ENSMUSG00000002059 + 10 0.0959955 0.904005 0.0959955 0.040755 1 6.96774 164 164 0.01517 1 2.74194 178 178 
124 1 88256549 88256650 
Mroh2a/ 
ENSMUSG00000079429 + 10 0.0964254 0.903575 0.0964254 0.047971 1 52.7568 1014 1013 0.036458 1 40.6757 1047 1046 
125 3 89217941 89218027 
Thbs3/ 
ENSMUSG00000028047 + 10 0.0964467 0.903553 0.0964467 0.275951 1 36.9688 97 97 0.204741 1 33.4688 130 130 
126 2 25278505 25279171 
Anapc2/ 
ENSMUSG00000026965 + 189 0.0969528 0.0969528 0.903047 0.006907 0.995807 3.34555 479 479 0.014723 1 7.78534 515 515 
127 17 49479965 49480429 
Daam2/ 
ENSMUSG00000040260 - 10 0.0973731 0.902627 0.0973731 0.052672 1 9.78571 176 152 0.028375 1 6.95055 238 223 
128 9 108978162 108978349 
Col7a1/ 
ENSMUSG00000025650 + 10 0.0978127 0.0978127 0.902187 0.03223 0.632768 0.84507 19 19 0.218635 1 4.19718 14 14 
129 19 6954299 6954380 
Plcb3/ 
ENSMUSG00000024960 - 10 0.0979069 0.0979069 0.902093 0.018313 1 2.27586 122 122 0.047132 1 6.03448 122 122 
130 13 21319079 21319480 
Gpx6/ 
ENSMUSG00000004341/ 
known-exon + 10 0.0989707 0.0989707 0.901029 0.293095 1 332.522 802 795 0.324192 1 331 690 686 
131 4 43495621 43495696 
Ccdc107/ 
ENSMUSG00000028461/ 
known-exon + 10 0.0994974 0.0994974 0.900503 0.085963 1 26.3333 279 279 0.118811 1 39.3704 291 290 
 
  
221 
 
Supplementary Table S2: The IR ratio of individual mouse.  
Intron retention (IR) ratio 
 
WT KO 
Intron-GeneName/GeneID 1 2 3 1 2 3 
Pkd1/ENSMUSG00000032
855 
0.17732 0.154874 0.136886 0.0789474 0.0501157 0.0526316 
D15Ertd621e/ENSMUSG00
000037119 
0 0 0 0.0113636 0.0510204 0.0215545 
Larp1/ENSMUSG00000037
331 
0.0220175 0.0262009 0.0279472 0.0307566 0.0541576 0.0441512 
Sptan1/ENSMUSG0000005
7738 
0.0104325 0.0120385 0.0129808 0.00450817 0.00592527 0.00231653 
Dgkq/ENSMUSG00000004
815 
0.125 0.25 0.285714 0 0 0 
Stxbp2/ENSMUSG0000000
4626 
0.0170564 0.0231776 0.00979672 0.0508001 0.0313725 0.0236194 
Nadk/ENSMUSG00000029
063 
0.0202703 0.049157 0.0310657 0.0652504 0.0830409 0.0634146 
1700067K01Rik/ENSMUS
G00000046408 
0.0169446 0.055566 0.0247854 0.012987 0.0107527 0 
Nckipsd/ENSMUSG000000
32598 
0.125 1 0.166667 0 0.0385604 0 
P4hb/ENSMUSG00000025
130 
0.013289 0.0120928 0.0151246 0.00650575 0.00310559 0.00347222 
1700018F24Rik/ENSMUSG
00000029620 
0.0459699 0.0672308 0.0569627 0.0756882 0.0780602 0.0673047 
Chp2/ENSMUSG00000030
865 
0.0178341 0.010101 0.00384481 0.058566 0.11593 0.0188983 
Cpsf1/ENSMUSG00000034
022 
0.0307461 0.0302302 0.0517349 0.0060241 0.0171649 0.0218341 
Prr19/ENSMUSG00000058
741 
0.0339031 0.0192893 0.0242816 0.0435914 0.0418167 0.0509045 
Myo1a/ENSMUSG0000002
5401 
0.0201842 0.036571 0.0507484 0 0.00990099 0.0171411 
Ppp6r2/ENSMUSG000000
36561 
0.0409836 0.0293542 0.0427689 0.00787402 0.02 0.015655 
Cep44/ENSMUSG0000003
8215 
0.0920193 0.115437 0.0919081 0.158045 0.156193 0.151261 
222 
 
Zfp598/ENSMUSG0000004
1130 
0.0923586 0.114346 0.102972 0.135899 0.172741 0.148544 
H2-
Ke6/ENSMUSG000000734
22 
0.0381139 0.0839695 0.1 0.120069 0.181818 0.128205 
Fam71e1/ENSMUSG00000
051113/known-exon 
0.0448524 0.0501135 0.0436462 0.0501286 0.061797 0.0611411 
Rabggta/ENSMUSG00000
040472 
0.0711253 0.0717982 0.0566997 0.115032 0.129682 0.110923 
P2rx2/ENSMUSG00000029
503 
0.0969439 0.108816 0.125413 0.058296 0.0666667 0.0758024 
Grina/ENSMUSG00000022
564 
0.0149297 0.0118431 0.0119326 0.00726054 0.0112781 0.00722429 
Dock6/ENSMUSG0000003
2198 
0.0427596 0.0416667 0.00374933 0 0.000837872 0 
Dennd6b/ENSMUSG00000
015377/known-exon 
0.133954 0.151293 0.143892 0.0913905 0.113424 0.11441 
Arrdc1/ENSMUSG0000002
6972/known-exon 
0.454545 0.374659 0.546218 0.15917 0.312102 0.268859 
Lrp10/ENSMUSG00000022
175 
0.0280833 0.0250696 0.0212353 0.037224 0.0550651 0.0705718 
Gnptg/ENSMUSG0000003
5521 
0.032967 0.074518 0.09342 0.095082 0.109198 0.18429 
Timm21/ENSMUSG000000
24645 
0.13149 0.117055 0.0932203 0.136791 0.189542 0.186813 
Jmjd8/ENSMUSG0000002
5736 
0.025 0.0474485 0.0212766 0 0.00811542 0 
Pnkp/ENSMUSG00000002
963 
0 0.0117647 0.0121951 0.0294118 0.047619 0.0317623 
Tgfb1/ENSMUSG00000002
603 
0.0301199 0.00857642 0.0153064 0 0.00605578 0 
Tomm40l/ENSMUSG00000
005674 
0.0342052 0.13253 0.105127 0.136986 0.191011 0.250975 
Znhit6/ENSMUSG0000007
4182 
0.00511811 0.0234279 0.00519584 0 0 0 
Hirip3/ENSMUSG00000042
606 
0.110133 0.103527 0.0983414 0.0927176 0.08168 0.058611 
Dnase1l1/ENSMUSG00000
019088 
0 0.00180505 0 0.134247 0.166667 0.185185 
223 
 
Ccdc183/ENSMUSG00000
026940/known-exon 
0.133525 0.145798 0.137327 0.148757 0.188476 0.163934 
Cnnm3/ENSMUSG000000
01138 
0.22451 0.389189 0.489458 0.203205 0.163615 0.1805 
Uba1y/ENSMUSG0000006
9053 
0 0 0 0.0408163 0.0188679 0.0140845 
Trp53bp2/ENSMUSG00000
026510 
0.026113 0.0769231 0.112867 0 0 0 
Clcn7/ENSMUSG00000036
636 
0.113194 0.153846 0.086217 0.0144181 0.0338369 0.0828295 
Tdp2/ENSMUSG00000035
958 
0.0159744 0 0.0153846 0.0231362 0.017094 0.0551524 
Matk/ENSMUSG00000004
933/known-exon 
0.2 0 0.194444 0.387324 0.608108 0.416107 
Gpsm3/ENSMUSG000000
34786 
0.126437 0.0322581 0.0739236 0.3 0.198946 0.380098 
Tdrkh/ENSMUSG00000041
912/known-exon 
0.515052 0.479487 0.430983 0.543049 0.602599 0.603426 
Ube2d2a/ENSMUSG00000
091896 
0.0137551 0.0166199 0.0102389 0.00847547 0.00985076 0.00821603 
Mast3/ENSMUSG0000003
1833 
0.0111438 0.0421176 0.0454545 0 0.00308642 0 
4930519G04Rik/ENSMUS
G00000029564 
0.158253 0.160534 0.156773 0.177395 0.181514 0.213752 
Cad/ENSMUSG000000136
29 
0.0165639 0.0473961 0.0113636 0 0 0.00506175 
Mocs1/ENSMUSG0000006
4120 
0 0 0 0.0798834 0.0666667 0.0311093 
Idh3g/ENSMUSG00000002
010 
0 0 0.00769231 0.0173445 0.00869565 0.0229885 
Lck/ENSMUSG000000004
09 
0 0 0 0.0833333 0.333333 0.0428571 
Idh3g/ENSMUSG00000002
010 
0.00454368 0.00053198 0.000786016 0.00599379 0.0232558 0.0188679 
Mrpl28/ENSMUSG0000002
4181 
0 0.00422089 0 0.0138675 0.0178752 0.00433683 
Arhgap21/ENSMUSG0000
0036591 
0 0 0.0526316 0.333333 0.0666667 0.125 
Rapgef3/ENSMUSG00000
022469 
0.1 0.0553231 0.0321761 0 0 0.0237028 
224 
 
Tstd3/ENSMUSG00000028
251 
0.0125 0.0217391 0.0063313 0.000160617 0 0 
Uhrf1/ENSMUSG00000001
228 
0.0631598 0.0523438 0.0464548 0.0338576 0.041069 0.0368486 
Pkd1/ENSMUSG00000032
855 
0.109039 0.185798 0.11556 0.0666667 0.0370121 0.0939597 
Fgfr3/ENSMUSG00000054
252 
0.1 0.0769231 0.111111 0 0 0.00504202 
Cdc42bpg/ENSMUSG0000
0024769 
0 0 0 0.027326 0.08 0.0134267 
Fanca/ENSMUSG0000003
2815 
0.0277778 0.010266 0.108659 0 0.00407391 0 
Nras/ENSMUSG00000027
852 
0.00849858 0.0156631 0.0147783 0.00527704 0.00543478 0.0058309 
Tmem131/ENSMUSG0000
0026116 
0.0195122 0.0094583 0.0153846 0.000243605 0 0.00325733 
Adad2/ENSMUSG0000002
4266 
0.101586 0.088451 0.0730838 0.0498584 0.0645679 0.0715222 
Dock6/ENSMUSG0000003
2198 
0.000683761 0.00667976 0 0.0357143 0.0294118 0.0384615 
Gramd4/ENSMUSG000000
35900 
0 0.0146628 0 0.5 0.0372493 0.166667 
Kdm5d/ENSMUSG0000005
6673 
0 0 0.0109091 0.305785 0.0285714 0.142857 
Rpusd4/ENSMUSG000000
32044 
0.0285714 0.027027 0.0301954 0.110375 0.0490857 0.103448 
Tle6/ENSMUSG000000347
58 
0 0.0211039 0 0.0259166 0.1 0.038565 
Ckb/ENSMUSG000000012
70 
0.0971787 0.121212 0.075 0.0427529 0.0263158 0.0304679 
Il17re/ENSMUSG00000043
088 
0.114754 0.0833333 0.217391 0.0423645 0.08 0.0759358 
Prickle4/ENSMUSG000000
96549 
0.159555 0.266533 0.0944528 0.0637733 0.0895522 0 
Ddx51/ENSMUSG0000002
9504 
0.0242424 0.0397862 0.0268456 0.0091257 0.0143369 0.0193078 
Dda1/ENSMUSG00000074
247 
0.0202575 0.0137378 0.011415 0.00824728 0.00956938 0.0109605 
Fads3/ENSMUSG0000002
4664 
0 0 0.0163488 0.0577096 0.0428212 0.141809 
225 
 
Matk/ENSMUSG00000004
933 
0.0174072 0 0.0360634 0.0769089 0.0381166 0.065534 
Esyt3/ENSMUSG00000037
681 
0.0593743 0.0585395 0.037037 0.080939 0.121082 0.113321 
Cd209g/ENSMUSG000000
79168 
0.0225806 0.226415 0.23125 0.705036 0.528736 0.349206 
Gpkow/ENSMUSG0000003
1148 
0.0083682 0 0.00521059 0.0243902 0.0212766 0.0175439 
AI481877/ENSMUSG00000
038598 
0.0210617 0.0311251 0.0362164 0 0.012966 0.00735294 
Nrn1l/ENSMUSG00000044
287 
0.2 0.25 0.2 0 0.0778923 0 
Nckipsd/ENSMUSG000000
32598 
0.235294 0.246377 0.43956 0.11194 0.151515 0.111111 
St5/ENSMUSG0000003102
4 
0.0437484 0.0397121 0.0393223 0.0208032 0.0371219 0.0201342 
Ppp2r5b/ENSMUSG00000
024777 
0.0415074 0.0454545 0.0688217 0 0 0 
Pkd1l3/ENSMUSG0000004
8827 
0 0 0.00711032 0.0161127 0.00781635 0.00809631 
Asah2/ENSMUSG0000002
4887 
0.022335 0.171084 0.163889 0 0.0110906 0 
Itgad/ENSMUSG00000070
369 
0.263158 0.2 0.185185 0.380054 0.34944 0.279926 
Mnt/ENSMUSG000000002
82 
0.054339 0.0914286 0.0221574 0 0 0.0197103 
Npm2/ENSMUSG0000004
7911 
0 0 0 0.00668896 0.0381862 0.0716878 
Ttc19/ENSMUSG00000042
298 
0 0.0149506 0.00770264 0.0151033 0.0607927 0.0579165 
Fam193b/ENSMUSG00000
021495 
0.21194 0.231043 0.227981 0.170868 0.158137 0.17414 
Lck/ENSMUSG000000004
09 
0.0465699 0.0442727 0.0374688 0 0.0285714 0.0110725 
Slc28a1/ENSMUSG000000
25726 
0 0 0 0.0309278 0.142857 0.208333 
Dph5/ENSMUSG00000033
554/known-exon 
0.00605473 0.047619 0.0199871 0 0 0 
Cdc42bpg/ENSMUSG0000
0024769 
0.0728477 0.133333 0.0104948 0 0 0 
226 
 
Glb1l2/ENSMUSG0000003
6395 
0.00996016 0.00422974 0.0106344 0.0211435 0.0155042 0.0286645 
Pwp2/ENSMUSG00000032
834 
0.232353 0.25 0.1 0.065277 0.0308742 0 
Prss36/ENSMUSG0000007
0371 
0.0381955 0.231508 0.071002 0.0324484 0.0327654 0.0249703 
Rsrc1/ENSMUSG00000034
544 
0.0418033 0.0392442 0.0470043 0.0508355 0.0572944 0.0723051 
Rabggta/ENSMUSG00000
040472 
0.0263405 0.0157729 0.0174854 0.0404387 0.0293454 0.05 
Celf3/ENSMUSG00000028
137 
0.418744 0.464239 0.424419 0.563095 0.511563 0.498054 
Flt3/ENSMUSG000000428
17 
0 0 0.0323625 0.071511 0.0935961 0.103896 
Strn/ENSMUSG000000240
77 
0.0285714 0.0156639 0.03125 0 0 0 
Cmip/ENSMUSG00000034
390 
0.0106194 0.00392597 0.0140835 0.00351162 0 0.00171264 
Pdcd11/ENSMUSG000000
25047 
0.0432493 0.0466699 0.0402414 0 0.000520201 0.039707 
Tnfrsf4/ENSMUSG0000002
9075 
0 0.00319489 0 0.0468432 0.0346535 0.164179 
Tcirg1/ENSMUSG0000000
1750 
0 0 0.0183758 0.0588235 0.0416667 0.05 
Cdh24/ENSMUSG0000005
9674 
0 0.0740741 0 0.34555 0.25 0.142857 
Sfxn3/ENSMUSG00000025
212 
0.0401097 0.0685598 0.0705394 0.0299698 0.0298507 0.0298507 
Arhgef25/ENSMUSG00000
019467 
0.201983 0.228864 0.232 0.335897 0.286372 0.28 
Tmem210/ENSMUSG0000
0026963 
0.0255347 0.032928 0.0312161 0.0351705 0.0420348 0.0372953 
Tmem67/ENSMUSG00000
049488 
0.00854701 0.0243551 0.00477241 0 0.0044335 0.00366898 
Fhod1/ENSMUSG0000001
4778 
0.0937355 0.113311 0.0891434 0.0748609 0.0446841 0.0707434 
Ogfod2/ENSMUSG000000
23707 
0.0461611 0.0443686 0.0281433 0.0491284 0.0657022 0.0566858 
Sap25/ENSMUSG0000007
9165 
0.324645 0.256198 0.222222 0.178571 0.160156 0.182331 
227 
 
Elmod2/ENSMUSG000000
35151 
0.0203474 0.0588235 0.00580201 0.0714286 0.0916031 0.0723627 
Plppr3/ENSMUSG0000003
5835 
0 0 0 0.0501319 0.2 0.333333 
Spns1/ENSMUSG0000003
0741 
0.23945 0.400455 0.212198 0.2 0.208885 0.133824 
Ptprh/ENSMUSG00000035
429 
0.170549 0.100347 0.177428 0.206829 0.290045 0.288153 
Bahcc1/ENSMUSG000000
39741 
0.0525727 0.246201 0.125 0 0.0366972 0 
Itpkc/ENSMUSG00000003
752 
0.0280843 0.0422683 0.027027 0.0114066 0.0204082 0.0087204 
Rab34/ENSMUSG0000000
2059 
0.055176 0.0535957 0.03125 0.0020903 0.0178571 0.022739 
Mroh2a/ENSMUSG000000
79429 
0.039667 0.0610807 0.0416727 0.0343487 0.0395847 0.0346739 
Thbs3/ENSMUSG0000002
8047 
0.25641 0.304348 0.251637 0.209581 0.208217 0.208989 
Anapc2/ENSMUSG000000
26965 
0.0074641 0.00292386 0.00975907 0.0108634 0.0201217 0.0108467 
Daam2/ENSMUSG000000
40260 
0.0415029 0.0475908 0.0674353 0.0223711 0.0321516 0.0305867 
Col7a1/ENSMUSG0000002
5650 
0.0634921 0.0622517 0 0.209354 0.204036 0.249471 
Plcb3/ENSMUSG00000024
960 
0.0208333 0.00918993 0.0285714 0.0588235 0.0339084 0.0662879 
Gpx6/ENSMUSG00000004
341/known-exon 
0.281335 0.293448 0.300869 0.331383 0.303319 0.348662 
Ccdc107/ENSMUSG00000
028461/known-exon 
0.0849282 0.102095 0.0686275 0.102407 0.123635 0.134031 
AVERAGE RATIO 0.068862605 0.088836566 0.076887997 0.083511173 0.08626762 0.084904982 
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In	   view	  of	   the	   controversy	   related	   to	   the	   generation	   of	   off-­‐target	  mutations	   by	   gene	  
editing	   approaches,	   we	   tested	   the	   specificity	   of	   TALENs	   by	   disrupting	   a	   multi-­‐copy	   gene	  
family	  using	  only	  one	  pair	  of	  TALENS.	  We	  show	  here	  that	  TALENS	  do	  display	  a	  high	  level	  of	  
specificity	  by	  simultaneously	  knocking	  out	  the	  function	  of	  the	  three	  genes	  that	  encode	  for	  
H2A.B.3.	  This	  represents	  the	  first	  described	  knockout	  of	  this	  histone	  variant.	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Despite	  being	  discovered	  over	  a	  decade	  ago	  1,	  the	  in	  vivo	  importance	  of	  the	  mammalian	  
histone	   H2A	   variant	   H2A.B	   remains	   unknown.	   H2A.B	   appeared	   late	   in	   evolution	   in	   mice	  
(H2A.B.3)	   and	   humans	   (H2A.B),	   and	   it	   is	   predominantly	   expressed	   in	   the	   testis	   with	   low	  
expression	   levels	   in	   the	   brain	   2,3.	   The	   availability	   of	   a	   H2A.B.3	   knockout	   would	   be	   an	  
invaluable	  tool	  for	  investigating	  the	  importance	  of	  H2A.B,	  however,	  as	  the	  H2A.B.3	  protein	  
is	  expressed	  from	  three	  different	  genes,	  this	  is	  a	  technically	  challenging	  feat.	  Our	  aim	  was	  to	  
devise	   the	  most	   efficient	   and	   specific	   strategy	   to	   inhibit	   the	   function	   of	   all	   three	   genes.	  
Here,	  we	  report	  a	  simplified	  TALEN	  approach	  that	  achieves	  this	  goal.	  	  
Previously,	   transcription	  activator-­‐like	  effector	  nucleases	   (TALENs)	  were	   the	   choice	   to	  
perform	   gene	   and	   genome	   editing	   4,5	   but	   more	   recently	   this	   technology	   has	   been	  
superseded	   by	   the	   CRISPR-­‐Cas9	   system	   6.	   However,	   while	   improvements	   are	   continually	  
being	  made	  7-­‐9,	  one	  issue	  has	  been	  the	  extent	  of	  off-­‐targets	  mutants	  generated	  with	  the	  use	  
of	   CRISPR-­‐Cas9,	   which	   appears	   to	   be	   greater	   when	   compared	   with	   TALENs	   10-­‐13.	   One	  
attractive	   feature	   of	   TALENs,	  which	   enables	   a	   higher	   level	   of	   specificity,	   is	   that	   the	   FOK1	  
nuclease	  domain	  will	  only	  cleave	  DNA	  when	  dimerized,	  which	  occurs	  when	  the	   two	  TALE-­‐
domains	  bind	  to	  DNA	  (on	  opposite	  strands)	  in	  close	  proximity	  to	  each	  other.	  Here,	  we	  used	  
TALENs	   to	   genetically	   impair	   the	   function	   of	   all	   three	   H2A.B.3	   encoding	   genes	   and	  
moreover,	  we	  used	  only	  one	  pair	  of	  TALENS	  to	  do	  this.	  To	  our	  knowledge,	  this	  has	  not	  been	  
done	  before.	  
There	  are	  three	  H2A.B.3-­‐encoding	  genes	  (H2Afb3,	  Gm14920,	  H2Afb2,	  which	  are	  >92%	  
identical)	  plus	  a	  pseudogene	  (Gm14904)	  all	  located	  on	  the	  X	  chromosome	  in	  the	  mouse	  (this	  
pseudogene	   was	   present	   in	   the	   Ensemble	   release	   57	   but	   subsequently	   removed)	  
(Supplementary	   Table	   1).	   We	   confirmed	   the	   expression	   of	   the	   three	   H2A.B.3-­‐encoding	  
genes	  in	  the	  testis	  and	  as	  expected,	  the	  pseudogene	  was	  not	  expressed	  (Supplementary	  Fig	  
1).	  In	  order	  to	  test	  the	  specificity	  of	  TALENs	  against	  the	  H2A.B.3	  gene	  family,	  two	  groups	  of	  
H2A.B.3-­‐targeting	   TALENs	  were	   designed.	   The	   first	   group	   of	   12	   TALENs	  were	   designed	   to	  
target	  only	  one	  gene,	  H2Afb3.	  The	  second	  group	  of	  7	  TALENs	  was	  design	  to	  target	  all	  three	  
H2A.B.3	  genes	  (Supplementary	  Table	  2).	  
The	  activity	  and	  specificity	  of	   the	  TALENs	  were	   tested	  by	  employing	  a	  Dual-­‐Luciferase	  
Single	  Strand	  Annealing	  Assay	  (DLSSA)	  and	  by	  the	  Cel1	  cleavage	  assay.	  The	  TALEN	  plasmids	  
were	  co-­‐transfected	  into	  Neuro2a	  cells	  in	  pairs	  in	  various	  combinations	  (Supplementary	  Fig.	  
2).	  The	  results	  for	  the	  first	  group	  showed	  that	  all	  TALEN	  pairs,	  in	  different	  combinations,	  had	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the	  highest	  activity	   for	   the	  H2Afb3	  gene,	  with	  some	  TALEN	  pairs	   indeed	  only	  cleaving	   the	  
H2Afb3	  gene	  (e.g.	  101408:101412).	  The	  second	  group	  of	  TALENs	  showed	  nuclease	  activity	  
for	  all	  genes,	  with	  2	  pairs	  (101421:101422	  and	  101421:101423)	  having	  the	  highest	  activity.	  
Cel1	   assays	   confirmed	   these	   findings	   (Supplementary	   Fig.	   3).	   These	   in	   vitro	   results	  
demonstrate	  the	  high	  specificity	  of	  TALENs;	  some	  of	  the	  targeted	  DNA	  sequences	  of	  the	  first	  
group,	  designed	  against	  the	  H2Afb3	  gene,	  differed	  by	  only	  2-­‐3	  base	  pairs	  compared	  to	  the	  
second	  group,	  and	  yet	   specificity	   for	  only	   the	  H2Afb3	  gene	  was	  achieved	   (Supplementary	  
Fig.	  4).	  The	  TALEN	  pair	  101421:101422	  was	  used	  to	  knock	  out	  (KO)	  the	  function	  of	  all	  three	  
H2A.B.3	  genes	  in	  mice	  (Supplementary	  Fig.	  4).	  
Prior	   to	   creating	   the	   H2A.B.33	   KO,	   we	   determined	   whether	   any	   off-­‐target	   genomic	  
locations,	  which	  have	  limited	  sequence	  homology	  to	  the	  TALEN	  pair	  101421:101422,	  can	  be	  
identified	   by	   using	   NCBI	   BLAST	   against	   the	  mouse	   reference	   genome	  mm10	   built	   on	   the	  
C57BL/6J	   strain.	   Even	   relaxing	   this	   BLAST	   search	   to	   only	   8	   bp	   out	   of	   the	   15	   bp	   DNA	  
recognition	  sequence	  returned	  no	  matches	  (data	  not	  shown).	  
In	  order	  to	  produce	  H2A.B.3	  KO	  mice,	  FVB/NJArc	  mice	  (derived	  in	  Jackson	  Laboratories	  
and	   sourced	   from	   Australian	   Animal	   Resource	   Centre	   (ARC),	   hence	   an	   extra	   suffix,	   JArc)	  
were	  used.	  Capped,	  poly-­‐adenylated	  and	  purified	  in	  vitro	  transcribed	  mRNA	  was	  adjusted	  to	  
10	   ng/µl	   for	   each	   TALEN	   pair	   (101421:101422)	   and	   injected	   into	   532	   fertilised	   one-­‐cell	  
embryos	   and	   cultured	   overnight	   to	   the	   2-­‐cell	   stage.	   153	   surviving	   2-­‐cell	   embryos	   that	  
displayed	  normal	  morphology	  were	  implanted	  in	  pseudo	  pregnant	  females,	  resulting	  in	  the	  
birth	  of	   19	  pups.	  Of	   these	  19	  pups,	   9	   contained	   TALEN-­‐induced	  H2A.B.3	  mutations.	  Most	  
interestingly,	   TALENs	   activity	   produced	   an	   all-­‐or-­‐nothing	   effect,	   i.e.,	   for	   each	   of	   the	   9	  
founder	  pups,	  all	  three	  H2A.B.3	  genes	  were	  mutated	  while	  for	  the	  10	  unmodified	  pups,	  no	  
gene	  copies	  of	  H2A.B.3	  were	  modified	  (Table	  1).	  Moreover,	   in	  female	  pups,	  both	  alleles	  of	  
H2Afb3,	  Gm14920	  and	  H2Afb2	  were	  modified,	  and	  each	  H2A.B.3	  gene	  contained	  a	  unique	  
indel	  as	  the	  result	  of	  TALEN	  activity	  (identified	  by	  Sanger	  sequencing).	  Therefore,	  one	  pair	  of	  
TALENS	  can	  edit	  6	  homologous	  alleles	  simultaneously.	  
Most	  of	  the	  mutants	  carried	  small	  deletions.	  Interestingly,	  in	  2	  founders,	  L90-­‐4	  and	  L90-­‐
8,	  at	   least	  one	  of	   the	  H2A.B.3	  genes	   (usually	  gm14920	  or	  H2Afb2)	  was	  not	  amplifiable	  by	  
PCR.	   However,	   when	   we	   used	   mixed	   primer	   pairs	   for	   PCR	   amplification	   (e.g.	   gm14920-­‐
forward	  and	  H2Afb2-­‐reverse)	  we	  were	  able	  to	  detect	  an	  amplification	  product	  and	  following	  
Sanger	   DNA	   sequencing,	   demonstrated	   that	   a	   fusion	   between	   gm14920	   and	   H2Afb2	   had	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occurred	  (data	  not	  shown).	  Also	  unexpectedly,	  when	  the	  founder	  L74-­‐5	  mouse,	  which	  only	  
displayed	  the	  deletions	  and	  insertions	  described	  in	  Table	  1,	  was	  bred	  with	  a	  wild-­‐type	  (wt)	  
female,	   the	   resulting	  G1	  progeny	  displayed	  a	   chimera	  between	   the	  gm14920	  and	  H2Afb2	  
genes	   (Supplementary	   Fig.	   5).	   Continued	   breeding	   from	   these	   chimeric	   G1	   H2A.B.3-­‐/x	  
females	  with	  wt	  males	  (up	  to	  4	  generations),	  revealed	  that	  these	  additional	  mutations	  were	  
lost	   after	   G2,	   but	   maintained	   original	   founder	   mutations	   (H2Afb3	   X∆+286,	   gm14290	   X∆15,	  
H2Afb2	   X∆17).	   This	   can	   be	   explained	   by	   the	   fact	   that	   TALEN	   activity	   can	   be	   retained	   for	  
several	  cell	  divisions	  following	  their	  injection	  into	  the	  2-­‐cell	  stage,	  thus	  producing	  a	  mosaic	  
genotype,	   as	   previously	   observed	   14,15.	   Collectively,	   the	   G1	   generation	   of	   the	   9	   founder	  
H2A.B.3	  genetically	  modified	  mice	  produced	  22/78	  mice	  displaying	  mosaicism,	  but	  by	  G3	  a	  
pure	  non-­‐mosaic	  mouse	  colony	  was	  derived.	  
The	   strategy	   for	   the	   identification	   of	   possible	   TALEN-­‐induced	   off-­‐target	  mutations	   in	  
H2A.B.3-­‐/y	   mice	   was	   based	   on	   the	   sequencing	   of	   exomes	   of	   three	   related	   non-­‐mosaic	  
H2A.B.3-­‐/y	   mice	   from	   three	   consecutive	   generations	   (G1-­‐G3).	   This	   strategy	   avoids	   the	  
problem	  observed	  in	  previous	  studies	  where	  unrelated	  mice	  were	  compared	  to	  assess	  off-­‐
target	  effects	  12.	  Each	  exome	  sample	  was	  sequenced	  using	  100bp	  paired-­‐end	  reads	  on	  the	  
Illumina	  HiSeq	  2000	  sequencer	  to	  a	  depth	  of	  350	  -­‐	  600x	  coverage,	  yielding	  between	  129x106	  
and	   228x106	   reads	   per	   sample	   (Supplementary	   Table	   3).	   The	   breeding	   began	  by	   crossing	  
♀L90-­‐3	  with	  ♂L74-­‐5	   to	   produce	   phenotype	  NM4-­‐G1	  H2Afb3	   (X∆5Y),	   gm14920	   (X∆10Y)	   and	  
H2Afb2	  (X∆64Y)	  mice.	  Subsequent	  crosses	  between	  genetically	  modified	  H2A.B.3	  female	  mice	  
and	  wt	  males	  produced	  NM4-­‐G2	  and	  G3	  H2Afb3	  (X∆5Y),	  gm14920	  (X∆10Y)	  and	  H2Afb2	  (X∆64Y)	  
mice	   for	   exon	   sequencing.	  By	   crossing	  mutant	   females	  with	  wt.	  males	   any	   true	  off-­‐target	  
mutations	  would	  be	  identified	  because	  they	  would	  be	  diluted	  by	  50%	  after	  each	  generation.	  
On	  the	  other	  hand,	  natural	  sequence	  variations	  due	  to	  mouse	  strain	  differences	  would	  not	  
be	   diluted	   by	   breeding	   (see	   below).	   Sequenced	  mouse	   exomes	  were	   run	   through	   our	   in-­‐
house	   variant	   detection	   pipeline	   (see	   Online	   Methods)	   to	   detect	   SNVs,	   small	   indels	   and	  
larger	  structural	  variants.	  Importantly,	  TALENS	  do	  not	  usually	  produce	  SNVs,	  thus	  this	  type	  
of	  variant	  serves	  as	  an	  internal	  measure	  for	  mouse	  strain	  differences.	  
As	   expected,	   alignment	   with	   the	   mm10	   genome	   identified	   a	   large	   number	   of	   SNVs	  
(~1.7x106	   for	   G1	   and	   G2,	   and	   ~0.69x10x6	   for	   G3)	   and	   indels	   (~1.7x105	   for	   G1	   and	   G2,	  
~0.6x105	  for	  G3)	  (Supplementary	  Table	  4),	  however	  neither	  followed	  a	  dilution	  pattern	  but	  
rather	   correlated	  with	   the	   original	   number	   of	   sequencing	   reads.	   To	   remove	   the	   effect	   of	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mouse	  strain	  differences,	  a	  filter	  for	  FVB/NJ	  was	  included	  into	  the	  alignment,	  which	  indeed	  
greatly	   reduced	   the	   number	   of	   SNVs	   and	   indels	   (Supplementary	   Table	   5).	   Again,	   the	  
remaining	   SNVs	   and	  putative	   indels	   did	   not	   follow	  a	   dilution	  pattern	   following	   successive	  
generations.	  
An	   additional	   analysis	   was	   conducted	   to	   separate	   heterozygous	   from	   homozygous	  
indels	  16.	  As	  shown	  (Supplementary	  Table	  6),	  after	  filtering	  against	  the	  FVB/NJ	  genome,	  417	  
NM4-­‐G1,	  420	  NM4-­‐G2	  and	  325	  NM4-­‐G3	  heterozygous	  (0/1+0/2+1/2)	  indels	  remained	  after	  
alignment	  with	   the	  mm10	  genome,	  but	  again	  did	  not	  display	  a	  50%	  dilution	  pattern	   from	  
G1-­‐G3.	  To	  provide	  further	  evidence	  that	  these	  remaining	  indels	  are	  due	  to	  strain	  differences	  
between	  FVB/NJArc	  and	  FVB/NJ	  mice,	  we	   interrogated	   the	  19	   indels	  common	  to	  all	   three	  
NM4	  G1-­‐G3	  mice	  (Supplementary	  Fig.	  6,	  the	  location	  of	  these	  putative	  indels	  are	  shown	  in	  
Supplementary	  Table	  7).	  
We	  amplified	  ~300-­‐450	  bp	  regions	  spanning	  all	  19	  indels	  and	  compared	  them	  to	  the	  wt	  
FVB/NJArc	   mice.	   The	   results	   for	   all	   19	   regions	   (Fig.	   1a)	   clearly	   show	   that	   the	   amplified	  
fragments	  were	  identical	  in	  size	  for	  the	  H2A.B.3-­‐/y	  and	  wt	  FVB/NJArc	  mice.	  Furthermore,	  we	  
sequenced	  5	  of	  these	  putative	  indels,	  which	  confirmed	  that	  the	  H2A.B.3-­‐/y	  and	  wt	  mice	  are	  
identical	  in	  the	  nucleotide	  sequence	  where	  the	  indels	  were	  predicted	  to	  be	  (Fig.	  1b	  and	  c).	  
Further,	  the	  computational	  prediction	  tools	  are	  often	  inaccurate,	  not	  only	  in	  predicting	  the	  
size	  of	  a	  putative	  deletion	  but	  also	  in	  falsely	  predicting	  that	  a	  deletion	  exists	  (Fig.	  1c	  and	  d).	  
Overall,	   our	   results	   suggest	   that	   the	   predicted	   indels	   in	   our	   H2A.B.3	   -­‐/y	   are	   due	   to	   DNA	  
sequence	  differences	  in	  our	  in-­‐house	  FVB/NJArc	  mouse	  strain,	  and	  computational	  errors	  in	  
predicting	   indels.	   Finally,	   to	   detect	   structural	   variants	   in	   NM4-­‐G1,	   NM4-­‐G2	   and	   NM4-­‐G3,	  
analyses	   using	   Pindel	   and	   Janda	   were	   performed.	   In	   addition	   to	   the	   three	   expected	  
deletions	   in	  H2A.B.3	  genes:	  H2Afb3	  (5	  bp),	  gm14920	  (10	  bp),	  a	   larger	  deletion	  of	  64	  bp	   in	  
H2Afb2	  was	  also	  detected	  (Supplementary	  Fig.	  7).	  	  
Despite	   the	   fact	   that	   H2A.B.3-­‐deficient	   mice	   produce	   neither	   wt	   H2A.B.3	   mRNA	   nor	  
protein	   (Supplementary	   Fig.	   8a	   and	   b),	   they	   can	   obviously	   reproduce.	   To	   investigate	  
whether	  the	  loss	  of	  H2A.B.3	  does	  affect	  fertility,	  we	  set	  up	  a	  breeding	  regime	  whereby	  age-­‐
matched	  male	  wt	  H2A.B.3	  and	  H2A.B.3-­‐/y	  were	  mated	  with	  3-­‐6	  month	  female	  mice	  and	  the	  
litter	  sizes	  were	  recorded	  (Supplementary	  Fig.	  8c).	  The	  results	  showed	  that	  H2A.B.3-­‐/y	  mice	  
were	   subfertile,	   producing	   significantly	   smaller	   litter	   sizes	   and	   thus	   demonstrating	   that	  
H2A.B.3	  is	  required	  for	  fertility.	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In	  conclusion,	  a	  major	  ongoing	  question	  is	  whether	  a	  RNA	  (e.g.	  CRISPR)-­‐	  or	  protein	  (e.g.	  
TALEN)-­‐based	  mechanism	  will	  ultimately	  prove	  to	  be	  more	  specific	  for	  genome	  editing	  and	  
this	  will	  be	  critical	  for	  future	  medical	  therapies.	   In	  this	  study,	  we	  have	  successfully	  applied	  
the	   TALEN	   technology,	   whereby	   we	   used	   one	   pair	   of	   TALENs	   to	   specifically	   and	  
simultaneously	  disrupt	  three	  gene	  copies	  of	  a	  gene	  family.	  Many	  human	  diseases	  are	  caused	  
by	  gene	  copy	  number	  variations	   17	  and	   therefore	   the	  use	  of	  a	   limited	  number	  of	  genome	  
editing	  enzymes	  might	  help	   in	   the	   future	  treatment	  of	  such	  diseases.	  The	  use	  of	  only	  one	  
pair	  of	  TALENs,	   rather	   than	  multiple	  pairs,	   reduces	   the	  complexity	  of	   the	  TALEN	  approach	  
(and	  hence	  the	  cost)	  and	  would	  reduce	  the	  likelihood	  of	  mosaicism	  and	  most	   importantly,	  
reduce	  the	  possibility	  of	  off-­‐target	  mutations.	  Indeed,	  our	  rigorous	  exome	  analyses	  did	  not	  
reveal	  any	  TALEN-­‐induced	  off-­‐target	  mutations.	  We	  also	  found	  that	  the	  computational	  tools	  
used	  to	  predict	  putative	  SNVs	  and	  indels	  have	  limitations,	  and	  therefore	  wet-­‐lab	  validation	  
is	  required	  before	  any	  conclusions	  can	  be	  made	  about	  off-­‐target	  mutations.	  
Finally,	   the	   TALEN	   approach	   did	   expose	   several	   interesting	   phenomena.	   Firstly,	   the	  
simultaneous	   knockout	   of	   highly	   homologous	   H2A.B.3	   genes	   leads	   to	   the	   formation	   of	  
chimeras	  between	  these	  genes.	  As	  every	  chimera	  contained	  a	  small	  deletion,	  it	  is	  likely	  that	  
terminal	  microhomology,	  a	  mechanism	  of	  NHEJ,	  was	  involved	  18.	  It	  is	  important	  to	  point	  out	  
that	   other	   technologies	   that	   rely	   on	   NHEJ	   for	   inducing	   mutations,	   like	   CRISPR/Cas9	  
technology,	   will	   also	   likely	   produce	   chimeras	   between	   highly	   homologous	   genes.	   Several	  
rounds	  of	  backcrossing	  can	  successfully	  eliminate	  such	  small-­‐scale	  genomic	  rearrangements.	  
Secondly,	  we	   observed	   an	   all-­‐or-­‐nothing	   effect	  whereby	   the	   TALENs	   either	  modified	   all	   3	  
H2A.B.3	  genes	  or	  modified	  none,	  which	  reduced	  the	  need	  for	  a	  more	  complex	  breeding	  and	  
screening	  strategy	  to	  establish	  a	  H2A.B.3	  KO	  colony.	  	  
	  
METHODS	  
Methods	  are	  available	  in	  the	  online	  version	  of	  the	  paper.	  
	  
Note:	  Any	  Supplementary	  Information	  is	  available	  on	  the	  online	  version	  of	  the	  paper.	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ONLINE	  METHODS	  
	  
TALEN	  Design.	  
The	  TALENs	  were	  assembled	  using	  the	  method	  previously	  described	  5,19.	  The	  TALEN	  target	  
sites	  were	  searched	  using	  a	  computer	  script	  developed	  in	  Sangamo.	  	  The	  four	  most	  common	  
repeat	  variable	  diresidue	  (RVD),	  NI,	  HD,	  NN	  and	  NG,	  were	  used	  to	  recognize	  bases	  A,	  C,	  G	  
and	  T,	  respectively.	   	  The	  NK	  RVD	  was	  sometimes	  used	  to	  specify	  the	  3'	  half	  repeat	  T	  base.	  
TALENs	   were	   generated	   by	   linking	   several	   pre-­‐made	   TALE	   repeat	   blocks	   in	   the	   forms	   of	  
monomer,	  dimer,	  trimer,	  or	  tetramer.	  	  The	  desired	  repeat	  blocks	  were	  PCR	  amplified	  using	  
position-­‐specific	   primers.	   	   The	   PCR	   products	  were	   pooled,	   digested	  with	   BsaI	   and	   ligated	  
into	   the	   TALEN	   expression	   vector,	   pVAXt-­‐3Flag-­‐NLS-­‐TALE-­‐Bsa3-­‐C63-­‐FokI,	   which	   had	   been	  
linearized	   with	   the	   BsaI	   restriction	   enzyme.	   Ligations	   were	   transformed	   into	   E.	   coli	  
competent	  cells,	  and	  single	  clones	  were	  picked	  and	  sequence	  verified.	  
	  
Dual-­‐Luciferase	  Single	  Stranded	  Annealing	  Assay.	  
The	   Dual-­‐Luciferase	   Single	   Stranded	   Annealing	   Assay	   (DLSSA)	   is	   based	   on	   the	   Dual-­‐
Luciferase	   Reporter	   Assay	   System	   from	   Promega	   (Madison,	  WI).	   In	   the	  DLSSA,	   the	   Firefly	  
luciferase	   reporter	   gene	   is	   split	   into	   two	   inactive	   fragments	   with	   overlapping	   repeated	  
sequences	  separated	  by	  stop	  codons	  and	  one	  of	  the	  three	  H2A.B.3	  genes.	  Introduction	  of	  a	  
double	  strand	  break	  in	  the	  H2A.B.3	  gene	  by	  the	  TALEN	  pair	  initiates	  recombination	  between	  
the	   flanking	   repeats	   by	   the	   single	   stranded	   annealing	   pathway	   and	   produces	   an	   active	  
luciferase	  gene.	  Neuro2a	  cells	  (ATCC	  #CCL-­‐131)	  were	  cultured	  in	  Dulbecco’s	  Modified	  Eagle	  
Medium	   (DMEM:	   Cellgro	   Cat#:	   10-­‐013-­‐CV)	   plus	   10%	   FBS	   and	   2mM	   L-­‐Glu	   (PSG	   optional	  
antibiotic).	   	  One	  day	  before	  transfection,	  20,000	  cells	  per	  well	  were	  seeded	   into	  a	  96-­‐well	  
plate.	   	   Cells	   were	   transiently	   transfected	   using	   Lipofectamine	   2000	   (Thermo	   Fisher	  
Scientific)	  with	  four	  plasmids	  including	  a	  pair	  of	  TALENs,	  the	  SSA	  Firefly	  luciferase	  reporter,	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and	  the	  internal	  control	  Renilla	  Luciferase	  reporter	  (6.25	  ng	  DNA	  for	  each	  component).	  The	  
luciferase	   assay	   was	   performed	   24	   hours	   post-­‐transfection	   according	   to	   manufacturer's	  
instructions.	   TALEN	   activity	   was	   measured	   as	   the	   ratio	   of	   the	   Firefly	   and	   the	   Renilla	  
luminescence	  units.	  
	  
Surveyor	  Nuclease	  Assay.	  
The	  assay	  has	  been	  described	   in	  detail	  previously	  5.	  Briefly,	  mouse	  Neuro2A	  cells	   (2	  x	  105)	  
were	   seeded	   into	   a	   96-­‐well	   plate	   the	   day	   before	   transfection.	   	   The	   cells	   were	   then	  
transfected	  with	  a	  pair	  of	  TALEN	  DNAs	  (400ng	  of	  each)	  using	  Lipofectamine	  2000	  (Thermo	  
Fisher	  Scientific).	  	  The	  genomic	  DNA	  was	  purified	  48	  hours	  post-­‐transfection.	  Gene	  specific	  
primer	  pairs	  were	  used	  to	  amplify	  each	  of	  the	  H2A	  gene	  variants.	  The	  primer	  sequences	  are:	  
H2Aafb3	   forward	   (5’-­‐CAGCAGAAAGCAGCCAAGTGG)	   and	   reverse	   (5’-­‐
GCAGGTCAGCCAAGAAGCA);	   Gm14920	   forward	   (5’	   GTACGGTACAAAGGGAG	   ATG)	   and	  
reverse	  (5’-­‐GAGCAGGTCAGCCAAGCAGAG);	  H2afb2	  forward	  (5’-­‐CAGGTCAGCAGAGAGCAATT)	  
and	   reverse	   (5’-­‐CTCCATACTGCTGTAGACCT);	   and	   pseudo	   Lap	   forward	   (5’-­‐
GTCAGCAGAATGCAGCCAAATAT)	   and	   reverse	   (5’-­‐CAAGCCAGTAGCCAACATCAAG).	   The	   PCR	  
products	  were	  treated	  with	  Surveyor	  Nuclease	  (Cel-­‐1)	  and	  resolved	  on	  PAGE.	  The	  nuclease	  
activity	   of	   TALENs	   was	   measured	   by	   quantifying	   the	   proportion	   of	   the	   cleaved	   DNA	  
fragments.	  
	  
Talen	  mRNA	  synthesis.	  
Plasmids	  (in	  Sangamo	  backbone)	  were	  linearized	  with	  XbaI	  and	  the	  products	  were	  purified	  
(PCR	  Cleanup	  kit,	  Qiagen).	  Using	   linearized	  plasmid	  as	  template,	  capped	  and	  poly(A)-­‐tailed	  
mRNA	   transcripts	  were	   produced	  using	  mMESSAGE	  mMACHINE	   T7	  Ultra	   Transcription	   Kit	  
(Life	   Technologies)	   following	   manufacturer’s	   instructions.	   mRNA	   was	   purified	   using	   a	  
MEGAclear	   kit	   (Life	   Technologies)	   and	   was	   eluted	   in	   RNase-­‐free	   water	   and	   single-­‐use	  
aliquots	  were	  frozen.	  
	  
Production	  of	  Talen-­‐mediated	  genetically	  modified	  mice.	  
All	   mouse	   work	   was	   conducted	   according	   to	   protocols	   approved	   and	   authorised	   by	   the	  
University	  of	  Queensland	  Animal	  and	   the	  Australian	  National	  University	  Ethics	  Committee	  
(Protocol	  A2014/33).	  Prior	  to	  injection,	  mRNA	  was	  diluted	  to	  10	  ng/µl	  in	  filtered	  RNase-­‐free	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microinjection	  buffer	  (10	  mM	  Tris-­‐HCl,	  pH	  7.4,	  0.25	  mM	  EDTA).	  TALEN	  mRNA	  was	  delivered	  
into	   the	   pronucleus	   of	   single-­‐cell	   embryos	   (FVB),	   using	   standard	   techniques.	   Injected	  
embryos	   were	   cultured	   overnight	   to	   the	   two-­‐cell	   stage,	   then	   surgically	   transferred	   into	  
oviducts	  pseudopregnant	  CD1	  mice,	  using	  standard	  techniques.	  
	  
Analysis	  of	  potential	  founders	  and	  genotyping	  of	  successive	  generations.	  
Transgenic	  founders	  with	  mutated	  H2A.B.3	  genes	  were	  identified	  among	  live	  born	  mice	  by	  
PCR	  (Supplementary	  Table	  8)	  genotyping	  of	  ear	  notch	  tissue.	  Genomic	  DNA	  was	  extracted	  
from	   ear	   punches	   using	   Quick	   Extract	   Solution	   (Epicentre)	   following	   manufacturer’s	  
instructions.	  The	  H2afb3,	  gm14920	  and	  H2afb2	  genes	  were	  amplified	  in	  25µl	  volume	  using	  
the	   same	   gene-­‐specific	   primers	   as	   for	   the	   Cel1	   assay.	   PCR	   mix	   (1x	   Platinum	   Taq	   buffer,	  
1.5mM	  Mg2Cl;	  0.2mM	  dNTP;	  0.2µM	  of	  forward	  and	  reverse	  primer;	  2	  units	  of	  Platinum	  Taq	  
polymerase	   (Thermo	   Fisher))	   was	   amplified	   using	   28	   cycles	   of:	   95°C	   30s	   denaturation,	  
followed	  by	  56-­‐65°C,	  30s	  annealing	  and	  72°C,	  4min	  extension.	  
	  
Exome	  Sequencing	  and	  bioinformatic	  analyses.	  	  
The	  male	  mice	  that	  were	  chosen	  for	  exome	  sequencing	  were	  genotyped	  prior	  to	  sequencing	  
to	   confirm	   that	   all	   three	   generations	   had	   the	   same	   H2A.B.3	   genotype	   (H2Afb3	   (X∆5Y),	  
gm14920	   (X∆10Y)	   and	   H2Afb2	   (X∆64Y)).	   The	   purified	   gDNA	   was	   subjected	   to	   exome	  
enrichment	  using	   the	  Agilent	  SureSelectXT2	  All	  Exon	  Kit.	  The	  exome	  capture	  efficiency	  was	  
uniformly	  high	  with	  approximately	  45-­‐50	  %	  of	  all	  DNA	  sequenced	  being	  exonic.	  Sequenced	  
mouse	   exomes	   were	   analyzed	   using	   our	   in-­‐house	   variant	   detection	   pipeline	   described	   in	  
detail	  previously	  20,21.	  	  In	  short,	  reads	  were	  aligned	  to	  the	  mouse	  reference	  genome	  mm10	  
using	  BWA	  22	  and	  sorted	  BAM	  alignment	  files	  were	  generated	  using	  SAMTools	  23.	  Candidate	  
PCR	   duplicate	   reads	   were	   annotated	   using	   Picard	   software	  
(http://broadinstitute.github.io/picard/),	   specifically	   the	   MarkDuplicate	   command.	   SNVs	  
and	  small	  indels	  were	  called	  using	  SAMTools	  Mpileup	  24	  and	  variants	  were	  annotated	  using	  
the	  Variant	  Effect	  Predictor	  25.	  	  To	  detect	  larger	  structural	  variants,	  both	  Pindel	  26	  and	  Janda	  
(unpublished;	  https://sourceforge.net/projects/janda/)	  were	  utilised.	  To	  reduce	  the	  number	  
of	  total	  variants	  called,	  variants	  specific	  to	  the	  FVBN	  mouse	  strain	  were	  downloaded	  from	  
the	   Sanger	   Institute	   ftp	   site	   (ftp://ftp-­‐mouse.sanger.ac.uk/REL-­‐1206-­‐FVBNJ/).	   	   As	   these	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variants	  were	  originally	  reported	  relative	  to	  reference	  genome	  mm9,	  the	  UCSC	  liftOver	  tool	  
(https://genome.ucsc.edu/cgi-­‐bin/hgLiftOver)	  was	  used	  to	  map	  the	  FVBN	  variants	  to	  mm10.	  
These	   FVBN	   specific	   variants	   were	   annotated	   and	   not	   considered	   for	   further	   off-­‐target	  
analysis.	  
For	  the	  detection	  of	  INDELs	  in	  the	  TALEN	  mouse	  exome	  sequencing	  data,	  we	  followed	  the	  
GATK	   recommendations	   “Best	   Practices	   for	   Germline	   SNP	   &	   Indel	   Discovery	   in	   Whole	  
Genome	  and	  Exome	  Sequence”	  16.	  Briefly,	  the	  alignment	  files	  in	  BAM	  format	  were	  realigned	  
and	   base	   re-­‐calibration	   was	   performed.	   The	   cleaned	   alignments	   of	   all	   sequenced	  mouse	  
exomes	  were	  then	  used	  as	  input	  for	  the	  “HaplotypeCaller”	  program	  resulting	  in	  raw	  variants	  
in	  VCF	  format,	  containing	  both	  SNVs	  and	   INDELs.	  We	  then	  performed	  hard	  filtering	  of	   the	  
called	  variants	  to	  only	   include	  INDELS	  and	  applied	  a	  quality	  cut-­‐off	  score	  of	  100	  to	  include	  
only	   high-­‐confidence	   INDEL	   calls.	   In	   order	   to	   identify	   potential	   TALEN	   off-­‐targets,	   we	  
inspected	  the	  frequency	  of	  INDELs	  in	  each	  generation	  of	  TALEN	  mice,	  expecting	  a	  “dilution”	  
effect	  due	  to	  back-­‐crosses.	  
In	  order	  to	  search	  the	  mm10	  reference	  genome	  for	  potential	  off-­‐target	  sites,	  we	  used	  the	  in	  
silico	  PCR	  function	  of	   the	  UCSC	  Genome	  Browser	  at	  http://genome.ucsc.edu/cgi-­‐bin/hgPcr	  
27.	  We	  used	   the	  TALEN	  target	  sequences	  as	   forward	  and	  reverse	  primers,	  and	  relaxed	   the	  
minimum	   perfect	   match	   parameter	   to	   8	   nucleotides	   (nt)	   and	   constrained	   the	   maximum	  
product	  size	  to	  100bp.	  
	  
Experimentally	  validation	  of	  putative	  indels.	  	  
To	  interrogate	  whether	  the	  19	  putative	  indels	  are	  present	  in	  NM4	  G1-­‐G3	  mice,	  the	  gDNA	  of	  
wild	   type	  FVB/NJArc	   in-­‐house	  mice	  and	  NM4	  G1-­‐G3	  KO	  mice	  were	  amplified	  with	  primers	  
surrounding	  the	  predicted	   indels,	   listed	   in	  Supplementary	  Table	  9.	  The	  PCR	  products	  were	  
analyzed	  by	  electrophoresis	  (7%	  acrylamide	  gel)	  and	  Sanger	  sequencing.	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FIGURES	  
	  
Figure	  1.	   Interrogation	  of	  predicted	  off-­‐target	  heterozygous	  deletions	   in	  H2A.B.3.3-­‐/y	  mice.	  
(a)	   300-­‐400bp	   regions	   surrounding	   19	   common	   predicted	   heterozygous	   deletions	   were	  
amplified	  from	  gDNA	  of	  H2A.B.3.3-­‐/y	  KO	  and	  FVB/NJArc	  in-­‐house	  wt	  mice.	  PCR	  product	  sizes	  
for	  wt	  and	  H2A.B.3.3-­‐/y	  were	  compared	  by	   resolving	   the	  products	  on	  a	  7%	  polyacrylamide	  
gel,	   side	   by	   side.	   The	   predicted	   deletion	   is	   indicated	  with	  △,	   followed	   by	   the	   number	   of	  
nucleotides	   (nt)	   predicted	   to	   be	   deleted.	   (b)	   Positive	   controls	   showing	   that	   a	   deletion	   as	  
small	   as	  5-­‐10	  nt	   can	  be	   resolved	  on	  7%	  polyacrylamide	  gel.	   Lane	  1,	  a	  heterozygous	  △5nt,	  
not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (which was. http://dx.doi.org/10.1101/233379doi: bioRxiv preprint first posted online Dec. 13, 2017; 
	   15	  
lanes	   2,	   3,	   4	   wt.;	   lane	   5,	   homozygous	   △10nt.	   	   (c)	   5	   out	   of	   the	   19	   PCR	   products	   were	  
sequenced	   by	   Sanger	   sequencing	   to	   show	   that	   FVB/NJArc	   and	   H2A.B.3.3-­‐/y	   mice	   have	  
identical	   sequences	   but	   they	   are	   different	   from	   the	   mm10	   reference	   genome.	   (d)	   Table	  
showing	  that	  the	  prediction	  tools	  are	  often	  inaccurate	  at	  predicting	  the	  presence	  or	  the	  size	  
of	  a	  putative	  deletion.	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#1(△4) 
wt   KO 
#4(△5) 
wt   KO 
#5(△5) 
wt   KO 
#3(△38) 
wt   KO 
#2(△12) 
wt   KO 
#6(△21) 
wt   KO 
#8(△6) 
wt   KO 
#12(△27) 
wt   KO 
#11(△5) 
wt   KO 
#13(△5) 
wt   KO 
#15(△34) 
wt   KO 
#14(△88) 
wt   KO 
      #7(△14).     
wt      G1-KO   G3-KO 
#17(△6) 
wt   KO 
#18(△5) 
wt   KO 
#19(△16) 
wt   KO 
#16△31) 
wt   KO 
      #9(△4).     
wt     G1-KO   G3-KO 
      #10(△4).     
wt     G1-KO   G3-KO 
a 
c 
Deletion #1!
mm10 CTGAAGGCCCAGTGGAAGCCCTGGACTAATGGGACTTGTCAACTGTTTTTGTCCTGCTT!
wt   CTGAAGGCCCAGTGGAGAC----------------TTGTCAACAGTTTTTGTCCTGCTT!
KO   CTGAAGGCCCAGTGGAGAC----------------TTGTCAACAGTTTTTGTCCTGCTT!
     ***************** *                ******** *************** !
!Deletion #3!
mm10 AGTCCCCGCCTGAGCTGTGGAAGTCCTCGCCTGAGCTGTGGAAGTCCCCGCCTGAGCTGTG!
wt   AGTCCCCGCC------------------------------------------TGAGCTGTG!
KO   AGTCCCCGCC------------------------------------------TGAGCTGGG!
     **********                                          ******* *!
!
Deletion #14!
CGCTCACCGGGGCATCCTGCTGTAGGTGGTGGTGCAACAGCTGGGAGTGGGGCTGCTG!
CGCTCACCGGGGCATCCTGCTGTAGGTGGTGGTGCAACAGCTGGGAGTGGGGCTGCTG!
CGCTCACCGGGGCATCCTGCTGTAGGTGGTGGTGCAACAGCTGGGAGTGGGGCTGCTG!
**********************************************************!
!Deletion #15!
TTTGGAGAGCTCTGAACTCTGGCCATTCAACACTTTGGAGAGCTCTGAACTCTGGCC!
TTTGGAGAG---------------------------------CTCTGAACTCTGGCC!
TTTGGAGAG---------------------------------CTCTGAACTCTGGCC!
*********                                 ***************!
!Deletion #16!
mm10 TGGCTTTGAGGTGTCTGCCTCCATGGGTGCTGGCTGCGAGGTGTCTGCCTCCATGGGTGCTGGCTGCGAGGTCTCTGCCTCCATG!
wt   TGGCTATGAGGTG------------------------------------------------------------TCTGCCTCCATG!
KO   TGGCTTTGAGGTG------------------------------------------------------------TCTGCCTCCATG!
     ***** *******                                                            ************!
!
Dele$on #1 #3 #14 #15 #16 
Predicted △4 △38 △88 △34 △31 
Observed	  in	  FVB/NJArc	  and	  H2A.B.3-­‐/y	  	  KO	   △16 △42 Nil △33 △60 
d 
b           Positive control                               
1       2       3       4       5 
300	  
400	  
300	  
400	  
150	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# Pup ID Genotype by Sanger sequencing H2Afb3 Gm14920 H2Afb2 
1 ♀ L74-1 XX (wt) XX (wt) XX (wt) 
2 ♀ L74-2 XX (wt) XX (wt) XX (wt) 
3 ♀ L74-3 XX (wt) XX (wt) XX (wt) 
4 ♂ L74-4 XY (wt) XY (wt) XY (wt) 
5 ♂ L74-5* X∆5 +286Y X∆15 Y X∆17 Y 
6 ♀ L79-1 X∆10 X∆10 X
∆12 X∆12 
Chimera of b/∆/c 
X∆15 X∆15 
Chimera of c/∆/b 
7 ♀ L89-1* X
∆22 X ∆160 
 
X∆5 X∆17 
Chimera c/∆/b) 
X∆5 X∆5 
 
8 ♂ L89-2 X∆65 Y XC/T, A/G Y X
∆42 Y 
Chimera b/∆/c) 
9 ♂ L89-3 X
∆26 Y 
Chimera c/∆/a) 
X∆10 Y 
Chimera b/∆/c) 
X∆10 Y 
Chimera b/∆/c) 
10 ♀ L90-1 XX (wt) XX (wt) XX (wt) 
11 ♀ L90-2 XX (wt) XX (wt) XX (wt) 
12 ♀ L90-3* X∆28 X∆5 X∆10 X∆10  X∆64 X∆64  
13 ♀ L90-4 X
∆15 X∆10 
 
No successful PCR 
amplification 
No successful PCR 
amplification. 
14 ♀ L90-5 XX (wt) XX (wt) XX (wt) 
15 ♀ L90-6 X
∆17 X∆17 
Chimera c/∆/a) 
X∆5X∆5 
Chimera b/∆/c) 
X∆5X∆5 
Chimera c/b/∆/c) 
16 ♀ L90-7 XX (wt) XX (wt) XX (wt) 
17 ♂ L90-8 X
∆16 Y 
 
X∆17 Y 
Chimera c/∆/c/b) 
No successful PCR 
amplification. 
18 ♂ L90-9 XY (wt) XY (wt) XY (wt) 
19 ♂ L90-10 XY (wt) XY (wt) XY (wt) 
 
Table 1. Genotype of all 19 pups born following TALEN injections. Wild type 
(Wt.) offspring. ∆n,deletion of n nucleotides; +n, insertion of n nucleotides. * 
denotes mice that were used as founders to establish H2A.B.3KO colonies. 	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Expression level of H2A.B.3 in the testis of FVB/NJArc mice  
Supplementary Figure 1: The relative expression of H2A.B.3 gene family 
members in the testis of FVB/NJArc mice. Gene expression was assessed 
relative to mHPRT using qPCR. 
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Supplementary Figure 2. TALEN pair specificity tested by the DLLS assay. 
TALEN pairs designed to target the H2Afb3 gene only (Group 1) or all three 
H2A.B.3 genes (Group 2). One day before transfection, 20,000 cells per well 
were seeded into a 96-well plate.  Cells were transiently transfected with four 
plasmids including a pair of TALENs, the SSA Firefly luciferase reporter, and the 
internal control Renilla Luciferase reporter. The luciferase assay was performed 
24 hr post-transfection. The pair 101421:101422 was used to create the H2A.B.3 
KO mouse. 
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Supplementary Figure 3. Cel 1 assays. Neuro2a cells were transiently transfected 
with various TALEN pairs and extracted genomic DNA was amplified by PCR with 
gene-specific primers and subjected to Cel1 digestion. TALEN activity is represented 
by the % cleaved  (% genomic mutation, GM) shown below each lane. Cleaved DNA 
products (arrow heads), uncut DNA (arrow). TALEN pair 101421:101422, highlighted 
in red, showed the highest activity for all three H2A.B.3 genes. 1,2,3 and P denotes 
H2Afb3, gm14920, H2Afb2 and pseudo H2A.B.3 genes, respectively. Two biological 
replicates are shown. Empty GFP-vector was used as a negative control.  
 
                                               101408 CGCCGCCACCGTCGCT !
! ! !           101407 CGCCGCCACCGTCG!
! ! ! ! !   101421 CCCGCACCTCCAGAG!
H2Afb3 !ATGCCAAGGAACAGGGAAAACTGTCTTCGAGAGTCTTCAGGTCGCCGCCACCGTCGCTCCCGCACCTCCAGAGCT!
gm14920 !---------------------------------------------------------------------------!
H2Afb2 !-------------C--------------A-AG-----------A------A-A--A-----------------G-!
Pseudo !----------G--CA------A-------T-G-G--------T--A------T-T------:------------C!
 !
      !  CGATTAGAAACGACAC 101410!
     !     TTAGAAACGACAC 101412!
H2Afb3 !GAGCTAATCTTTGCTGTGAGCCTGGTGGAACAGCATCTGAGGGAGGTTAGCCGTGCCCGGAGGCTCAGTGATACG!
gm14920 !-----G--------A------------------------------A-----------T---------------T-!
H2Afb2 !-----G--------A----------------------------------------------------------T-!
Pseudo !-----G------A-A------------------AG---------CC------A----T---------------T-!
!               CACTCGGACCACCTTG 101422!
! ! !             !
! ! ! ! ! !
H2Afb3 !GTGCCCATCTTCCTGGCAGCCATCCTGGAGTCCCTCACCCGCAGGTTGCTGGAGCTTGCCGGCAATGAGGCCCAA!
gm14920 !-----------------------------------------------------------G---------------!
H2Afb2 !------G---C-----T--------------T-------A-------------------G---------------!
Pseudo !-----A—T-----------------------T-------TA----C-------------G---------A----G!
 !
H2Afb3 !CGCAGAGGTACCGAGAGGCGCATCAACTCCTGAACTGCTGGACTTGGCTGTCTACAGCAATATGGAGCTAAGTGA!
gm14920 !---------------------------------------------------------------------------!
H2Afb2 !------------C------T-----------C---C-----------AG----------G---------------!
Pseudo !-AG---------C---T-A----------------------------AG-----T---------C---------- !
Supplementary Figure 4. TALEN-targeted DNA sequences. The alignment of H2A.B.3 genes and the pseudogene. 
TALENs  specific to H2afb3 are in blue and those common for all H2A.B3 genes are in red.  
  NM10   
7   6   5 L 
  NM10   
7   6   5 L 
 NM10 
7   6    L 
gm14920 Fw/Rev H2afb2 Fw/Rev gm14920 Fw H2afb2 Rev 
a	   b	  
c	  
Supplementary Figure 5. An example of chimeras formed between 
gm14920 and H2afb2 in some G1 mice produced by crossing founder L74-5 
with a wt. female. (a) genes gm14920 and H2afb2 are not amplified with 
gene-specific primers in pups #6 and #7, respectively but is amplified in a 
pup #5. (b) amplification with gm14920-Fw and H2afb2-Rev primers shows 
the chimeric product in pups  #6 and 7. (c) A schematic diagram showing that 
a chimera was formed between gm14920 and H2afb2 genes with a small 
deletion between these fused genes suggesting that NHEJ mechanisms 
were involved. Fw, forward primer; Rev, reverse primer; number; L, DNA 
ladder. 
gm14920 H2afb2 
G1	   G2	  
G3	  
19	  
306	  
419	  398	  
Supplementary Figure 6: Computational analysis predicted 19 putative 
heterozygous deletions shared between all 3 generations of H2A.B.3-/y KO mice. 
If TALENs introduced off-target mutations in G0 founder mice, then those 
mutations would be inherited by their progeny as heterozygous.   
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Supplementary Figure 7. Exome sequencing reveals all the three expected 
mutations in H2A.B.3 genes. The screen shots are the output from SVs call by 
Pindel for all H2A.B.3 genes. The orange border box indicates the deleted region 
detected for each gene by SAMtools.  
♀H2A.B.3 +/+ x ♂ H2A.B.3 +/+ ♀H2A.B.3 +/+ x ♂ H2A.B.3 -/Y 
c 
wt KO 
15 kDa 
10 kDa 
b 
a 
0	  
20	  
40	  
60	  
80	  
100	  
wt	   KO	  
Ex
pr
es
sio
n	  
re
la
7v
e	  
to
	  H
PR
T	  
H2afb3 
0	  
20	  
40	  
60	  
80	  
100	  
wt	   KO	  
gm14920 
0	  
20	  
40	  
60	  
80	  
100	  
wt	   KO	  
H2a=2	  
IP: anti-H2A.B.3 
WB: anti-H2A.B.3 
Supplementary figure 8. H2A.B.3-/Y KO males have impaired fertility. (a). 
The mRNA level of each H2A.B.3 gene was determined by real-time 
quantitative PCR, relative to HPRT. Primers were designed to anneal within 
the TALEN induced deletions. (b). Confirmation that H2A.B.3 protein is not 
produced in in H2A.B.3-/Y mice. H2A.B was immunoprecipitated from  total 
testis lysates followed by Western Blotting using anti-H2A.B.3 polyclonal 
antibodies. (c) The breeding was conducted using age matched wt females 
(3-6 months) and age matched wt  (n=5) and H2A.B.3-/Y (n=5) males. Total 
number of pups produced was 201 and 256 for wt and KO males, ***p 
value=≤0.001(ANOVA test). 
Gene names/length Strand Chromosome Start End % Identity 
H2afb3, 348bp 
ENSMUSG00000083616 - X 117426357 117426704 100 
Gm14920, 348bp 
ENSMUSG00000067441 + X 114128366 114128713 98.28 
H2afb2, 349bp 
EG624153 + X 113794787 113795134 92.55 
Gm14904(Pseudo), 
345bp 
ENSMUSG00000084053 
+ X 113311798 113312139 87.83 
 
Supplementary Table 1. The genomic coordinates of H2A.B.3 coding genes. The 
degree of homology between the genes is indicated as % Identity. 
 
 
 
 
 
 
 
 
Target genes Design # Targeted sequence 
 
 
 
 
H2Afb3 
(Group 1) 
101406 ttCAGGTCGCCGCCACCGTcg 
101407 gtCGCCGCCACCGTCGCTcc 
101408 gtCGCCGCCACCGTCGCTCcc 
101409 ctCACAGCAAAGATTAGCTca 
101410 ctCACAGCAAAGATTAGCtc 
101412 ctCACAGCAAAGATTag 
101413 ctGAGCTAATCTTTGCTgt 
101415 ctAATCTTTGCTGTga 
101416 ctAATCTTTGCTGTGAgc 
101417 ctAACCTCCCTCAGATGCTgt 
101418 ctAACCTCCCTCAGATgc 
101419 ctCCGGGCACGGCTAACCTcc 
 
H2Afb3, 
Gm14920, 
H2afb2 
(Group 2) 
101421 ctCCCGCACCTCCAGAGct 
101422 ctGTTCCACCAGGCTCACag 
101423 ctGCTGTTCCACCAGGCTca 
101424 ctGGTGGAACAGCATCTga 
101426 gtATCACTGAGCCTCCgg 
101427 gtTGCTGGAGCTTgc 
101429 gtACCTCTGCGTTcc 
 
Supplementary Table 2. List of TALENs designed to target H2A.B.3 genes. 
  
 Sample ID Total reads Read length (bp) Approximate coverage (x) 
NM4-G1-28 226,900,000 100 613 
NM4-G2-18 228,900,000 100 619 
NM4-G3-32 129,800,000 100 351 
 
Supplementary Table 3. The exome sequencing coverage. 3 consecutive 
generations of mice from the NM4 H2A.B.3 KO colony were sequenced using 
paired-end sequencing with a 100bp read length.  
 
 
 
 
Sample ID SNVs Small deletions Small insertions 
NM4-G1-28 1,745,670 82,379 90,762 
NM4-G2-18 1,768,957 81,956 90,005 
NM4-G3-32 693,686 33,823 38,321 
 
Supplementary Table 4. Putative SNVs and Indels identified in H2A.B.3 KO mice 
using the mm10 mouse genome as a reference. 
 
 
 
 
 
Sample ID SNVs Small deletions Small insertions 
NM4-G1-28 21,256 3,889 4,378 
NM4-G2-18 26,646 4,064 4,445 
NM4-G3-32 13,417 1,589 2,032 
 
Supplementary Table 5. Putative SNVs and Indels identified in H2A.B.3 KO mice 
after applying the FVB/NJ strain filter.  
  
Sample ID 
Genotype   
Homozygous Heterozygous  
Total 
0/0 1/1 2/2 0/1 0/2 1/2 No Call 
NM4-G1-28 131 732 2 388 2 27 111 1393 
NM4-G2-18 127 727 3 392 3 25 116 1393 
NM4-G3-32 219 527 8 306 4 15 314 1393 
 
Supplementary Table 6. Predicted putative homozygous and heterozygous 
polymorphic variants (off-target deletions) in three consecutive generations of 
H2A.B.3-/y mice. Exome data was referenced to mm10 genome, followed by filtering 
of FVB/N-specific variants and analysed for genome polymorphism using Pindel tool. 
Homozygous polymorphisms: no polymorphic alleles (0/0), both alleles differ from 
reference (1/1), and both alleles differ from reference and from 1/1 (2/2). 
Heterozygous polymorphisms: one allele differs from the reference genome (0/1), 
one allele defers from the reference genome and from 0/1 (0/2), both alleles differ 
from the reference genome and from each other (1/2). No call, not assigned to any 
type.  
  
 
#	   Chromosome	   Locus	  start	   Locus	  end	   Deletion	  size	  (bp)	   Gene	  ID	  
1	   1	   171573961	   171573965	   4	   ENSMUSG00000004709	  
2	   1	   173270636	   173270648	   12	   ENSMUSG00000049605	  
3	   1	   173760152	   173760189	   38	   ENSMUSG00000073489	  
4	   12	   115158545	   115158549	   5	   ENSMUSG00000093894	  
5	   12	   115335195	   115335199	   5	   ENSMUSG00000095197	  
6	   12	   115808522	   115808526	   21	   ENSMUSG00000091087	  
7	   12	   115833994	   115834007	   14	   ENSMUSG00000096020	  
8	   17	   23882468	   23882474	   7	   ENSMUSG00000096445	  
9	   17	   35266213	   35266218	   6	   ENSMUSG00000073411	  
10	   17	   36189406	   36189415	   10	   ENSMUSG00000054128	  
11	   17	   48145527	   48145531	   5	   ENSMUSG00000073386	  
12	   2	   119618224	   119618250	   27	   ENSMUSG00000072980	  
13	   3	   7604075	   7604079	   5	   ENSMUSG00000040329	  
14	   4	   41195246	   41195333	   88	   ENSMUSG00000028433	  
15	   4	   42871823	   42871856	   34	   ENSMUSG00000050141	  
16	   5	   113819659	   113819689	   31	   ENSMUSG00000048163	  
17	   7	   8245023	   8245027	   5	   ENSMUSG00000053720	  
18	   7	   47981089	   47981093	   5	   ENSMUSG00000067173	  
19	   X	   95940663	   95940678	   16	   ENSMUSG00000057421	  
 
Supplementary Table 7. 19 common putative heterozygous polymorphisms 
identified in all 3 generations of H2A.B.3-/y mice. 
  
 
Supplementary Table 8. PCR primers for genotyping of H2A.B.3 encoding genes in 
founders and the H2A.B3KO colonies. 
 
 
# Indel  Gene ID Sequence (5’-3’) 
Expected 
product 
length (bp) 
1 ENSMUSG00000004709 (∆4) F- AAGAAGACAGAACAGGGCTCAC 
R- TAGCTCACATTGTCATCCTTGG 
419 
2 ENSMUSG00000049605 (∆12) F- GACAGTGTACACATTGGTCATT 
R- TGGAGATGATGAGAATGTAAGA 
458 
3 ENSMUSG00000073489(∆38) F- TTAATGCCACATGATCAGTTAT 
R- CCTAGACCATCTATTTTGGTTT 
426 
4 ENSMUSG00000093894 (∆5) F-AAGTCTACAAGCAAACCTTCTC 
R-CATATACATGGGTGACAATGAC 
452 
5 ENSMUSG00000095197 (∆5) F-GCTGTATCTGAGCAAGTCTACA 
R-ATACACTTGGGTGACAATGAC 
464 
6 ENSMUSG00000091087 (∆21) F-TAGATGGACATTTACAAAGCTG 
R-TATCCTCACCTGTTCCAAAC 
412 
7 ENSMUSG00000096020 (∆14) F-TAGATGGACATTTACAAAGCTG 
R-GCTACACCTTCACAAGCTACTA 
402 
8 ENSMUSG00000096445 (∆6) F-GTTGTGATGTCTTCTGTGCTC 
R-GTACTCAGAACTGCCCACATA 
405 
9 ENSMUSG00000073411 (∆5) F-GGAAGGAGCAGAATTACACAT 
R-GTTCAAGGAAGATCTTGACACT 
468 
10 ENSMUSG00000054128 (∆10) F-GTGCACTCCTGTGTCTTTTT 
R-GCTGGACTACTACAACCTGAGT 
451 
11 ENSMUSG00000073386 (∆5) F-TTCTTGAGTCCTCTTCAACTCT 
R-CTCTCTGACAGGAAGCATTTAT 
413 
12 ENSMUSG00000072980 (∆27) F-ACTCGGGAAAACAAAACAAAC 
R-AAAGAAATATGGCGACTCTCT 
418 
13 ENSMUSG00000040329 (∆5) F-CAATGAAAGGGGTATAGTTCAT 
R-AATTGTGAGAAGTTTCATTGTG 
445 
14 ENSMUSG00000028433 (∆88) F-CAGGGTCTAGTTTGTCCAGTAT 
R-TTGCCATCTTTATCCTACAGAC 
401 
15 ENSMUSG00000050141 (∆34) F-AGGAGCTGACAGAGTCAATTT 
R-GACGACTCCTGTGCTCAGAT 
401 
16 ENSMUSG00000048163 (∆31) F-CAGACGTTGTAAACAGAGTTTT 
R-ACACAGTGGAGTCTAACCTCAG 
409 
17 ENSMUSG00000053720 (∆5) F-CAGACACTGAAGAACACTAGCA 
R-TCACATTTGGAATTGTATTCAC 
409 
18 ENSMUSG00000067173 (∆5) F-CAGGTAGAGGCTCTTCATCA 
R-ACCCGATGTTTTTGTTTATAGT 
418 
19 ENSMUSG00000057421 (∆16) F-TCTACATCATCACTTTCCTCAA 
R-GCGAGTCTGTTCCATTTATACT 
411 
Supplementary Table 9: List of primers to amplify 19 putative Indels from TALEN 
mutant mice. Symbols: ∆, deletion. 
H2A.B gene 
family 
Sequence  
(5’-3’) 
 
Size of amplicon 
H2A.Afb3 
 
Fwd: CAGCAGAAAGCAGCCAAGTGG 
Rev: GCAGGTCAGCCAAGAAGCA 440 bp 
Gm14920 Fwd: GTTGGGCATTGGACTTGGAC 
Rev: CAGCCAAGTCCAGCAGTTC 398 bp 
H2Afb2 Fwd- CAGGTCAGCAGAGAGCAATT 
Rev- CTCCATACTGCTGTAGACCT 374 bp 
